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Since the discovery of the green fluorescent protein (GFP) from the jellyfish Aequorea
victoria, a multitude of fluorescent proteins have been derived from the original GFP and
its homologs by protein engineering. Their characteristics were especially adapted to the
requirements of different types of live-cell fluorescence microscopy. This includes super-
resolution microscopy techniques, which overcome the diffraction barrier by distinguishing
fluorophores based on different molecular states. Fluorescent proteins in the subclass of
reversibly switchable fluorescent proteins (RSFPs) can be switched from a fluorescent to a
non-fluorescent state and vice versa by light of certain wavelengths. These RSFPs can be
utilized as fusion tags in reversible saturable optical fluorescence transition (RESOLFT)
microscopy to achieve diffraction-unlimited resolution. Compared to the green-emitting
RSFPs, the application of red-emitting RSFPs benefits from the longer excitation and
switching wavelengths utilized and the associated less phototoxicity. However, the number
of red RSFPs applicable for live-cell RESOLFT microscopy is limited until now and the
available red RSFPs exhibit undesirable characteristics like dimerization tendency.
This work presents the development of novel red RSFPs for RESOLFT microscopy. In order
to identify superior red RSFPs, a microscopic screening of mutant libraries expressed in
E. coli colonies was employed. To additionally facilitate the screening for improved
fluorescent proteins in a mammalian expression system, a monoclonal Bxb1 landing pad
cell line was generated using CRISPR/Cas9 genome engineering. Since the application of
these Bxb1 landing pad cells enables the expression of only a single mutant from a
transfected library in each cell, this strategy was suitable to screen for red RSFPs with higher
brightness and offers a large potential to establish further screening approaches.
By semi-rational design and screening, novel red RSFPs with opposing switching modes
were generated from bright conventional red fluorescent proteins. Three positive-switching
RSFPs were developed on the basis of mRuby2 and two negative-switching RSFPs were
derived from mScarlet. All of these five RSFPs are monomeric, feature low residual
fluorescence in the off-state (below 5 %), and are among the red RSFPs with the highest
molecular brightness known today. The characterization of their performance as fusion tag
in transient and stable expressions suggest that the novel red RSFPs are suitable for live-cell
microscopy. The quantum yields of the switchable mScarlet variants are the highest
determined for red RSFPs to date and the switching kinetics of the new negative-switching
RSFPs exceeded those of the recently published rsFusionRed2 and rsFusionRed3. In
addition, the generated RSFPs based on mRuby2 outperformed rsCherry in all analyzed
IV
switching characteristics and represent the only red fluorescent and positive-switching
candidates for live-cell RESOLFT microscopy. A resolution beyond the diffraction limit was
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The invention and development of light microscopy paved the way to non-invasive
investigations of structures and components in living organisms which are not visible to the
naked eye. In the 17th century, a light microscope allowed Robert Hook to discover and
identify cells [1], the basic elements of living organisms. Since these findings, light
microscopes were further improved and soon became an elementary tool in life sciences. In
the first types of light microscopes, the visualization of objects was limited to the intrinsic
contrast of the examined structures. The development of fluorescence microscopy in
combination with labeling with fluorophores enabled the targeted investigation of sub-
cellular compartments and processes. Further labeling strategies including genetically
encodable fluorescent proteins pushed the examination of biological processes even
further [2].
However, already in 1873, Ernst Abbe described that the obtainable resolution in
conventional light microscopes is restricted by the diffraction of light, meaning that objects
within this diffraction limit cannot be discerned [3]. The full width half maximum (FWHM)
of the lateral resolution in the focal plane is given by
Δr ≈ 2 sin




with λ describing the wavelength of the focused light, n the refractive index of the media
and α the half aperture angle of the objective lens. Hence, the resolution is dependent on
the employed wavelength and on the numerical aperture (n sin α) of the objective lens.
Using light of the visible spectrum and objectives with common numerical apertures, the
lateral resolution is restricted to about 200 nm and the axial resolution to about 450 nm [4].
Several strategies can improve the contrast and the resolution, like confocal laser scanning
microscopy [5] and structured illumination microscopy (SIM) [6]. However, these
microscopy techniques are still diffraction-limited and do not allow imaging at the
nanoscale. In the 1990s, the first concepts for diffraction-unlimited fluorescence
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microscopy emerged and several approaches which overcome the diffraction barrier were
reported by now (chapter 1.1.1).
1.1.1 Diffraction-unlimited microscopy techniques
The light microscopy strategies which break the diffraction limit, often referred to as super-
resolution microscopy or nanoscopy, utilize at least two different molecular states of the
markers applied, typically a fluorescent and a non-fluorescent state. Due to the different
states, fluorophores within the diffraction-limited distance become distinguishable. These
concepts allow only a small ensemble or even a single molecule to be detectable during the
fluorescence readout [4] and can be divided into three groups, the coordinate-stochastic
nanoscopy, the coordinate-targeted nanoscopy and nanoscopy with minimal photon fluxes
(MINFLUX) [7, 8].
Figure 1.1-1: Diffraction-unlimited microscopy methods.
Different concepts of super-resolution fluorescence imaging techniques. A: Coordinate-targeted nanoscopy
methods use a light pattern in combination with light-driven transitions to allow only a small fraction of the
fluorophores to be in a detectable state. A doughnut-shaped beam (red) is an example for an applied light
pattern. B: Coordinate-stochastic nanoscopy methods utilize stochastic transitions of single fluorophores within
the diffraction limit. The technique is implemented by a wide-field illumination and a camera-based readout.
The localization of the single fluorophores is calculated from the fluorescence intensity spot. C: The
combination of stochastic transitions from non-fluorescent to the fluorescent states with the coordinate targeted
readout is applied in MINFLUX imaging. A doughnut-shaped excitation beam (green) can be used for the
coordinate-targeted readout. Adapted from Sahl et al., 2017 [7], with permission from Springer Nature.
In the coordinate-stochastic methods, the transitions between the different states of the
molecules appear in a stochastic manner. Only a single fluorophore is wanted to emit in the
diffraction-limited distance within one frame of the camera-based readout by wide-field
illumination (Figure 1.1-1 B). The coordinates of the single fluorophores are calculated by
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a Gaussian fit of the detected diffraction-limited fluorescence spot. Examples for
coordinate-stochastic methods are stochastic optical reconstruction microcopy (STORM)
[9], photoactivated localization microcopy (PALM) [10] and ground state depletion
followed by individual molecule return (GSDIM) microcopy [11]. These differ in the
strategy used to implement stochastic transitions of single molecules to the fluorescent state.
The second category comprises the coordinate-targeted methods. Here, a light pattern is
applied to transfer molecules into a different state at defined positions by exploiting light-
driven transitions. The light pattern includes local intensity-zeros where the respective
transition does not occur (Figure 1.1-1 A). The coordinate-targeted methods can be
implemented by a doughnut-shaped beam or an array with local intensity-zeros
(parallelization), with the addition of a fluorescence readout. The resolution in these
methods can be approximated by
Δr ≈
2 sin 1 + /
with Imax being the maximal intensity surrounding the zero and IS being the saturation
intensity at which the amounts of molecules in both states are equal [4].
In the coordinate-targeted method stimulated emission depletion (STED) microscopy, the
molecules are transferred from the fluorescent (S1) to the non-fluorescent state (S0) by the
process of stimulated emission [12]. This concept was the first of the coordinate-targeted
methods to be implemented [13]. The light intensities applied for STED microscopy are
comparatively high and range from several tens to a hundred MWcm-2, because the
stimulated emission of the excited molecules in the periphery has to precede the de-
excitation by fluorescence emission which occurs in a few nanoseconds [14].
Other coordinate-targeted strategies are based on a different reversible transition to
separate the molecules. In ground state depletion (GSD) microscopy, the transition into
long-lived dark triplet states and the thermal relaxation are exploited [15]. In addition, the
light-driven switching of reversibly switchable fluorescent proteins (RSFPs) between a
fluorescent and a non-fluorescent state in both directions can be utilized and was first
proposed in 2003 [16]. Due to the long-lived fluorescent and non-fluorescent states, less
light intensities are needed for the transitions and range in kWcm-2 [14]. Furthermore,
fluorescent proteins can be genetically encoded. These two aspects render this coordinate-
targeted approach especially suitable for super-resolution microscopy of living cells.
Initially, the term reversible saturable optically linear fluorescence transitions (RESOLFT)
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included all coordinate-targeted strategies [14, 17]. To date, RESOLFT microscopy is
mainly associated with the strategy based on RSFPs and photoswitchable dyes.
In the concept of MINFLUX, the stochastic transtitions from a non-fluorescent to a
fluorescent state in combination with coordinate-targeted readout  is uitlized to determine
the fluorophore localization with high precision [7, 18].
The work presented here focusses on the design and characterization of GFP-like RSFPs
suitable for RESOLFT microscopy. Therefore, the class of GFP-like fluorescent proteins is
introduced first (chapter 1.2) and then the subclass of RSFPs (chapter 1.3) and their
application in RESOLFT microscopy (chapter 1.3.5) is described in more detail.
1.2 GFP-like fluorescent proteins
1.2.1 Naturally occurring fluorescent proteins
The green fluorescent protein from the hydrozoan jellyfish Aequorea victoria (avGFP) was
first described by Osamu Shimomura and coworkers in 1962 [19] and the first analysis of
its chromophore was reported in 1979 [20]. However, it was not until 1992 that avGFP was
cloned [21] which was followed by the first demonstration of avGFP as a fluorescent tag in
living cells in 1994 [22]. The chromophore of avGFP is formed autocatalytically and the
formation is only dependent on molecular oxygen and not on any other cofactors or
substrates [23, 24]. This qualifies the genetically encodable fluorescent protein for labeling
of whole cells and as fluorescent tag for specific labeling of structures or individual proteins
within the cell.
Later on, homologs of avGFP were identified in other species including corals [25-28],
crustaceans [29, 30] and lancelets [31, 32]. The first naturally occurring fluorescent protein
which emits in the red region of the visible spectrum was DsRed from the mushroom
anemone Discosoma sp. [25]. Further examples for naturally occurring red fluorescent
proteins are asFP595 from the sea anemone Anemonia sulcate [33] and eqFP611 from the
sea anemone Entacmaea quadricolor [26]. While avGFP is monomeric at low
concentrations [23], almost all GFP-like proteins from the class of Anthozoa are dimeric or
tetrameric [26-28, 34]. Although the sequence homology of the GFP-like proteins from




1.2.2 The overall structure and chromophore maturation
The protein structure of avGFP was reported independently by two groups in 1996 (Figure
1.2-1 A+B) [36, 37]. Later, the structures of avGFP homologs were solved as well and
revealed a high similarity (DsRed: Figure 1.2-1 D+E) [38-40]. The sequences of the GFP-
like fluorescent proteins consist of 220-240 amino acids [2] which corresponds to a
molecular weight of 25-30 kDa [35]. The peptide sequence forms 11 β-sheets. These are
connected via loops and are arranged in a beta-barrel structure with an α-helix passing
through the center. Oligomeric fluorescent proteins were shown to attach via distinct
exterior interfaces of the beta-barrel. The chromophores of the fluorescent proteins are
autocatalytically formed within the beta-barrel by three amino acids of the α-helix [41].
Figure 1.2-1: Beta-barrel structures and chromophores of avGFP and DsRed.
Tertiary structure of avGFP (green) and DsRed (red) from side view (A+D) and top view (B+E). avGFP: PDB
1EMA [36], DsRed: PDB 1ZGO, subunit A [42]. The chromophore inside the beta-barrel is indicated in dark
green for avGFP and in dark red for DsRed. The conjugated π-system is marked green or red in the chemical
structures of the avGFP (C) or DsRed chromophore (F). Both fluorescent proteins contain a chromophore in
the cis-conformation.
In avGFP, the chromophore-forming amino acids are serine, tyrosine and glycine at
positions 65-67 [21]. The tyrosine and glycine are highly conserved in naturally occurring
fluorescent proteins, whereas the amino acid at the first position in the chromophore differs
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among the GFP-like fluorescent proteins. The maturation process of the chromophore can
only take place inside the beta-barrel of the folded protein [43]. In avGFP, the maturation
is initiated by a nucleophilic attack of the amide nitrogen of amino acid Gly67 on the
carbonyl-carbon atom of amino acid Ser65 (Figure 1.2-2 (1)) [44]. The cyclization is most
likely followed by an oxidation and a subsequent dehydration (Figure 1.2-2 (2-4)) [45, 46].
The resulting chromophore consists of a hydroxyphenyl ring and an imidazolinone ring
connected by a methine bridge (Figure 1.2-1 C). The avGFP chromophore is stabilized in
the interior of the beta-barrel by non-covalent interactions and exhibits a conjugated π-
system. The excitation of the avGFP chromophore with violet light induces emission of
green fluorescence [2, 23].
Compared to the avGFP chromophore, the chromophore of red fluorescent proteins
comprises an extended π-system (Figure 1.2-1 F), which explains the higher excitation and
emission wavelengths of these proteins [38]. The chromophore of the red fluorescent DsRed
is formed by the amino acids glutamine, tyrosine and glycine at the positions 66-68 [47].
The cyclization appears as well by a
nucleophilic attack, but the following
maturation steps are more complex [46].
The maturation of the DsRed chromophore
involves the formation of a blue
intermediate (Figure 1.2-2 (5)) containing
an acylimine group [48, 49]. The oxidation
of this blue intermediate yields the red
fluorescent chromophore (Figure 1.2-2 (6))
[48].
Figure 1.2-2: Maturation of avGFP- and DsRed-
like chromophores.
The maturation inside the beta-barrel is initiated by a
nucleophilic attack of the nitrogen atom of the third
chromophore amino acid on the carbonyl-carbon
atom of the first chromophore amino acid (1). By an
oxidation of this cyclized product (2), the formation of
the imidazolinone ring follows (3). The dehydration
yields either the green fluorescent chromophore (4,
avGFP) by formation of a methine bridge or a blue
fluorescent intermediate (5) by formation of an
acylimine group. Proceeding from the blue
intermediate, the red fluorescent chromophore (6,
DsRed) is formed by an additional oxidation step.
Adapted with permission from Dedecker et al., 2013
[35], American Chemical Society.
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The maturation process is presumably similar in other red fluorescent proteins including
eqFP611 [50], whose chromophore is formed by the amino acids methionine, tyrosine and
glycine [26, 39]. In addition, the maturation of some orange or red fluorescent proteins
involves further chromophore modification [35]. In asFP595, a protein backbone break
appears during the maturation process [51].
The chromophore of the fluorescent proteins can either adopt a cis- or a trans-conformation
at the methine bridge. The crystal structures of a large number of examined GFP-like
fluorescent proteins revealed chromophores in the cis-conformation (e.g. avGFP [36]).
However, fluorescent proteins do exist which exhibit a chromophore in the trans-state (e.g.
eqFP611 [39]). In addition, the chromophore can be either in an anionic or a neutral form
by deprotonation or protonation of the hydroxyphenyl ring. The protonation of this
hydroxyl group shifts the absorption band of the chromophore to shorter wavelengths [23].
The conformation and the protonation state of the chromophore are influenced by the
chromophore-surrounding amino acids.
1.2.3 Engineering of fluorescent proteins
The initial avGFP and its homologs were modified by protein engineering to adapt their
characteristics for different applications [24]. The fluorescent proteins were mutated at
specific sites or randomly. Afterwards, the mutants were characterized or the mutant
libraries were screened for specific characteristics. One of the first mutants which was
generated from avGFP and which is still widely used to date, is the enhanced GFP (EGFP).
The F64L and S65T mutations in EGFP are located next to the chromophore and in the
chromophore itself and shifted the excitation maximum from 395 nm to 488 nm. The
addition of these and further mutations in EGFP improved the molecular brightness
(product of quantum yield and extinction coefficient) compared to avGFP [52, 53].
Most of the naturally occurring fluorescent proteins are dimers or tetramers [26-28, 34],
which make them unusable in most applications. Hence, the goal was to monomerize the
available fluorescent proteins. This was achieved by mutations which disrupt the
attachment interfaces on the outside of the beta-barrel. However, the monomerization is
commonly accompanied by a strong reduction or even loss of fluorescence [50]. The ability
to fluoresce was partly recovered by further mutagenesis and screening. Among others, the
monomeric and red fluorescent proteins mRFP1, mRuby and TagRFP were developed from
the naturally occurring DsRed, eqFP611 and eqFP578 applying this strategy [27, 54, 55].
Furthermore, for some of the fluorescent proteins, the codon usage was optimized for
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expression in the mammalian system [53, 54, 56] and the N- and C-terminus were
exchanged by the EGFP termini to improve their performance in fusion constructs [57-59].
1.2.3.1 Tuning the excitation and emission wavelengths
The excitation and emission wavelengths of the naturally occurring fluorescent proteins and
their monomeric mutants already covered different parts of the visible spectrum. In
addition, protein engineering efforts were capable to produce fluorescent proteins with
hypsochromic or bathochromic shifted excitation spectra, emission spectra or both (Figure
1.2-3). This allows multicolor labeling and as a result, imaging of different compartments
or proteins in the same cell. Compared to avGFP and EGFP, a bathochromic shift in the
excitation and emission spectra was achieved in EYFP by the introduction of the T203Y
mutation [36]. The bathochromic shift results from a π-π stacking of the tyrosine at position
203 and the hydroxyphenyl ring of the chromophore [60]. Variants of avGFP with blue-
shifted emission spectra were obtained by exchanging the tyrosine located in the
chromophore by histidine (blue fluorescent) or tryptophan (cyan fluorescent) and thereby
modifying the conjugated π-system [41]. An additional blue fluorescent protein was
generated from the red fluorescent protein TagRFP by trapping the blue maturation
intermediate [61].
The longer excitation wavelengths needed for orange, red and near-infrared fluorescent
proteins in live-cell microscopy have the advantage of reduced autofluorescence, light-
scattering and phototoxicity [62]. Furthermore, expanding the color palette in this region
of the spectrum provides more options for multicolor imaging. Most red fluorescent
proteins were engineered from fluorescent proteins of Anthozoa species [24, 62]. The
hypsochromic shift in the spectra of the orange fluorescent protein mOrange [58] compared
to its progenitor mRFP1 results from the M65T mutation in the chromophore and
cyclization of this residue with the acylimine group [63].  An even further hypsochromic
shift was induced in the yellow fluorescent protein mHoneydew by the chromophore
mutation Y66W [58].
The shifts to longer wavelengths were attainable by stabilization of the red fluorescent
chromophores in the cis-form instead of the trans-form [64] or introduction of π-π-stacking
interactions with amino acids in the chromophore environment [65]. A different strategy
involves the stabilization and the extension of the π-system by hydrogen bonds to the
phenolat or acylimine group [50, 66]. Thus, the development of red fluorescent proteins
with longer excitation and emission wavelengths is highly dependent on interactions of
surrounding amino acids with the chromophore. The proteins TagRFP657 (Excmax: 611 nm,
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Emmax: 657 nm) [67] and TagRFP675 (Excmax: 598 nm, Emmax: 675 nm) [68] are examples of
available GFP-like fluorescent proteins with long excitation and emission wavelengths.
However, the near-infrared fluorescent proteins typically suffer from a low molecular
brightness (Figure 1.2-3) [24]. As an alternative, infrared fluorescent proteins on the basis
of bacterial phytochromes were introduced, but these are dependent on the binding of the
external chromophore biliverdin, which can be disadvantageous in some applications [24].
Figure 1.2-3: Brightness and emission wavelengths of GFP-like fluorescent proteins.
Fluorescent proteins emitting in different spectral ranges were developed by protein engineering. The
molecular brightness relative to EGFP of the individual proteins is plotted against the respective emission
wavelength. The trend of the molecular brightness is indicated by the dashed black line. Adapted from
Adam et al., 2014 [69], with permission from Elsevier.
1.2.3.2 Improving further characteristics
In addition to the monomerization and the changes of the spectral properties, the protein
engineering was aimed to improve the GFP-like fluorescent proteins regarding other
characteristics. A high molecular brightness and a high effective brightness in living cells
were targeted, since these are key parameters for most applications [70-72]. Using
fluorescent proteins as labels in light microscopy, brighter fluorescent proteins allow to
visualize the structure of interest with improved signal-to-noise ratio. Moreover, a lower
dose of the excitation light is needed for brighter fluorescent proteins to visualize the
respective structure [2]. The effective brightness in living cells is not only affected by the
molecular brightness, but also by the expression, folding and maturation rate of the
fluorescent proteins [73, 74]. The temperature, the local pH as well as other cellular and
environmental factors can additionally have an influence on the effective brightness in cells.
However, the comparison of different fluorescent proteins is mainly based on their
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molecular brightness [75], since the effective brightness in living cells can vary depending
on the applied cell type and experimental setup.
The performance as fusion tag and the cytotoxicity in mammalian cells are further
parameters determining the applicability of fluorescent proteins in light microscopy and
were as well approached by protein engineering [76]. For applications with long-term
illumination like time-lapse imaging, the photostability of the fluorescent proteins is an
important factor and was therefore often targeted by mutagenesis and screening [70, 77,
78]. Other characteristics including the fluorescence lifetime, the pH stability [79], the
Stokes shift [80, 81] and the performance as fluorescence resonance energy transfer (FRET)
acceptor or donor [70, 82] are other parameters which were analyzed in screenings to obtain
fluorescent proteins with suitable characteristics for specific applications. For examle, the
fluorescent protein mRuby2 is a slightly brighter and more photostable variant of mRuby
and was identified by screenings for an improved FRET acceptor [57].
Thus, protein engineering approaches gave rise to a multitude of GFP-like fluorescent
proteins with large variations in their characteristics. The structural data of new fluorescent
proteins gave insights into the influence of single amino acids and mutations on the
characteristics. Since the overall structure and the positions of some highly conserved amino
acids show high similarity among all GFP-like fluorescent proteins, this knowledge can
guide the choice of mutation sites for other fluorescent proteins [83, 84].
In order to give rise to an additional template for the engineering of red fluorescent proteins,
a synthetic gene was generated based on the knowledge about naturally occurring and
engineered red fluorescent proteins like mCherry [85]. This synthetic gene template termed
mRed7 was applied in mutagenesis and screening rounds which resulted in mScarlet and
two further mutants. mScarlet is the monomeric red fluorescent protein with the highest
molecular brightness (2.1 fold to EGFP) and the longest fluorescence lifetime to date [85].
The application fields of the GFP-like fluorescent proteins evolved with the occurrence of
fluorescent proteins with different characteristics [24]. In addition to the labeling of cells,
cellular structures or specific proteins, fluorescent proteins are used in the investigation of
protein interactions and movements, in genetically encoded sensors, and in the control of
promoter activities [2]. Further application fields emerged with the appearance of
phototransformable fluorescent proteins. These can be transformed either irreversibly or
reversibly from one state to another by illumination with light [69]. These proteins and in




1.3 Reversibly switchable fluorescent proteins
In addition to the conventional GFP-like fluorescent proteins, three subclasses of
phototransformable fluorescent proteins exist. In the subclass of photoactivatable
fluorescent proteins, the proteins can be irreversibly transferred from a non-fluorescent to
a fluorescent state, while photoconvertible fluorescent proteins can be irreversibly
converted from one emission color to another. The third subclass includes the reversibly
switchable fluorescent proteins (RSFPs) [69]. RSFPs can be reversibly switched from a
fluorescent on-state to a non-fluorescent off-state and vice versa by light of certain
wavelengths. Due to their reversible switching, RSFPs are potential probes for super-
resolution methods [86], in particular for RESOLFT microscopy (see chapter 1.1.1). This
work aimed to develop novel RSFPs, therefore this class is described in detail in the
following.
The first GFP-like protein with reversible switching behavior was introduced in 2000 and
was named asFP595 [33]. The excitation of this naturally occurring and tetrameric protein
with green light yields red fluorescence. Illuminating an ensemble of asFP595 proteins with
green light additionally increases the fluorescence emission until all asFP595 proteins are
switched to the on-state, whereas the illumination with blue light transfers these proteins to
the off-state. The next reported RSFP was the green fluorescent protein Dronpa. This
protein is a monomerized mutant of the fluorescent protein 22G, which was derived from
a Pectiniidae coral [87]. The fluorescence intensity of a Dronpa ensemble decreases when
excited with light of 490 nm and the proteins can be switched back to the on-state by
illumination with light of 400 nm.
In the following years, the underlying switching mechanisms were investigated (chapter
1.3.4) and key amino acids responsible for the switching were identified. Especially the
amino acids in the direct chromophore environment have a direct impact on the switching
ability of fluorescent proteins. The mutagenesis of these amino acids changed the switching
characteristics of Dronpa [88, 89] and introduced switching to conventional GFP-like
proteins including mEGFP or mCherry [90, 91]. Further site-directed mutagenesis in
combination with error-prone mutagenesis was able to adjust the characteristics of new
RSFPs (see chapter 1.3.3).
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1.3.1 Switching modes of RSFPs
The reversible switching between the on- and off-state in RSFPs can be distinguished in
three different switching modes: Negative, positive and decoupled switching [88, 92]. In
negative-switching RSFPs like Dronpa [87], the light that induces fluorescence emission
also switches the proteins off. As a result, the fluorescence intensity decreases until the
proteins are entirely switched off (Figure 1.3-1 A). A second wavelength, which is usually
80-130 nm shorter than the off-switching wavelength, can transfer the negative-switching
GFP-like proteins back into the on-state [93].
In contrast, in positive-switching RSFPs like asFP595 [33], the excitation wavelength, which
induces fluorescence, switches the proteins to the on-state. The on-switching is measurable
as an increase of the fluorescence signal (Figure 1.3-1 B). A second shorter wavelength can
switch the positive-switching fluorescent proteins into the off-state.
Figure 1.3-1: Negative- and positive-switching mode for red-emitting RSFPs.
Reversible switching illustrated for red fluorescent proteins with negative- or positive-switching mode. The grey
fluorescent proteins present the off-state, the red fluorescent proteins present the on-state. A: Negative-
switching: The light that is used to induce fluorescence (yellow-green), switches the protein off. A second
wavelength switches the protein into the on-state (blue). B: Positive-switching: The light which induces
fluorescence switches the protein on (yellow-green). A second wavelengths is used for off-switching (blue).
A+B right: Schematic switching curves. The illumination with the light for off-switching yields a reduction in the
fluorescence intensity, while the on-switching is visible by an increase in the fluorescence intensity.
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In negative- and positive-switching RSFPs, the excitation inducing fluorescence and the
switching into one direction are coupled. For RSFPs with decoupled switching mode, an
excitation wavelength which induces fluorescence does not provoke switching. Instead, the
on- and off-switching are induced by two further wavelengths [92].
1.3.2 Crucial characteristics of RSFPs
Several biological applications of RSFPs have been demonstrated including protein tracking
and photochromic FRET, but until now, RSFPs were mostly used in super-resolution
microscopy. RSFPs have been applicable in coordinate-stochastic methods [91], protected
STED [94], nonlinear SIM [95] and RESOLFT microscopy [90]. Every nanoscopy method
relies on specific protein properties, thereby the techniques differ in their requirements [86].
This work focusses on the application of RSFPs in live-cell RESOLFT microscopy, because
this method facilitates diffraction-unlimited imaging of living cells with lower light doses
than STED microscopy [14].
Since the RSFPs are applied as fusion tags in eukaryotic cells [96, 97], RSFPs with fast
maturation, good performance in fusions and low cytotoxicity are desired, preferentially
with high molecular and effective cellular brightness (see chapter 1.2.3.2). In contrast to the
conventional GFP-like proteins, the RSFPs can adopt two states (on and off) which differ in
their molecular brightness [82]. At thermal equilibrium, an ensemble of RSFPs in solution
or in living cells can be a mixture of proteins in the on- and in the off-state [88, 91]. This
equilibrium state can be calculated by the ratio of the fluorescence signal in the thermal
equilibrium to the fluorescence signal in the on-state. To compare the RSFPs regarding their
maximal ensemble fluorescence, the examined RSFP ensemble needs to be switched to the
on-state before the fluorescence is measured.
Furthermore, the switching characteristics of the RSFPs largely determine their applicability
in RESOLFT microscopy. One of these switching parameters is the residual fluorescence
signal in the off-state in relation to the fluorescence signal in the on-state [91], which was
used in this work to compare RSFPs. Alternatively, the switching contrast can be
calculated [82], which is defined as the fluorescence signal in the on-state divided by the
fluorescence signal in the off-state. Low residual fluorescence in the off-state or high
switching contrast is essential for the application in RESOLFT microscopy [98].
Other important characteristics of RSFPs are their on- and off-switching kinetics [86]. The
switching speed is dependent on the applied light intensity and switching wavelengths. For
this reason, the absolute switching times can differ using dissimilar methods in different
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experimental setups. For a reliable comparison of various RSFPs, the proteins should be
expressed in the same type of organism using an equal construct and the switching curves
should be acquired with the same microscope using the same light intensities. RSFPs with
fast switching kinetics are beneficial for RESOLFT microscopy by reducing the required
switching times [96].
The repetitive switching of an RSFP ensemble is accompanied by a reduction in the maximal
fluorescence signal due to the destruction of some of the RSFPs in each cycle. This effect is
termed switching fatigue. The switching fatigue is related to the process of photobleaching
in conventional fluorescent proteins [99], which describes the loss of fluorescence at
continuous fluorescence excitation. RSFPs are typically compared by the number of
switching cycles until 50 % of the maximal fluorescence signal in the first cycle is reached
[96, 100]. Another aspect of switching fatigue can be an increase of the residual fluorescence
in the off-state [91] and thereby a reduction of the switching contrast. A low switching
fatigue is desirable for RESOLFT microscopy, since the imaging schemes require multiple
switching cycles [101].
1.3.3 Engineering of RSFPs
Until now, several RSFPs were developed by introduction of switching to conventional
fluorescent proteins or by improving existing RSFPs. Since RSFPs are applied as fusion tags
in living cells, the development of new RSFPs was focused on monomeric fluorescent
proteins. The generation of new or improved RSFPs usually involves site-directed
mutagenesis of the amino acids in the chromophore environment, as these have a major
impact on the switching ability of the fluorescent proteins [82, 88, 89, 91, 102]. This
approach is often combined with error-prone mutagenesis [82, 88, 91]. The majority of the
available RSFPs show a negative-switching mode and more exist which emit in the green
part of the spectrum (green RSFPs) than those which emit in the yellow or red part of the
spectrum (yellow and red RSFPs) (see chapter 1.3.3.1 and 1.3.3.2).
1.3.3.1 Green and yellow RSFPs
The green RSFPs are commonly switched using the wavelengths 405 nm and 488 nm. The
excitation of the green RSFPs at 488 nm induces fluorescence emission. Based on the
negative-switching Dronpa [87], further green RSFPs with altered switching characteristics
were generated. The site-directed mutagenesis of positions in the direct chromophore
environment yielded the faster switching rsFastLime and Dronpa-M159T [89].
Interestingly, the M159Y mutation in Dronpa inverted the switching mode from negative-
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to positive-switching. Including this mutation, the positive-switching Padron was evolved
from Dronpa using site-directed and error-prone mutagenesis [88]. Padron and its
descendant Kohinoor [100] represent the only positive-switching and green fluorescent
proteins so far.
A series of green RSFPs with negative-switching mode, namely rsEGFP [90], rsEGFP2 [96],
rsGreen1, rsGreenF [103], rsFolder1 and rsFolder2 [104], were developed from mEGFP
[105] and superfolder GFP [71], which are both constitutively fluorescent avGFP variants.
These RSFPs differ in their expression and maturation efficiencies and show slight
differences in their switching characteristics. Especially rsEGFP2 features an extraordinary
low switching fatigue and is for this reason most frequently applied in RESOLFT
microscopy.
Further green RSFPs were evolved from the photoconvertible fluorescent proteins mEos2
[106] (mGeos-X [107]), mEos3.1 [108] (Skylan-S, Skylan-NS [95, 109]) and mMaple3 [110]
(GMars-X [102, 111, 112]) by replacing the histidine in the chromophore and by addition
of further mutations. The proteins mIrisFP [113] and NijiFP [114] were as well derived from
photoconvertible fluorescent proteins. These two proteins are still photoconvertible (from
green to red fluorescent) and additionally negative-switching in both fluorescent forms.
The yellow RSFP Dreiklang [92] and its mutant SPOON [115] are the only RSFPs found
with decoupled switching mode. Dreiklang was generated from the avGFP variant Citrine
[79] and can be switched to the on-state by light of 365 nm and to the off-state by light of
405 nm [92]. The fluorescence emission of Dreiklang in the on-state can be induced by
excitation at 515 nm. Although the decoupled switching mode can be beneficial for
RESOLFT microscopy, the two switching wavelengths in the ultraviolet and violet regions
of the spectrum and some additional unfavorable switching characteristics (high switching
fatigue, slow switching kinetics) limit the use of Dreiklang in live-cell RESOLFT
microscopy.
1.3.3.2 Red RSFPs
The available red RSFPs are usually switched with light of 405-510 nm and with light of 540-
592 nm with the latter range inducing fluorescence emission. The naturally occurring
asFP595 as well as the generated asFP595 mutants are positive-switching and red
fluorescent [33, 74, 116]. Although the first proof of concept RESOLFT imaging was
performed using purified asFP595, the tetrameric state of asFP595 and its mutants prevent
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their application in live-cell RESOLFT microscopy. So far, no monomeric variant of this
protein has been reported.
The next introduced red RSFPs were rsCherry and rsCherryRev [91] which were developed
from the conventional fluorescent protein mCherry [58]. While rsCherry switches in a
positive mode, rsCherryRev is a negative RSFP. The Q163M mutation in the proximity of
the chromophore is responsible for the opposing switching mode in rsCherryRev. Further
mutagenesis of rsCherryRev in combination with screening yielded the negative-switching
rsCherryRev1.4 [98]. This red RSFP showed a dimerization tendency, but was the first red
RSFP applicable in live-cell RESOLFT microscopy.
The negative-switching rsTagRFP [117] was generated from the monomeric and red
fluorescent protein TagRFP [27]. The absorption spectra of on- and off-switched rsTagRFP
proteins feature significant differences, which could not be measured for rsCherryRev. Due
to these spectral differences, rsTagRFP was applicable as acceptor in photochromic FRET
[117], but no applications in RESOLFT imaging have been shown yet.
The converted red forms of NijiFP [114] and mIrisFP [113] (chapter 1.3.3.1) emit at lower
wavelengths (Emmax: 569 nm and 578 nm) than the other red RSFPs mentioned above (585-
610 nm) [82, 91, 98]. The need for photoconversion with violet light, the dimerization
tendency of NijiFP [114] and unfavorable switching characteristics (high switching fatigue,
low switching contrast) render both unsuitable for RESOLFT microscopy in the red spectral
range.
In the course of this work, the red RSFPs rsFusionRed1, rsFusionRed2 and rsFusionRed3
with negative-switching mode were introduced [118]. These RSFPs were generated based
on FusionRed [76], which is a descendant of TagRFP [27]. The variant rsFusionRed1
showed 33.6 % residual fluorescence in the off-state and is thus not suitable for RESOLFT
microscopy. The two RSFPs rsFusionRed2 and rsFusionRed3 differ in only one mutation
and exhibited a low residual fluorescence in the off-state (8 % and 5 % of the on-state signal).
Both showed faster off-switching than other negative-switching red fluorescent proteins
(rsCherryRev, rsCherryRev1.4, rsTagRFP). Furthermore, rsFusionRed2 and rsFusionRed3
were successfully applied in parallelized live-cell RESOLFT microscopy [118].
The overall number of available red RSFPs is not only lower, but most green RSFPs also
outperform the red RSFPs regarding their molecular brightness and switching
characteristics [86]. However, due to the longer switching and excitation wavelengths, red
RSFPs with superior switching characteristics would be highly welcome as valuable probes
for live-cell RESOLFT microscopy.
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1.3.4 Mechanistic aspects of photoswitching
The mechanism of switching in RSFPs was examined by numerous studies utilizing
different methods like X-Ray crystallography, NMR spectroscopy, molecular dynamics
simulations and ultrafast spectroscopy (e.g. [40, 116, 117, 119-123]). For all examined
RSFPs except Dreiklang, cis-trans isomerization in the chromophore is involved in
switching [124]. Almost all crystal structures of on-switched RSFPs showed a chromophore
in the cis-conformation, whereas the chromophore in the off-state was found in the trans-
conformation [99, 124, 125]. The only exception was recently revealed for rsGamillus-S,
which exhibited a trans chromophore in the on-state and a cis chromophore in the off-state
[126].
Although the cis-trans and trans-cis isomerization appears to be a key event in switching,
the conformational change alone cannot explain the different fluorescence abilities of the
chromophores in the on- and off-states [125]. For most RSFPs, a change in the protonation
state induced by the switching process was postulated or confirmed. The chromophore of
the negative-switching Dronpa is deprotonated in the on-state and protonated in the off-
state [120, 122]. In contrast, the chromophore of its positive-switching variant Padron is
deprotonated in the off-state and partially protonated and deprotonated in the on-state
[123, 127]. In addition, a higher flexibility of the chromophore in the off-state and the
associated non-radiative processes are discussed to contribute to the non-fluorescent state
[121]. Another factor could be a change in the planarity of the chromophore [120].
However, the stabilization and distortion of the hydroxyphenyl ring in the on- and off-state
vary in the different examined RSFPs [40, 117, 120, 123].
Figure 1.3-2: Chromophore environment of rsTagRFP and TagRFP.
Structures of the direct chromophore environment of rsTagRFP in the on- (A) and off-state (B) in comparison
to the chromophore environment of TagRFP (C). In the cis- (A) and trans-conformation (B) of the rsTagRFP
chromophore, the hydroxyphenyl ring only adopts hydrogen bonds to internal water molecules (shown in red
dashed lines with distances in ångström). The trans chromophore of the non-switching TagRFP is stabilized
by hydrogen bonds to Ser158 and Asn143. Adapted from Pletnev et al., 2012 [117], with permission of Elsevier.
Introduction
18
In all aspects mentioned, the reversible switching in positive- and negative-switching RSFPs
is highly dependent on the chromophore-surrounding amino acids. On the one hand, steric
effects might hinder the cis-trans isomerization of the chromophore. On the other hand, the
amino acids can stabilize one or both conformations by non-covalent bonds and can affect
the protonation state. Already mutational studies of asFP595 revealed the significant impact
of the amino acids in the direct chromophore environment, namely A148 and S165, on the
switching ability of this protein [116]. The A148S mutation improved the quantum yield
and the switching of asFP595. Later, this serine was shown to stabilize the chromophore in
the cis-form by an additional hydrogen bond to the phenolate group [40].
The introduction of switching to mCherry was achieved by exchanging the isoleucine at
position 161 in the close proximity of the chromophore to the smaller and polar amino acid
serine. Further mutagenesis of chromophore-surrounding amino acids (among others:
S146, Q163) yielded rsCherry and rsCherryRev [91]. In TagRFP, the switching was
introduced by the mutations N143A and S158G. The addition of further mutations (among
others: F174L) yielded rsTagRFP [117]. In contrast to the former amino acids, the
introduced alanine and glycine at positions 143 and 158 are nonpolar. Thus, the
hydroxyphenyl ring of the chromophore in rsTagRFP is no more stabilized by hydrogen
bonds to the amino acids of the protein scaffold (Figure 1.3-2). In addition, the added
mutations enabled the cis-trans isomerization [117]. Different to other RSFPs like Dronpa
and Padron [120, 121, 123], the crystal structures of rsTagRFP revealed a similar coplanarity
in both chromophore conformations [117].
Investigations of the switching in the RSFP Dreiklang with decoupled switching mode
revealed a different type of switching mechanism. The off-switching induces a disruption
of the π-system by hydration of the imidazolinone ring, while a dehydration during on-
switching reverses this effect [92, 128].
1.3.5 Application of RSFPs in RESOLFT microscopy
The first experimental demonstration of RESOLFT microscopy with RSFPs was shown in
2005 using purified asFP595 [17]. In 2011, the first application of RESOLFT microscopy in
living cells was demonstrated using the green fluorescent and negative-switching rsEGFP
in a point-scanning implementation [90]. In the point-scanning approach, the image is
acquired by stepwise scanning and, at each position, a switching pulse scheme is applied
(Figure 1.3-3). First, the RSFPs in the focal plane are switched on using a Gaussian beam of
the on-switching wavelength. Subsequently, a doughnut-shaped beam with an intensity
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zero in the center is applied which switches the RSFPs in the periphery off. Only the RSFPs
in the center stay in the on-state. The fluorescence readout is performed by a Gaussian beam
for excitation. The pulse scheme is repeated at the next scanning positions and the
RESOLFT image is composed of the fluorescence signals at each position.
Figure 1.3-3: Point-scanning RESOLFT using negative- or positive-switching RSFPs.
Point-scanning RESOLFT schemes for red RSFPs with negative-switching (A) or positive-switching mode (B)
at a single position. First, the RSFPs are switched to the on-state using a Gaussian beam of the on-switching
wavelength (left). Next, the RSFPs in the periphery are switched to the off-state using a doughnut-shaped
beam of the respective off-switching wavelength (middle). The RSFPs in the center remain in the on-state.
Finally, the fluorescence signal of RSFPs in the on-state is readout. The same switching scheme is then applied
at the next scanning position. The final RESOLFT image arises from the pixel-by-pixel scanning of the field of
interest.
The acquisition times in point-scanning RESOLFT are highly dependent on the switching
speed of the RSFPs, since the on- and off-switching are more time-consuming than the
fluorescence readout [90, 96, 98]. In order to reduce the imaging times, several parallelized
RESOLFT schemes were developed. In these approaches, arrays of intensity zeros are
applied to simultaneous facilitate sub-diffraction fluorescence readout at different
positions. The on-switching and readout is implemented by wide-field illumination [129,
130] or by individual foci [131]. In the alternative smart-scanning concept, the imaging time
and the applied light dose in point-scanning RSOLFT are reduced as a result that the
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switching scheme is only applied at those positions with a fluorescence signal higher than a
certain threshold [132].
The green RSFP rsEGFP2 is characterized by a low switching fatigue [96] and was applied
in multiple RESOLFT implementations. This includes RESOLFT microscopy of
endogenous proteins tagged with rsEGFP2 in mammalian cells [97] and rsEGFP2-α-tubulin
expressed in tissue and larvae of Drosophila melanogaster [133]. These experiments
demonstrated the suitability of RESOLFT microscopy, in particular with rsEGFP2, for live-
cells and tissue.
The applicability in RESOLFT imaging was as well shown for other green RSFPs with
negative-switching mode [102-104, 111, 134] and for the yellow fluorescent protein
Dreiklang with decoupled switching [92, 135]. So far, the application of a positive-switching
RSFP is restricted to a single demonstration using the green fluorescent Kohinoor [100]. At
the beginning of this work, rsCherryRev1.4 was the only red RSFP which was applicable in
live-cell RESOLFT microscopy despite its dimerization tendency [98, 130]. In 2018,
parallelized live-cell RESOLFT microscopy with the red fluorescent rsFusionRed2 and
rsFusionRed3 was reported [118].
Dual channel RESOLFT implementations were based on the different characteristics of
specific RSFPs. On the one hand, different switching kinetics and fluorescence lifetimes of
two RSFPs were utilized [136]. On the other hand, the different spectral characteristics of
the red fluorescent rsCherryRev1.4 and the green fluorescent rsEGFP2 [98] or the yellow
fluorescent Dreiklang [130] was exploited. However, dual color RESOLFT microscopy is
limited due to the low number of available red RSFPs with suitable characteristics. Thus,
the demand for novel red RSFPs with superior switching characteristics is still high.
1.4 Screening of fluorescent proteins and RSFPs
1.4.1 Realized screenings for fluorescent proteins
The large palette of available GFP-like fluorescent proteins including RSFPs were to a large
extent generated by protein engineering (see chapter 1.2.3 and 1.3.3). Protein engineering
commonly involves the production of mutant libraries, for instance by in vitro mutagenesis
at selected or random positions. Most mutant libraries were expressed in Escherichia coli
(E. coli) cells, either in liquid cultures or in colonies on agar plates [35, 84]. Subsequently,
single mutants were characterized or, in most cases, the mutant libraries were screened. The
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chosen screening approach is dependent on the size of the library and the characteristics to
be analyzed. The screenings for fluorescent proteins with enhanced brightness, folding or
maturation were usually implemented by fluorescence analysis of the transformed E. coli
cells in flow cytometry or by fluorescence readout of the expressing E. coli colonies [32, 54,
58, 76, 85, 137]. Further screening approaches analyzed other characteristics like the
fluorescence lifetime, photostability or spectral shifts [35]. The identification of new and
improved RSFPs was mostly achieved by on- and off-switching of the proteins expressed in
bacterial colonies using a microscope followed by the analysis of the acquired switching data
[92, 96, 98, 100, 118]. While the flow cytometry analysis of single cells allows for high
throughput, a microscopic screening provides more information and allows the readout of
various characteristics at the same time.
The conditions in a cell and the expression differ between mammalian and bacterial cells.
Therefore, the effective cellular brightness and other characteristics of fluorescent proteins
can also vary in different cell types. Since multiple applications of fluorescent proteins are
carried out in eukaryotic cells, the screening of mutant libraries expressed in mammalian
cells is preferable [84]. However, the implementation is not practicable by simple
transfection of mammalian cells with a mutant library for transient expression. In contrast
to the transformation of E. coli cells, the transient transfection of mammalian cells yields
the uptake and expression of hundreds to thousands of plasmids. For this reason, the
transfection of a plasmid library results in the expression of different variants per cell which
does not allow to trace changes back to a single mutant.
To date, the realized screenings of fluorescent proteins based on the expression in
mammalian cells are limited. For example, the fluorescent proteins mRaspberry and mPlum
exhibit bathochromic shifted excitation or emission spectra compared to their template
mRFP1.2 and were generated using the B lymphocyte cell line Ramos. The coding sequence
of mRFP1.2 was stably introduced to these cells by retroviral infection and the fluorescent
protein was mutated in vivo utilizing the cell type specific somatic hypermutation [138].
Thus, this approach is restricted to random-mutagenesis. However, the option for rational
choice of mutation sites and site-directed mutagenesis is desirable, since this strategy can
drastically reduce the size of the library to be screened.
In another approach, mutagenic libraries were generated in vitro and were then stably
integrated into the genome of mammalian cells using retroviruses. This strategy was applied
in the development of the fluorescent protein Kriek which is characterized by a higher
photostability compared to its progenitor mCherry [139]. Even if the multiplicity of
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infection is kept low, the application of viruses bear the risk of multiple transgene
integrations per cell [84]. In addition, the transgene is randomly integrated into the genome
in this approach, but the expression of all variants from the same genomic context would
be beneficial for the comparison [140]. Due to these disadvantages of the viral approaches,
conceivable options for the screenings of mutant libraries exploiting the eukaryotic
expression machinery are discussed in the following.
1.4.2 Options for expression of a single fluorescent protein per cell
A perquisite for the screening of fluorescent proteins in mammalian cells is the expression
of a single variant from a mutant library per cell. Since this is not feasible by simple
transfection of a mutant library, a suitable approach might be the stable integration of a
single mutant into the genome of each mammalian cell. Preferably, all variants are expressed
from the same genomic locus to avoid effects of the integration sites on the expression [140].
Genome editing using zink finger nucleases [141], transcription activator-like effector
nucleases [142] or clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9
[143, 144] allow the knock-in of transgenes to a targeted genomic site. Nevertheless, more
than one integration per cell is possible in these methods depending on the copy number of
the locus in the genome. Furthermore, the shown off-target effects render these methods
inappropriate for screening approaches [145, 146].
The site-specific recombinase techniques are an alternative concept for stable integration of
single transgenes into the same genomic context of different cells [147, 148]. In one of these
strategies, a single recombinase attachment site is placed in the mammalian host genome
using a genome engineering method. A plasmid containing the complementary attachment
site can be integrated into the placed attachment site by recombination. The recombination
is catalyzed efficiently and precise by a site-specific recombinase [149, 150].
The phage Bxb1 recombinase is such a site-specific recombinase. It is part of the serine
recombinase family and mediates the unidirectional recombination of the specific
attachment sites Bxb1 attB (38 bp) and Bxb1 attP (52 bp) [147]. It was shown to be the most
efficient and accurate out of 15 recombinases in mammalian cells [151]. The application of
the Bxb1 recombinase and attachment sites for the stable integration of a transgene into the
genome of mammalian cells was successfully demonstrated [152].
Previously, Duportet et al. generated Bxb1 landing pad cell lines which contained a single
landing pad composed of an upstream CAG promotor and a Bxb1 attP attachment site
[140]. These Bxb1 landing pad cells were applied for the stable integration and expression
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of multi-gene vectors. A monoclonal Bxb1 landing pad cell line with a single landing pad
has the advantage that only a single plasmid can be integrated in the respective cell. At the
beginning of this work, a Bxb1 landing pad cell line had not been exploited for the screening
of fluorescent proteins.
1.5 Aim of the study
RESOLFT microscopy with RSFPs enables diffraction-unlimited imaging with live-cell
compatible light doses. While multiple green RSFPs with suitable characteristics for
RESOLFT microscopy exist, the number of red RSFPs is still limited. The molecular
brightness of the available red RSFPs is low and most of them exhibit undesirable
characteristics (chapter 1.3.3.2). However, RESOLFT microscopy with red RSFPs benefits
from the longer switching and fluorescence excitations wavelengths. In addition, red RSFPs
can be combined with green RSFPs for dual color imaging. Thus, this work aimed to develop
new red RSFPs with superior switching characteristics and higher molecular and cellular
brightness than the available red RSFPs.
To facilitate the development of novel red RSFPs with optimized characteristics, screening
systems had to be adapted and new screening approaches needed to be developed. This
includes the generation of a mammalian Bxb1 landing pad cell line to enable the expression
of a single variant from a mutant library per cell. The second part of this work covers the
development of novel red RSFPs with positive- and negative-switching mode utilizing site-
directed and random mutagenesis in combination with the established screening strategies.
Moreover, a detailed characterization of the generated red RSFPs could examine their
potential for live-cell RESOLFT microscopy.
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2 Materials and methods
All chemical components and reagents used in this work were obtained from Sigma-Aldrich
(St. Louis, MO, USA), Merck (Darmstadt, Germany), PanReac Applichem (Darmstadt,
Germany), SERVA (Heidelberg, Germany) and VWR (Radnor, PA, USA) unless otherwise
indicated.
2.1 Molecular biology methods
2.1.1 Isolation of plasmid DNA from bacterial cultures
Plasmid DNA was isolated from 5 ml or 50 ml E. coli cultures using the QIAprep Spin
Miniprep Kit or QIAGEN Plasmid Plus Midi Kit (QIAGEN, Hilden, Germany). DNA
isolation was performed according to the manufacturer’s protocol. DNA concentrations
were determined using the NanoDrop1000 Spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA).
2.1.2 Polymerase chain reaction for cloning and genotyping
Polymerase chain reaction (PCR) [153] was applied to amplify DNA fragments. For cloning
of DNA constructs, DNA fragments were either amplified using the Pfu or Q5 DNA
Polymerase. For genotyping of monoclonal cell lines, PCR reactions were performed on
genomic DNA using the Q5 DNA Polymerase protocol. In addition, PCR reactions were
conducted for the purpose of mutagenesis as described in chapter 2.1.10.
2.1.2.1 DNA amplification using Pfu DNA polymerase
In PCR reactions with the Pfu DNA polymerase (2.5 U/μl; biotechrabbit, Hennigsdorf,
Germany), the used 10x PCR buffer contained 100 mM Tris-HCl (pH 8.3), 500 mM KCl
and 25 mM MgCl2. The deoxyribonucleotide triphosphate (dNTP) stock solution was
composed of 10 mM of each dNTP (dATP, dGTP, dCTP, dTTP; Thermo Fisher Scientific,
Waltham, MA, USA). The PCR reactions were prepared as described in the following:
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  50-100 ng template DNA
  1 µl sense primer (10 µM)
  1 µl antisense primer (10 µM)
5 µl 10x PCR buffer
2 µl dNTP stock solution (10 mM each)
1 µl Pfu DNA polymerase
filled up to 50 µl with H2O
The PCR was carried out with a T-Personal Thermal Cycler (Biometra, Göttingen,
Germany) using the following protocol:
Temperature Time
94 °C 5 min
94 °C 1 min
55 °C 1 min 30x
72 °C 2 min/1 kb
72 °C 10 min
2.1.2.2 DNA amplification using Q5 DNA polymerase
For amplification of DNA fragments with the Q5 High-Fidelity DNA Polymerase (2 U/µl;
NEB, Ipswich, MA, USA), 5x Q5 Reaction Buffer (NEB, Ipswich, MA, USA) and dNTP
stock solution with 10 mM of each dNTP (dATP, dGTP, dCTP, dTTP) were used. The PCR
reactions with Q5 DNA Polymerase were prepared according to the following protocol:
50-100 ng plasmid DNA or 150 ng genomic DNA (template)
  2.5 µl sense primer (10 µM)
  2.5 µl antisense primer (10 µM)
  10 µl 5x Q5 Reaction Buffer
  1 µl dNTP stock solution (10 mM each)
  0.5 µl Q5 DNA Polymerase
filled up to 50 µl with H2O
The PCR was conducted using the following protocol:
Temperature Time
98 °C 2-5 min
98 °C 20 s
60-70 °C 20 s 30 x
72 °C 30 s/1 kb
72 °C 5 min
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2.1.3 Agarose gel electrophoresis
Agarose gels for analysis or purification of DNA fragments were prepared by boiling
1.2 % (w/v) agarose in 1x TAE buffer (40 mM Tris, 20 mM sodium acetate, 1 mM EDTA,
set to pH 7.2). The dissolved agarose solution was poured into gel chambers for analytical
or preparative gels. The PCR reactions were mixed in the ratio 5:1 with 6x DNA loading
buffer (6x TAE buffer, 30 % (v/v) glycerol, 0.15 % (w/v) bromophenol blue, 0.15 % xylene
cyanol FF) and were loaded to the gels together with 5 µl GeneRuler 1 kb Ladder (Thermo
Fisher Scientific, Waltham, MA, USA). Electrophoresis was carried out in 1x TAE buffer at
70-80 V for 45-50 min. The gel was stained in ethidium bromide solution for 10 min
(analytical gels) or 30 min (preparative gels). DNA bands were visualized and documented
with the gel documentation system Gel Jet Imager (INTAS Science Imaging Instruments,
Göttingen, Germany).
2.1.4 Purification of DNA fragments
PCR products and digested DNA fragments were either purified using the QIAquick PCR
Purification Kit (QIAGEN, Hilden, Germany) or with a preparative gel electrophoresis
followed by gel extraction using the NucleoSpin Gel and PCR Clean-up Kit (MACHEREY-
NAGEL, Düren, Germany). Both kits were applied according to the respective kit
instructions.
2.1.5 Restriction
DNA plasmids and purified PCR products were digested with respective enzymes for
cloning. 2-3 µg plasmid DNA or the whole purified PCR reaction were mixed with 1 µl of
each restriction enzyme (10 U/µl; Thermo Fisher Scientific, Waltham, MA, USA), 4 µl of a
suitable restriction buffer (NEBuffer 2, NEB, Ipswich, MA, USA; Buffer O, Thermo Fisher
Scientific, Waltham, MA, USA) and, if not contained in the restriction buffer, 4 µl bovine
serum albumin (BSA).The mixture was filled up to 40 µl with H2O and incubated at 37 °C
for 2 h. In case of the plasmid backbone DNA, 1 µl FastAP Thermosensitive Alkaline
Phosphatase (1 U/µl; Thermo Fisher Scientific, Waltham, MA, USA) was subsequently
added to the restriction reactions for dephosphorylation. These mixtures were incubated at
37 °C for further 30 min. All reactions were inactivated at 65 °C for 5-10 min. While
linearized plasmids were purified by gel extraction, digested PCR products were purified
with the QIAquick PCR purification kit.
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2.1.6 Assembly of DNA fragments
2.1.6.1 Ligation of DNA fragments using T4 DNA ligase
For ligation, the restricted and dephosphorylated plasmid backbone and the digested insert
DNA fragment were mixed in a 1:3 ratio (20-30 fmol backbone, 60-90 fmol insert). 2 µl T4
DNA ligase buffer (10x) and 1 µl T4 DNA ligase (5 U/µl; Thermo Fisher Scientific,
Waltham, MA, USA) were added and the mixture was filled up to 20 µl with H2O. The
ligation mixture was incubated at room temperature for 1 h and subsequently inactivated
at 65 °C for 10 min.
2.1.6.2 Gibson Assembly of DNA fragments
For Gibson Assembly [154] of DNA fragments, 1 µl DpnI was added to the PCR reactions
prior to the purification in order to digest the methylated template DNA (incubation: at
37 °C for 1 h). The linearized and purified plasmid backbone was mixed with the purified
DNA insert in the ratio 1:2 (20-30 fmol backbone, 40-60 fmol insert). 10 µl Gibson
Assembly Master Mix (2x; NEB, Ipswich, MA, USA) was added and the reactions were filled
up to 20 µl with H2O. Samples were incubated in a thermal cycler at 50 °C for 40 min.
2.1.7 Dialysis of DNA
The mutagenesis, ligation and Gibson Assembly reactions were dialyzed prior to the
transformation of E. coli. Therefore, samples were dialyzed on 0.025 µm membrane filters
(MF Millipore; Merck Millipore, Darmstadt, Germany) floating on H2O for 30-40 min.
2.1.8 Sequencing
Plasmid DNA and PCR fragments were sequenced by the company Microsynth Seqlab
(Balgach, Switzerland) in Göttingen. For sequencing of plasmid DNA, 0.7 to 1.2 µg DNA
were provided in 12 µl H2O. 3 µl of a suitable primer (10 µM) were added. For sequencing
of PCR fragments, the PCR products were purified using the QIAGEN PCR Purification kit
and 18 ng DNA per 100 bp were provided in 12 µl H2O with the addition of 3 µl primer.
2.1.9 Cloning
All clonings conducted in this work were controlled by sequencing. DNA maps in the
appendix were created using SnapGene (GSL Biotech LLC, Chicago, IL, USA).
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2.1.9.1 Cloning of pBad plasmids for cytosolic expression in E. coli
The pBad/His B plasmid was chosen as the expression vector for the cytosolic expression of
fluorescent proteins with an N-terminal poly-histidine tag in bacteria. The plasmid pBad-
mKalama1 [155] was provided by Robert Campbell (Addgene plasmid #14892; Addgene,
MA, USA) and served as backbone by replacing the mKalama1 gene with the coding
sequence of the red fluorescent proteins. The pBad plasmid was linearized using XhoI and
EcoRI. The Pfu DNA polymerase was used for amplification of the fluorescent protein genes
with addition of XhoI and EcoRI restriction sites (all primers for pBad cloning: see Appendix
Table 8). The coding sequence of the fluorescent protein mScarlet was amplified from the
plasmid pmScarlet_Giantin_C1 [85] (gift from Dorus Gadella; Addgene plasmid #85048),
the mRuby2 gene [57] was amplified from the plasmid pcDNA3.1-Clover-mRuby2 (gift
from Kurt Beam, Addgene plasmid #49089) and the FusionRed gene was amplified from
the plasmid FusionRed-pBAD [76] (this plasmid differs from the pBad-plasmid used in this
work; gift from Michael Davidson, Addgene plasmid #54677). The coding sequences of the
RSFPs rsFusionRed2 and rsFusionRed3 were amplified from the plasmids rsFusionRed2-
pBAD and rsFusionRed2-pBAD, which were generated by introduction of the published
mutations [118] into the plasmid FusionRed-pBAD using site-directed mutagenesis
(carried out by Nickels Jensen). The coding sequence of rsCherry [91] was amplified from
the plasmid pQE31-rsCherry (laboratory of Prof. Stefan Jakobs, lab ID: P559), the coding
sequence of mCherry [58] from plasmid pRSET B-mCherry (gift of Prof. Roger Y. Tsien),
the coding sequence of dTomato [58] from plasmid pRSETB-dTomato (gift of
Prof. Roger Y. Tsien) and the coding sequence of DsRed [25] from plasmid DsRed1-N1-
pRSETA [156]. The PCR products were cloned into the pBad/His B backbone using XhoI
and EcoRI restriction sites and ligation.
2.1.9.2 Cloning of Bxb1 landing pad donor plasmid
A monoclonal Bxb1 landing pad cell line for screening and characterization of fluorescent
proteins in mammalian cells was established in this work. The design of the landing pad of
Duportet et al. [140] was taken as template to some extent to design a Bxb1 attP landing pad
suitable for screening. Two Bxb1 landing pad donor plasmids were cloned for CRISPR/Cas9
genome editing of mammalian cells [144, 157]. In addition to the landing pad, the first
donor plasmid contains a cytomegalovirus (CMV) promotor and a Bxb1 recombinase gene
for stable expression of the recombinase. The CRISPR/Cas9 approach using this donor
plasmid did not yield positive monoclonal clones, with the result that this experiment is not
part of this work. However, this donor plasmid was used for cloning of the second landing
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pad donor plasmid. Thus, the cloning of the first donor plasmid is also explained in the
following.
The two Bxb1 landing pad donor plasmids were cloned in several consecutive steps. All PCR
reactions were performed with the Q5 DNA polymerase. All primers used are listed in
Appendix Table 9. A scaffold for the designed landing pad was obtained by gene synthesis
(sequence: Appendix I; Genscript, Piscataway, NJ, USA). The plasmid pTRE-TIGHT-EGPF
[158] (provided by Rudolf Jaenisch, Addgene plasmid #22074), which contains the
homology arms for the adeno-associated virus integration site 1 (AAVS1), served as the
vector backbone (from the right homology arm to the bGH PolyA signal). In order to clone
the landing pad scaffold into the donor plasmid backbone, primers were designed using the
NEBuilder Assembly Tool v2.2 (NEB, Ipswich, MA, USA). The two DNA fragments
amplified with these primers were assembled by Gibson Assembly.
Next, the CMV promotor for the expression of the Bxb1 recombinase was cloned into the
generated plasmid. For this purpose, the CMV promotor was amplified from the plasmid
pmKate21-vimentin (Evrogen #FP318; Evrogen, Moscow, Russia) and cloned into the
donor plasmid backbone using AflII and PacI restriction and subsequent ligation. The
plasmid thus obtained was used as backbone for the next cloning step. The CAG promotor
for the landing pad was amplified from the plasmid pCAGEN [159] (gift from Connie
Cepko; Addgene plasmid #11160). The plasmid pCAGEN was restricted with EcoRI and
SalI prior to the PCR reaction for higher product yields of this GC-rich promoter. In
addition, 0.8 M Betaine (5 M stock solution, Sigma-Adrich, St. Louis, MO, USA) and 5 %
DMSO were added to this PCR reaction. The PCR product was cloned into the MluI and
SalI sites of the donor plasmid using restriction and ligation (plasmid map: see Appendix
Figure 6.1-1). To obtain the final Bxb1 landing pad donor plasmid used in this work, the
CMV-Bxb1 recombinase-SV40 polyA element was removed by restriction with AgeI and
subsequent religation with the T4 DNA ligase  (plasmid map: see Appendix Figure 6.1-2).
2.1.9.3 Cloning of integration plasmids for the Bxb1 landing pad cell line
To enable stable expression of transgenes in the generated Bxb1 landing pad cells, a basic
integration plasmid was designed and cloned which contains the Bxb1 attB site and a small
multiple cloning site (MCS). The MCS was intended for the incorporation of fluorescent
protein genes or fusion constructs.  In addition, a C-terminal element composed of a porcine
teschovirus-1 2A self-cleaving peptide sequence (P2A) and a Hygromycin resistance gene
was included in the basic integration plasmid, which facilitates the selection of genomic
modified cells after successful integration by the Bxb1 recombinase. This basic integration
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plasmid pInt-MCS-P2A-HygroR was assembled by two DNA fragments. The first DNA
fragment was received by gene synthesis (sequence: Appendix II; Genscript, Piscataway NJ,
USA). For the second fragment, the backbone of the plasmid pmKate2-vimentin (Evrogen
#FP318) without CMV promotor was amplified by PCR using the Q5 Polymerase protocol
(all primers: see Appendix Table 10).  The two DNA fragments were assembled using NheI
and XhoI restriction and subsequent ligation (plasmid map: see Appendix Figure 6.1-3).
The generated plasmid pInt-MCS-P2A-HygroR was then used to generate a series of
integration plasmids for stable expression of different transgenes and fusion constructs. The
Hygromycin resistance gene was replaced by either the coding sequence of mEGFP or the
coding sequence of mCherry using SacI and XmaI restriction. For this purpose, the  coding
sequence of mEGFP [105] was amplified from the plasmid pQE31-mEGFP [160] (provided
byTim Grotjohann; lab ID: P640) and the coding sequence of mCherry was amplified from
the plasmid pBad-mCherry (see chapter 2.1.9.1). Restriction and ligation into the linearized
vector resulted in the plasmids pInt-MCS-P2A-mEGFP and pInt-MCS-P2A-mCherry. In
addition, the coding sequence of mEGFP with altered codon usage at the N- and C-terminal
ends (codEGFP) was cloned alike into the integration plasmid using a different primer
combination (see Appendix Table 10). The resulting plasmid pInt-MCS-P2A-codEGFP
simplifies the screening procedure, as some fluorescent proteins have the same N- and C-
terminal ends as mEGFP. An integration plasmid without any C-terminal tag was cloned
by amplifying the entire basic integration plasmid except for the P2A-HygroR element with
the addition of BamHI restriction sites to both DNA ends. The BamHI restriction of the
PCR product and religation yielded the plasmid pInt-MCS.
For the stable expression of cytoskeletal fusion constructs in the Bxb1 landing pad cell line,
the vimentin and keratin coding sequences were cloned into different integration plasmids.
The vimentin gene was amplified from pmKate2-vimentin (Evrogen #FP318) and the
keratin gene from pTagRFP-keratin (Evrogen #FP369). The coding sequences of the two
cytoskeleton proteins were cloned into the integrations plasmids by KpnI and XbaI
restriction sites and ligation. An overview of the integration plasmids together with the lab
IDs is given in Appendix Table 11.
For the characterization of the Bxb1 landing pad cell line, the coding sequences of mEGFP
and mRuby2 were cloned into the MCS site of various integrations plasmids according to
Table 1 (primer sequences are listed in Appendix Table 12). To screen for improved Ru63
variants in the Bxb1 landing pad cell line, the error-prone protocol described in
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chapter 2.1.10.3 was applied. The error-prone Ru63 variants were then cloned into the
plasmid pInt-MCS-P2A-mEGFP.
Table 1: Cloning of specific integration plasmids.
Primer sequences are listed in Appendix Table 12.
Construct Amplicon Primer (lab ID) Restriction sites usedforward reverse
pInt-mEGFP-P2A-HygroR mEGFP 7596 7597 XbaI, BamHI
pInt-mRuby2-P2A-HygroR mRuby2 7598 7599 XbaI, BamHI
pInt-mRuby2-P2A-mEGFP mRuby2 7598 7599 XbaI, BamHI
pInt-Keratin-mEGFP-P2A-HygroR mEGFP 7761 8185 HindIII  EcoRI
pInt-Vimentin-mEGFP-P2A-HygroR mEGFP 7761 7597 HindIII, BamHI
pInt-Keratin-mRuby2-P2A-mEGFP mRuby2 7602 8186 HindIII, EcoRI
pInt-Keratin-Ru63-P2A-mEGFP Ru63 7602 8186 HindIII, EcoRI
2.1.9.4 Cloning of fusion constructs for expression in mammalian cells
Various plasmids were cloned to control the correct expression and localization of RSFP
fusion constructs in mammalian cells. Table 2 lists the generated expression plasmids along
with the respective cloning details. The primer sequences of the corresponding primer
numbers are listed in Appendix Table 13. All plasmids were cloned by exchanging the
fluorescent protein genes in the available expression plasmids with the coding sequence of
the intended red RSFP (FP in Table 2). In order to do this, the coding sequences of the
RSFPs were amplified using the Pfu DNA polymerase PCR protocol. The PCR products
were then cloned into the vector backbones using the stated restriction enzymes and DNA
assembly method. As Sc10 and Sc21 contain an internal NotI restriction site, the Gibson
Assembly method was applied for some of these constructs.
The plasmids pEGFP-Hist1H2BN (Homo sapiens histone 1, H2BN; lab ID: P766) and
pmEGFP-PTS (peroxisomal targeting signal; lab ID: P1272) (both published in Kamper et
al., 2018 [161]) were used as backbones for cloning of Histone1 and PTS fusion constructs.
The plasmid Caveolin1-mEGFP-N (plasmid map: see Appendix Figure 6.1-4; lab ID: P1219)
was cloned earlier in the research group of Prof. Stefan Jakobs and was available for cloning
of Caveolin1 fusion constructs. The plasmid pcDNA3.1_Lifeact-EGFP was a gift of Carola
Gregor (plasmid map: see Appendix Figure 6.1-5). In addition, the plasmids pTagRFP-
keratin (Evrogen #FP369), pDsRed1-Mito (mitochondrial targeting sequence; #6928-1,
Clontech, CA, USA, provided by Peter Lipp, UKS Homburg), pmKate2-vimentin (Evrogen
#FP318) and pEF/myc/ER (endoplasmic reticulum signal; Invitrogen, Thermo Fisher
Scientific, Waltham, MA, USA) were used as backbones for cloning.
For the comparison of the expression and maturation in mammalian cells, constructs of red
RSFPs with a C-terminal P2A-mEGFP sequence were produced. The P2A-mEGFP served
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as an internal expression reference. The plasmid mEGFP-N (lab ID: P1184) was cloned
earlier in the research group of Prof. Stefan Jakobs (PCR on the mEGFP gene with primers
TCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTC, GTCGCGGCC-
GCTACTTGTACAGCTCGTCCATGCCGAGAG, cloned into the backbone of TagRFP-N
(Evrogen #FP142) using AgeI, NotI restriction sites) and was chosen as vector backbone.
The coding sequences of the red RSFPs were amplified with addition of the C-terminal P2A
sequence. The PCR products were cloned into the mEGFP-N plasmid at the 5’ end of the
mEGFP gene (see Table 2).
Table 2: Cloning of mammalian expression vectors.
Primers, restrictions and DNA assembly methods for the respective fusion constructs are listed. FP: fluorescent
protein. Primer sequences are listed in Appendix Table 13.
Fusion
construct Amplicon/FP
Primer (lab ID) Restriction DNA assembly
methodforward reverse PCR product vector
Caveolin1-FP Sc21 4605 4604 / AgeI, NotI
Gibson
Assembly
Ru87 5532 4604 AgeI, NotI AgeI, NotI ligation
Keratin-FP Sc21 7674 4604 / KpnI, NotI
Gibson
Assembly
Ru87 5532 4604 KpnI, NotI KpnI, NotI ligation
Lifeact-FP Sc21 8723 8724 / BamHI, NotI
Gibson
Assembly
Ru87 8719 8720 BamHI, NotI BamHI, NotI ligation
Mito-FP Sc21 4605 4604 / AgeI, NotI
Gibson
Assembly
Ru87 5532 4604 AgeI, NotI AgeI, NotI ligation
Vimentin-FP
Sc10; Sc21 7674 4604 BamHI BamHI GibsonAssembly
Ru63; Ru85;
Ru87 5532 4604 AgeI, NotI AgeI, NotI ligation
FP-ER
Sc10; Sc21 9244 9246 / SalI, NotI GibsonAssembly
Ru63; Ru85;
Ru87 9245 9247 SalI, NotI SalI, NotI ligation
FP-Histone1
Sc10; Sc21 9243 9241 NheI, BglII NheI, BglII ligation
Ru63; Ru85;
Ru87 8640 9242 NheI, BglII NheI, BglII ligation
FP-PTS
Sc10; Sc21 9240 9241 NheI, BglII NheI, BglII ligation
Ru63; Ru85;
Ru87 8639 9242 NheI, BglII NheI, BglII ligation
FP-P2A-
mEGFP
Sc10, Sc21 9411 9412 AgeI, EcoRI AgeI, EcoRI ligation
rsFusionRed2;
rsFusionRed3 9415 9416 AgeI, EcoRI AgeI, EcoRI ligation
pInt-Keratin-FP
Sc10; Sc21 8854 8855 HindIII, EcoRI HindIII, EcoRI ligation
Ru63; Ru85;
Ru87 7602 8439 HindIII, EcoRI HindIII, EcoRI ligation
Vimentin-FP-
Donor
Sc10 9249 9250 / NotI, NcoI GibsonAssembly
Ru87 8359 8360 NotI, NcoI NotI, NcoI ligation
The stable expression of cytoskeleton proteins tagged with the novel RSFPs was investigated
in monoclonal cell lines. Hence, pInt-Keratin-FP constructs were generated (vector
backbone: see chapter 2.1.9.3). In addition, donor plasmids were prepared for Sc10 and
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Ru87 in order to tag the endogenous vimentin gene using CRISPR/Cas9 genome editing.
For this, the plasmid pUC57-VIM-Dreiklang-Donor [162] (provided by Michael Ratz) was
used as vector backbone as it contains the homology arms for integration of the fluorescent
proteins at the 3’ end of the endogenous vimentin gene.
2.1.10 Mutagenesis
For the development of novel red RSFPs, three different PCR-based mutagenesis strategies
were applied to add specific or random mutations into the fluorescent protein template in
the pBad vector. After each mutagenesis protocol, the plasmids containing the mutated
fluorescent proteins were dialyzed and used for transformation of E. coli cells (see
chapter 2.2.2). After one to two days of growth and expression at 37 °C, the agar plates were
used for screening (see chapter 2.4.1). For the analysis of the amino acids and the mutation
sites in the beta-barrel structures, available crystal structures of mRuby and mScarlet (PDB
files 3U0N and 5LK4) were visualized in PyMOL Molecular Graphic System (version 1.8;
Schrödinger, New York, NY, USA).
2.1.10.1 Site-directed mutagenesis
The site-directed mutagenesis based on the QuickChange™ protocol (Stratagene, La Jolla,
CA USA) was applied to mutate one specific amino acid. The chosen amino acid was
exchanged to a predetermined or to a random amino acid. Therefore, primers were
designed, which were complementary to the template sequence except for the base triplet of
the mutation site (primers: see Appendix Table 14). In addition to the introduction of a
mutation, the conducted PCR reaction was used to amplify the entire plasmid. The 10x PCR
buffer and dNTP stock solution mentioned in the PCR protocol for the Pfu DNA
Polymerase (see chapter 2.1.2.1) were also used in this protocol:
  200 ng template DNA
1 µl sense mutation primer (10 µM)
1 µl antisense mutation primer (10 µM)
5 µl 10x PCR buffer
1 µl dNTP stock solution (10 mM each)
1 µl Pfu DNA polymerase
filled up to 50 µl with H2O




95 °C 30 s
95 °C 1 min
55 °C 1 min 16 x
68 °C 10 min
68 °C 10 min
Following the PCR reaction, the template DNA was removed by digestion with 1 µl DpnI at
37 °C overnight.
2.1.10.2 Multiple-site mutagenesis
For mutagenesis of several specific amino acids in one PCR reaction, the protocol of the
multiple-site mutagenesis of Sawano and Miyawaki [163] was chosen. This mutagenesis
strategy is divided into two PCR reactions. In the first PCR, the mutated sense strand of the
entire plasmid is synthesized by applying several 5’ phosphorylated sense primer, which are
complementary to the template except for the base triplet to be mutated (primers: see
Appendix Table 14). The 10x Taq DNA ligase buffer and the Taq DNA ligase (40 U/µl; NEB,
Ipswich, MA, USA) were added to ligate the synthesized DNA strands. The PCR reactions
were prepared as described in the following:
200-400 ng template DNA
1.4 µl of each 5’ phosphorylated sense mutation primer (10 µM)
2.5 µl 10x PCR buffer
2.5 µl 10x Taq DNA ligase buffer
1 µl dNTP stock solution (10 mM each)
1 µl Pfu DNA polymerase
0.5 µl Taq DNA ligase
filled up to 50 µl with H2O
The first PCR was conducted using the following protocol:
Temperature Time
65 °C 5 min
95 °C 2 min
95 °C 30 s
55 °C 30 s 18x
65 °C 10 min
75 °C 7 min
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After this PCR reaction, 1 µl DpnI and 1.5 µl of an antisense primer, binding the pBad-
vector backbone, were added. The DpnI digestion of the template DNA and the second PCR
for the amplification of the antisense DNA strand were performed using the following
protocol:
Temperature Time
37 °C 60 min
95 °C 30 s
95 °C 30 s
55 °C 1 min 2x
70 °C 10 min
2.1.10.3 Error-prone mutagenesis
Error-prone (ep) mutagenesis was used to insert a few random mutations into a fluorescent
protein template. The PCR protocol of Leung et al. [164] served as basis for the applied
protocol. In the ep PCR reaction, Taq DNA polymerase (GoTaq G2 DNA Polymerase,
40 U/µl; Promega, Madison, WI, USA) was used to amplify the fluorescent protein from the
respective pBad plasmid. To obtain the desired mutation rate, MnCl2 (10 mM stock
solution) and an ep dNTP stock solution with unequal ratios of the dNTPs (2mM dATP,
2 mM dGTP, 10 mM dCTP, 10 mM dTTP; Thermo Fisher Scientific, Waltham, MA, USA)
were added to the PCR reactions. The 10x ep PCR buffer contained 100 mM Tris-HCl
(pH 8.3), 500 mM KCl, 70 mM MgCl2 and 0.1 % (w/v) gelatin (from bovine skin, type B;
Sigma-Adrich, St. Louis, MO, USA). Primers used for cloning of mRuby2 and mScarlet into
the pBad vector (see Appendix Table 8) were also used in the ep PCR reactions:
1 µg template DNA
10 µl sense primer (10 µM)
  10 µl antisense primer (10 µM)
10 µl 10x ep PCR buffer
10 µl 10x ep dNTP stock solution
  1.5-2.5 µl MnCl2 (10 mM)
2 µl Taq DNA polymerase
filled up to 100 µl with H2O
Each 100 µl PCR reaction was divided into four PCR reaction tubes, which were incubated




95 °C 1 min
95 °C 30 s
55 °C 45 s 30x
72 °C 1 min 30 s
72 °C 2 min
After the ep PCR reaction, the divided reactions were pooled again. The PCR fragments
were purified using gel extraction and cloned into the pBad-backbone using the EcoRI and
XhoI restrictions sites and ligation.
2.1.11 Genotyping of monoclonal cell lines
The genomic DNA from monoclonal cell line cultures was isolated using the GenElute
Mammalian Genomic DNA Miniprep Kit (Sigma-Adrich, St. Louis, MO, USA) according
to the manufacturer’s protocol. Genomic DNA concentrations were determined with the
NanoDrop1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). To
verify the appropriate genetic modification of the generated cell lines, the genomic DNA
sequences to be examined were amplified in PCR reactions using the Q5 DNA polymerase
(primers: see Appendix Table 15). The presence and size of the PCR products were
controlled in analytical agarose gels. Additionally, PCR products were purified with the
QIAquick PCR Purification Kit and sequenced using the primers of the PCR reaction.
2.2 Cell biological methods
2.2.1 Escherichia coli culture
The E. coli strain DH5α (MAX Efficiency DH5αF’IQ Competent Cells; Life Technologies,
CA, USA) was used for cloning purposes and plasmid amplification, while the E. coli strain
TOP10 (TOP10 Electrocomp Kits; Invitrogen, Waltham, MA, USA) was used for protein
expression. E. coli cells were cultivated at 37 °C either in liquid lysogeny broth (LB) medium
[165] composed of 0.5 % (w/v) yeast extract (PanReac Applichem, Darmstadt, Germany),
1 % (w/v) peptone (from Casein (pancreatic digest); PanReac Applichem, Darmstadt,
Germany), 0.5 % (w/v) NaCl and 0.5 % 1N NaOH, or on agar plates (1.4 % (w/v) agar in LB
medium). Agar plates were prepared in 9.2 cm round dishes or 12 x 12 cm square dishes.
The growth medium was supplemented either with 50 µg/µl ampicillin or 50 µg/µl
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kanamycin (both PanReac AppliChem, Darmstadt, Germany) for selection and with 0.02 %
arabinose (Sigma-Adrich, St. Louis, MO, USA) for induction of protein expression.
2.2.2 Transformation of E. coli
E. coli cells were transformed using electroporation. Electro-competent E. coli strains were
prepared by a modified protocol initially described by Dower et al. [166]. An overnight
culture of the respective E. coli strain (DH5α, TOP10) was used to inoculate LB medium
with a volume ratio of 1:100. The E. coli cells were cultured in LB medium at 37 °C to an
optical density of 0.6-1 at the wavelength of 600 nm. Cells were then incubated on ice for
30 min and afterwards centrifuged at 4 °C and 4811x g for 15 min. The supernatant was
discarded, the bacterial pellets were resuspended in 1:1 volume of chilled H2O compared to
the initial culture volume and again pelleted by centrifugation. The next washing step was
performed with 1:2 volume of chilled H2O. After another centrifugation step, the cells were
washed in 1:50 volume of 10% (v/v) glycerol. The cells were pelleted by centrifugation and
the supernatant was discarded. The cells were resuspended in 1:500 volume of 10 % (v/v)
glycerol, aliquoted in 50 µl portions to 1.5 ml tubes, flash frozen in liquid nitrogen and
stored at -80 °C.
For the transformation, electroporation cuvettes (2 mm gap size; cell projects, Harrietsham,
United Kingdom) were chilled on ice. 50-150 µl ice-cold water were added to one tube of
electro-competent E. coli cells. Cells were thawed on ice and carefully resuspended. 1 µl
isolated plasmid DNA or 5 µl of the dialyzed reaction were pipetted into the cooled cuvette.
50 µl of the electro-competent bacteria solution were added and gently mixed. The E. coli
cells were electroporated in the Bio-Rad Gene Pulser (Bio-Rad, Hercules, CA, USA) at
2.5 kV, 200 Ω and 25 µF. Immediately after electroporation, 1 ml LB medium was added to
the cells. After resuspension, the cells were transferred to a 1.5 ml tube and incubated at
37 °C for 1 h while shaking.
For screening (chapter 2.4.1), cloning (chapter 2.1.9) and protein purification (chapter
2.3.1), the transformation reactions were plated on agar plates with a suitable antibiotic for
selection and with 0.02 % arabinose in case of TOP10 cells. The plates were incubated for
one to two days at 37 °C. For screening of RSFPs using the Bxb1 landing pad cell line, 700 µl
of the transformation reaction were used for inoculation of 50 ml LB medium.
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2.2.3 Mammalian cell culture
U2OS and HeLa cell lines as well as all generated monoclonal cell lines were cultivated in
Dulbecco’s Modified Eagle’s Medium (DMEM) (with 4.5 g/L D-glucose, GlutaMAX, phenol
red; Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10 % fetal bovine
serum (FBS) (FBS Superior; Biochrom, Berlin, Germany), 1 mM sodium pyruvate
(100 mM stock solution; Sigma-Aldrich, St. Louis, MO, USA), 100 U/ml penicillin and
100 µg/ml streptomycin (10,000 unit/ml, 10,000 µg/ml stock solution; Biochrom, Berlin,
Germany). Cells were grown at 37 °C and 5 % CO2 in well plates or T25 flasks (TC, Standard;
Sarstedt, Nürnbrecht, Germany). For passaging of cells, the culture medium was removed
and the cells were washed twice with warm phosphate buffered saline (PBS; 137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, set to pH 7.4). After removal of the PBS,
the cells were covered with 0.05 % trypsin/0.02 % EDTA solution (10x stock solution;
Biochrom, Berlin, Germany) and incubated at 37 °C until the cells were released from the
well or flask bottom. The trypsin reaction was stopped by adding three- to four-fold volume
of medium. Cells were seeded to a new flask or well.
For transfections and for imaging purposes, mammalian cells were seeded into 6-well plates
either with circular cover glasses (diameter of 18 mm, No 1.5H; Marienfeld Superior, Lauda-
Königshofen, Germany) for microscopy or without. Cells were transfected the next day (see
chapter 2.2.4). Cover glasses with transfected cells or with cells of the generated monoclonal
cell lines were mounted to microscope slides with cavities filled with 25 mM HEPES
buffered DMEM without phenol red (Thermo Fisher Scientific, Waltham, MA, US).
2.2.4 Transfection of mammalian cells
For transfection of mammalian cells, 2-4 µg plasmid DNA were diluted in 400 µl serum-
and antibiotic-free DMEM medium. 6 µl of the TurboFect Transfection Reagent (Thermo
Fisher Scientific, Waltham, MA, USA) were added and reactions were vortexed for 15 s.
After a short centrifugation, the transfection reactions were incubated at room temperature
for 15 min and then added dropwise to the respective well. The cells were further incubated
at 37 °C and 5 % CO2. If cells were cultivated longer than one day after transfection, the
medium was substituted the next day.
In order to stably integrate an integration plasmid into the Bxb1 attP site, cells of the Bxb1
landing pad cell line were cotransfected with 1 µg of the respective integration plasmid and
1 µg of the plasmid pCAG-NLS-HA-Bxb1 [167] (gift from Pawel Pelczar; Addgene plasmid
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#51271). The plasmid pCAG-NLS-HA-Bxb1 enables transient expression of the Bxb1
recombinase with a nuclear localization signal.
For the tagging of an endogenous vimentin gene using CRISPR/Cas9 genome editing, U2OS
cells were cotransfected with 2 µg of the respective vimentin-FP-donor plasmid (chapter
2.1.9.4) and 2 µg of the plasmid px330-VIM-gRNA1 [97, 162] (provided by Michael Ratz;
lab ID: P2463) encoding the Cas9 protein and the gRNA GCGCAAGATAGATTTGGAAT.
The transfection protocol for the generation of the Bxb1 landing pad cell line differed from
this protocol (see chapter 2.2.4.1).
2.2.4.1 Transfection for the generation of Bxb1 landing pad cell lines
For the generation of the Bxb1 landing pad cell line using CRISPR/Cas9 genome
engineering, HeLa cells were cotransfected with the Bxb1 landing pad donor plasmid
(chapter 2.1.9.2) and the plasmid px458-AAVS1 gRNA2 (gift of Till Stephan; lab ID: P2120;
backbone: pSpCas9(BB)-2A-GFP [143]), which encodes the Cas9 protein and the gRNA
sequence TGTCCCTAGTGGCCCCACTG. 100 µl serum- and antibiotic-free DMEM
medium were mixed with 1.2 µg of the px458-AAVS1 gRNA2 plasmid, 1.8 µg of the Bxb1
landing pad donor plasmid and 10.5 µl of the FuGENE HD Transfection Reagent (Promega,
Madison, WI, USA). The mixture was vortexed for 1 min and incubated at room
temperature for 20 min. After the incubation time, the complete transfection reaction was
added dropwise to the respective well. Cells were further cultivated at 37 °C and 5 % CO2.
These transfected cells were selected using the antibiotic Puromycin (see chapter 2.2.5) prior
to the single-cell sorting into 96 well plates (see chapter 2.2.6).
2.2.5 Antibiotic selection of cells
Antibiotic selection of genomic edited cells was realized by incubation in culture medium
supplemented with 1.25 µg/ml Puromycin (10 mg/ml stock solution; Invivogen, San Diego,
CA, USA) or 400 µg/ml Hygromycin B (50 mg/ml stock solution; Calbiochem, Darmstadt,
Germany). After three to four days, the antibiotic medium was replaced by the standard
cultivation medium. The Hygromycin B selection of K21 cells with positive integration was
controlled in the Cytation 3 Cell Imaging Multi-Mode Reader (BioTek, Winooski, VT,
USA) using the 465 nm LED.
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2.2.6 Flow cytometry of mammalian cells
Flow cytometry was used for sorting of single mammalian cells into 96-well plates in order
to generate monoclonal cell lines. Moreover, flow cytometry was applied for analysis of the
expression and maturation of RSFPs in HeLa cells. For these experiments, a group-modified
BD Influx cell sorter (BD Biosciences, Franklin Lakes, NJ, USA) was used. The mammalian
cells were released from the flask or well bottoms with trypsin as described above (chapter
2.2.3). The released cells were centrifuged at 100x g. Afterwards, the cell pellets were
resuspended in PBS. The PBS washing step was performed twice and subsequently cells were
again resuspended in PBS. The cells were sorted and analyzed by using lasers at 488 nm
(Genesis CX488; Coherent, Santa Clara, CA, USA) and 561 nm (Jive 75; Cobalt, Solna,
Sweden) for excitation. The green fluorescence was detected in the range of 495-525 nm,
while the two detection windows of 570-640 nm and above 645 nm (645 LP filter) were
analyzed for red fluorescence.
2.2.7 Generation of monoclonal cell lines
After single-cell sorting into 96-well plates using the flow cytometer, cells were cultivated
for 2-3 weeks. Cell colonies were then released from the 96-well plate bottom by removing
the culture medium and adding 100 µl Accutase Cell Detachment Solution (Capricorn
Scientific, Ebsdorfergrund, Germany). After 15 min of incubation at room temperature,
cells were resuspended and transferred to a 24-well plate containing 1 ml culture medium
per well. The monoclonal cell line cultures were further cultivated, characterized and
positive clones were frozen for long-time storage (see chapter 2.2.8).
To screen for positive Bxb1 landing pad cell lines, a part of the cell clones were seeded in
additional 24-well plates and cotransfected with pCAG-NLS-HA-Bxb1 and pInt-mEGFP-
P2A-HygroR (chapter 2.2.4). Transfected cell clones were controlled for green fluorescence
in the Cytation 3 Cell Imaging Multi-Mode Reader (BioTek, Winooski, VT, USA) using the
465 nm LED. For all other generated monoclonal cell lines, the stable transgene expression
was directly controlled in confocal microscopy (see chapter 2.4.2). In addition, genotyping
using PCR reactions (see chapter 2.1.11) was performed to control for the accurate genomic
modification.
2.2.8 Freezing of mammalian cell lines
For long-time storage of the generated monoclonal cell lines, cells were released from the
well or flask bottom using trypsin (chapter 2.2.3). After addition of cell culture medium, the
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entire cell suspension of a 24-well or 1/3 cell suspension of a T25 flask were centrifuged at
100x g for 5 min. The cell pellets were resuspended in 1 ml freezing medium (DMEM
supplemented with 20 % FBS, 10 % dimethyl sulfoxide (Hybri-Max; Sigma-Aldrich, St.
Louis, MO, USA)) and transferred into a 1.8 ml cryo tube. The tube was immediately placed
in a -80 °C freezer inside a freezing container. After at least 24 h, the cryo tube was
transferred into a nitrogen tank for long-time storage.
2.3 Characterization of purified fluorescent proteins
2.3.1 Isolation of histidine-tagged fluorescent proteins
Solutions of purified fluorescent proteins were used to analyze the spectral characteristics,
the pH stability and the oligomerization state of the RSFPs of interest (see chapters below).
For protein purifications, the fluorescent proteins were expressed with an N-terminal poly-
histidine tag from the respective pBad plasmid in TOP10 colonies grown on 12 x 12 cm
square agar plates at 37 °C for two days (induction of the protein expression by arabinose).
Two agar plates were used per fluorescent protein and per purification.
2.3.1.1 Isolation of switchable mScarlet variants and proteins for comparison
For the isolation of the switchable mScarlet variants and the fluorescent proteins for
comparison, 2-3 ml binding buffer (20 mM sodium phosphate, 0.5 M NaCl, 20 mM
imidazole, pH 7.4, prepared using the His Buffer Kit; GE Healthcare, Chicago, IL, USA)
were added to each agar plate and the bacterial colonies were scraped up using cell scrapers
(Blade 25; Sarstedt, Nürnbrecht, Germany). The bacteria were resuspended and 1.8-2 ml of
the suspension were transferred to a 2 ml tube on ice. Lysozyme (SERVA, Heidelberg,
Germany) (stock solution: 50 mg/ml) was added to a final concentration of 1 mg/ml for the
lysis of the bacterial cells. After 3-4 h of incubation, 80 µl protease inhibitor were added
(1 tablet solved in 2 ml H2O, cOmplete, EDTA-free Protease Inhibitor Cocktail; Roche
Diagnostics, Rotkreuz, Switzerland). The samples were frozen in liquid nitrogen and
subsequently thawed in warm water. After five freeze-thaw cycles, 0.5 µl Benzonase nuclease
(250 U/µl; Sigma-Aldrich, St. Louis, MO, USA) was added to each sample and incubated for
15 min. The samples were centrifuged at 16,200x g and 4 °C for 1.5-3 h to separate the
protein solution from the cell fragments. The supernatant was transferred to a new 2 ml
tube and stored at 4 °C. On the next day, the proteins were again centrifuged at 16,200x g
and 4 °C for 0.5-2 h.
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The histidine-tagged fluorescent proteins were isolated from other proteins by Ni-NTA
affinity chromatography using the spin columns His SpinTrap (GE Healthcare, Chicago, IL,
USA). Three spin columns were used per fluorescent protein. All centrifugation steps were
carried out at 100x g for 1 min. The spin columns were washed with 600 µl binding buffer
and the flow through was discarded. Up to 600 µl of the supernatant containing the
fluorescent proteins were added to the spin columns and the columns were incubated on a
rotator for 30 min. After the next centrifugation step, the remaining protein samples were
added to the spin columns, again incubated on the rotator for 30 min and centrifuged.
Subsequently, the spin columns were washed twice with 600 µl binding buffer and twice
with 200 µl washing buffer (20 mM sodium phosphate, 0.5 M NaCl, 50 mM imidazole pH
7.4). For elution of the fluorescent proteins, 200 µl elution buffer (20 mM sodium
phosphate, 0.5 M NaCl, 500 mM imidazole pH 7.4) were added to the columns and
incubated for 5 min. After centrifugation, the elution step was repeated once or twice. Eluted
samples of equal fluorescent proteins were united.
The purified protein samples were concentrated at 2700x g to a final volume of 150-400 µl
using the Vivaspin Turbo 4 Ultrafiltration Units (10,000 MWCO; Sartorius, Göttingen,
Germany). The buffer of the concentrated protein samples was exchanged using illustra
NAP5 columns (Sephadex G-25; GE Healthcare, Chicago, IL, USA), which were
equilibrated with protein buffer (100 mM Tris, 150 mM NaCl, set to pH 7.5). The protein
samples were added to the NAP5 columns and when the samples had sunk, protein buffer
was added again. Once the proteins eluted (visible by the color of the proteins), the protein
solutions were collected.
2.3.1.2 Purification of switchable mRuby2 variants and reference proteins
Since the final switchable mRuby2 variants precipitated during the protein isolation
protocol described in chapter 2.3.1.1, the protocol was adjusted for the isolation of these
RSFPs and for the fluorescent proteins for comparison. The changes include the addition of
1 mM EDTA to the binding buffer. The E. coli colonies on the agar plates were scraped off
as described in chapter 2.3.1.1 and incubated with 1 mg/ml lysozyme on ice for 2 h. After
the addition of the protease inhibitor, cells were lysed by sonication (duty cycle 40, output
control 4, 4x 15 s, 3 mm tip, Sonifier 450; Branson Ultrasonics, Danbury, CT, USA). The
incubation with Benzonase at room temperature was followed by addition of DTT
(1 M stock solution) to a final concentration of 1 mM. Cell fragments were separated by




For protein isolation and buffer exchange, 1 mM EDTA and 1 mM DTT were added to the
binding, washing, elution and protein buffer. Apart from that, the proteins in the
supernatant were isolated with His SpinTraps columns as described in chapter 2.3.1.1. The
elution step was only performed twice. The eluted proteins were not concentrated, but
immediately transferred into the protein buffer using the NAP5 columns as described
above. Purified proteins were stored covered at room temperature and characterized within
the next three days.
2.3.2 Determination of protein concentration
The protein concentration of isolated fluorescent protein samples was determined using the
Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA), which is based on the method of
Bradford [168]. 1-3 µl protein sample were diluted in 800 µl H2O and 200 µl Protein Assay
Dye Reagent Concentrate (Bio-Rad, Hercules, CA, USA) was added. After 5 min of
incubation, the absorbance at 600 nm was measured. The protein concentration was
calculated using a BSA standard curve.
2.3.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis
The isolation of the fluorescent proteins was controlled by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). The SDS gels were composed of a 5 %
stacking gel and a 15 % separation gel. For two separation gels, the following components
were mixed and poured into Mini-PROTEAN Tetra spacer plates (Bio-Rad, Hercules, CA,
USA):
3.45 ml H2O
3.75 ml separation gel buffer (1.5 mM Tris-HCl, pH 8.8)
7.5 ml 30 % (w/v) acrylamide / 0.8 % (w/v) biscarcylamide (Rotiphorese
Gel 30; Carl Roth, Karlsruhe, Germany)
150 µl 10 % (w/v) SDS
150 µl 10 % (w/v) ammonium persulfate (APS)
15 µl tetramethylethylenediamine (TEMED)
The gel solutions were covered with water-saturated isopropanol. When the gels were
completely polymerized, the isopropanol was discarded. The stacking gels were prepared as




2.5 ml stacking gel buffer (0.5 mM Tris-HCl pH 6.8)
1.7 ml 30 % (w/v) acrylamide / 0.8 % (w/v) biscarcylamide
100 µl 10 % (w/v) SDS
100 µl 10 % (w/v) APS
10 µl TEMED
A comb for 10 wells was inserted to prepare sample slots. 10 µl of the protein samples
(0.2 µg/µl) were mixed with 2 µl of a 6x SDS loading buffer (0.35 M Tris-HCl pH 6.8,
10.28 % (w/v) SDS, 36 % (v/v) glycerol, 0.6 M DTT, 0.012 % (w/v) bromophenol blue) and
boiled at 95 °C for 5 min. The protein samples and 5 µl of the size standards PageRuler
Prestained Protein Ladder (Thermo Fisher Scientific, Waltham, MA, USA) were loaded to
the 15 % SDS gels placed in the Mini-PROTEAN Tetra Cell system (Bio-Rad, Hercules, CA,
USA). The proteins were separated in SDS running buffer (25 mM Tris-HCl pH 6.8,
192 mM glycerol, 0.1 % (w/v) SDS) at 20-40 mA.
The proteins in the SDS gels were stained in protein staining solution (0.05 % (w/v)
Coomassie Brilliant Blue R-250, 25 % (v/v) isopropanol, 10 % (v/v) acetic acid) for 30 min.
The stained gels were destained in 10 % (v/v) acetic acid and afterwards recorded in the
Amersham Imager 600 (GE Healthcare, Chicago, IL, USA) in colorimetric epi-illumination
mode.
2.3.4 Analytical size-exclusion chromatography
The oligomeric state of the fluorescent proteins was controlled by analytical size-exclusion
chromatography in a Superdex 200 Increase 10/300 L column (GE Healthcare, Chicago, IL,
USA) using the chromatography system ÄKTA pure (GE Healthcare, Chicago, IL, USA).
The size-exclusion chromatography was conducted at 6 °C and at a constant flow rate of
0.75 ml/min (protein buffer, see chapter 2.3.1.1). 250 µl of the purified protein solutions
diluted to 10 µM were applied to the column. The elution of proteins was detected by
absorption measurements at 280 nm.
2.3.5 Measurement of absorption spectra
The absorption spectra of isolated protein samples were measured in a quartz cuvette with
an optical path length of 1.5 mm (105-252-QS; Hellma, Müllheim, Germany) using the Cary
4000 UV VIS spectrophotometer (Varian, Palo Alto, CA, USA). The protein samples were
diluted in protein buffer to an absorption of about 0.1 at 280 nm. For data analysis, baselines
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were subtracted from the spectra. The corrected spectra were normalized to 280 nm peak
absorbance and the spectra of replicates were averaged.
For the absorption spectra of on- and off-states, Sc10 and Sc21 were switched in a quartz
cuvette with an optical path length of 1 mm (QS; Hellma, Müllheim, Germany) and
subsequently spectra were recorded. The switching was performed by illumination of the
protein samples with a fiber coupled mercury vapour lamp (Leica Microsystems, Wetzlar,
Germany) for 1 min. For off-switching, a 550/40 nm band pass filter was used, while a
450/40 nm band pass filter was used for on-switching. The relaxation from the off-state to
the equilibrium state was observed for Sc10 and Sc21 by repeated measurements without
further illumination. The peak absorption of the deprotonated red chromophore at 570 nm
was plotted against the time to determine the thermal relaxation kinetics and fitted by a
monoexponential function using the iteration algorithm Levenberg Marquardt in
OriginPro 2016 (OriginLab, Northampton, MA, USA).
2.3.6 Measurement of excitation and emission spectra
The excitation and emission spectra were recorded for the same protein samples used in the
measurements of absorption spectra. Measurements were performed in the quartz cuvette
with an optical path length of 1.5 mm (105-252-QS; Hellma, Müllheim, Germany) using the
Cary Eclipse fluorescence spectrophotometer (Varian, Palo Alto, CA, USA). The slit size
was set to 5 nm. For the spectra of mScarlet and the switchable mScarlet variants, the PMT
voltage was set to 560-570 V, and for the spectra of mRuby2 and the switchable mRuby2
variants to 600 V. The excitation and emission spectra of replicates were averaged and
normalized to the fluorescence maximum, respectively.
2.3.7 Determination of quantum yields and extinction coefficients
The quantum yield (QY) and the extinction coefficient (ε) were determined for the
switchable mRuby2, mScarlet and FusionRed proteins. For this purpose, the absorption and
emission spectra of the RSFP and of the respective reference protein were measured
consecutively in the same cuvette, as described in chapter 2.3.5 and 2.3.6. The protein
mRuby2 served as reference for Ru63, Ru85 and Ru87, mScarlet for Sc10 and Sc21 and
FusionRed for rsFusionRed2 and rsFusionRed3. For Sc10 and Sc21, the QY and ε of the on-
state (on-switching with band pass 450/40 nm: see chapter 2.3.5) was determined
additionally to the QY and ε of the equilibrium state.
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For the determination of ε, the absorption spectra were corrected and normalized to the
absorption at 280 nm as described in chapter 2.3.5. As the extinction coefficient at 280 nm
did not differ for the RSFPs and their respective reference protein, no further corrections
were necessary. To calculate the ε, the ratio of the peak absorbance (deprotonated
chromophore) of the RSFP to the peak absorbance of the reference protein was multiplied
with the published ε of the reference protein.
For the relative determination of the QY, the integral of the emission spectrum was divided
by the absorbance at the chosen excitation wavelength. The ratio of this value for the RSFP
to the value for the respective reference protein was multiplied with the published QY of the
reference protein to determine the QY of the RSFP (relative method). In addition, the
absolute QY for Sc10 and Sc21 was measured using the quantum yield spectrometer
Quantarus-QY Absolute PL (Hamamatsu Photonics, Hamamatsu, Japan). The protein
concentrations were adopted to a maximal absorption of 0.1 at 540 nm by dilution with
protein buffer. For Ru63, Ru85 and Ru87, the absolute QY was measured by Alexey I.
Chizhik (Third Institute of Physics, Georg August University, Göttingen) using nanocavity-
based fluorescence quantum yield measurements described in Chizhik et al., 2013 [169].
2.3.8 Measurement of the pH stability and pH-dependent absorption spectra
To investigate the influence of the pH on the absorption and fluorescence of the generated
RSFPs, the purified fluorescent protein samples were diluted in buffers of different pH to
an end concentration of 5 µM (dilution: 1:20 for Ru63, Ru85, Ru87; 1:40 for Sc10, Sc21).
Each buffer contained 150 mM NaCl. Additionally, the buffers of pH 3 to 5.5 were
composed of 100 mM citric acid, and the buffers of pH 6 to 7 of 100 mM KH2PO4. The
buffers of pH 7.5 to 8.5 consisted of 100 mM Tris, and the buffers of pH 9 to 10 of 100 mM
Glycin. The pH values were adjusted with 1 N NaOH or 1N HCl.
The absorption spectra and the fluorescence of the different pH samples (3 replicates each)
were measured with respective blanks in 96-well plates (UV Star Microplate; Greiner Bio-
One, Kremsmünster, Österreich) using the Cytation 3 Cell Imaging Multi-Mode Reader
(BioTek, Winooski, VT, USA). For data anaylsis, the spectra of the respective blanks were
subtracted first, then the baselines. The corrected absorption spectra of the replicates were
averaged and normalized to the absorption at 280 nm. For the determination of the pKa
values, the fluorescence of the replicates were averaged, normalized to pH 9.5 and plotted
against the pH values of the buffers. The curves were fitted to the function
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y = maxvalue/(1+(pH/pKa)slope) [170] using the iteration algorithm Levenberg Marquardt in
OriginPro 2016 (OriginLab, Northampton, MA, USA).
2.3.9 Determination of the fluorescence lifetimes
The fluorescence lifetimes of Sc10 and Sc21 was determined using the fluorescence lifetime
spectrometer Quantaurus-Tau (Hamamatsu Photonics, Hamamatsu, Japan). 10,000 counts
were acquired to obtain fluorescence decay curves of the purified Sc10 and Sc21 samples
excited with the LED at 590 nm. The instrument response function was measured using
0.1 µm microspheres (Polybead Amino Microspheres 0.10μm; Polysciences, Warrington,
PA, USA). The fluorescence decay curves were fitted with a 2nd order exponential fit to read
out the average fluorescence lifetimes <τ>. The fluorescence lifetimes of Ru63, Ru85 and
Ru87 were measured and provided by Alexey I. Chizhik (see chapter 2.3.7).
2.4 Microscopy
2.4.1 Automated microscopy for screening and switching characterization
The screening for improved switchable fluorescent proteins and the switching
characterization of RSFPs were performed with an automated microscope, which was
constructed earlier within the research group. The automated microscope is based on a
Leica DM5500 B upright microscope (Leica Microsystems, Wetzlar, Germany) equipped
with a 20x/0.4 NA objective (N Plan; Leica Microsystems, Wetzlar, Germany). Four lasers
with the wavelengths of 405 nm (MLD, 100 mW), 445 nm (MLD, 50 mW), 488 nm (MLD,
50 mW) and 561 nm (Jive, 50 mW) (all: Cobolt, Solna, Sweden) were used in this work. The
beam splitter HC BS R561 and the bandpass filter 605/70 ET (AHF analysentechnik,
Tübingen, Germany) were used to separate the excitation and emission light. The
fluorescence signal was detected by a photomultiplier tube (Hamamatsu Photonics,
Hamamatsu, Japan). The microscope was controlled by a custom-made software
programmed within the group using the LabVIEW platform (National Instruments, Austin,
TX, USA). The sample rate was set to 10-200 µs depending on the switching times. An
autofocus using the 561 nm laser with an intensity of 1.9 kWcm-2 was applied before each
measurement. All measurements were conducted at room temperature. The
implementation of the screening and the characterization of RSFPs as well as the
investigated switching parameters are described in the following.
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2.4.1.1 Screening for new and improved red RSFPs
The mutant fluorescent protein libraries (see chapter 2.1.10) were expressed cytosolic in
bacterial colonies on agar plates grown at 37 °C for two days. The screening for new and
improved RSFPs was realized by direct movement to positions of selected colonies or by
stepwise automated scanning for colonies. In the second approach, a short 561 nm laser
pulse was applied at each position. Only if the fluorescence read-out was higher than a
defined threshold, the switching scheme was applied. For switching, light of 561 nm (9.2-
14.5 kWcm-2) and 445 nm (2.5-14.9 kWcm-2) was used alternating. The chosen switching
scheme was adjusted to the switching characteristics of the template protein. The alternating
irradiation at 445 nm (14.9 kWcm-2) for 10 ms and at 561 nm (14.5 kWcm-2) for 22 ms
represents an exemplary switching scheme, which was applied for the screening of positive-
switching RSFPs. The negative-switching RSFPs were switched for instance by alternating
irradiation at 445 nm (2.5 kWcm-2) for 20 ms and at 561 nm (14.5 kWcm-2) for 170 ms.
The acquired switching data was analyzed in respect to the fluorescence signal in the on-
state, the residual fluorescence in the off-state, the switching fatigue and the switching speed
(see chapters 2.4.1.3-2.4.1.5). If switching curves with improved characteristics were
obtained, the respective colony was picked and used for inoculation of an overnight culture
(5 ml). Thereupon, the pBad plasmid with the RSFP variant was isolated (chapter 2.1.1) and
the added mutations were analyzed by sequencing (chapter 2.1.8). New RSFP variants were
characterized using the automated microscope and if appropriate, applied as templates for
the next mutagenesis and screening round.
2.4.1.2 Switching characterization of new red RSFPs
The red RSFPs to be analyzed were as well expressed cytosolic from pBad plasmids in
bacterial colonies on agar plates. For the detailed characterization of switching, the
automated microscope was directed to selected bacterial colonies, where a suitable
switching scheme was applied for the respective analysis. To compensate for variations
caused by expression differences and technical fluctuations, the switching scheme was
applied to 5 or 10 colonies at two or three different days each. An overview of the switching
schemes and analysis are given in the following. The applied light intensities and switching
times are given in the results part.
2.4.1.3 Effective cellular brightness in E. coli and off-state fluorescence
Both, novel RSFPs and mutant RSFP libraries were analyzed regarding their fluorescence
signal in the on-state and the residual fluorescence in the off-state. To analyze these two
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parameters, the positive-switching RSFPs were switched into the off-state at 445 nm and
subsequently switched completely on at 561 nm. The effective ensemble brightness was read
out by the fluorescence signal in the on-state. The residual fluorescence in the off-state was
obtained by dividing the first measurement point of the on-switching curve by the averaged
last 10 points. The negative-switching red RSFPs were first switched to the on-state at
445 nm and subsequently switched completely off at 561 nm. The first point of the off-
switching curve was used to determine the effective ensemble brightness in the on-state.
The averaged last 10 points of the off-switching curve was divided by the first point to obtain
the residual fluorescence in the off-sate.
2.4.1.4 Switching kinetics
During screening for faster switching red RSFPs, the halftime of the 561 nm induced
switching curves was roughly estimated using the custom-made screening software. For the
final RSFP variants, the switching halftimes of the on- and off-switching were analyzed in
more detail. To do this, the RSFPs were switched off (positive-switching) or on (negative-
switching) with light of 445 nm and subsequently switching curves were acquired by
irradiation with varying 561 nm laser intensities. These switching curves were fitted by a
biexponential function (ExpDec2 or ExpGro2) using the iteration algorithm Levenberg
Marquardt in OriginPro 2016 (OriginLab, Northampton, MA, USA). The switching
halftimes for each 561 nm laser intensity was determined.
The switching of red RSFPs with light of 445 nm cannot be tracked due to insufficient
fluorescence emission induced by this wavelength. However, to obtain switching curves of
the 445 nm switching, the proteins were first completely switched on (positive-switching)
or off (negative-switching) with light of 561 nm and then irradiated at 445 nm with varying
switching times (0-500 ms). This was followed by a fluorescence readout using light of
561 nm. The ratio of the first readout signal to the fluorescence signal in the on-state was
plotted against the 445 nm switching times. The resulting switching curves were then fitted
and analyzed as described above. In addition, switching curves were acquired by
simultaneous irradiation at 405 nm, 445 nm or 488 nm and at 561 nm. These curves were
analyzed as well.
2.4.1.5 Switching fatigue
Another parameter analyzed in the screening and characterization is the switching fatigue
of the RSFPs occurring through the destruction of the fluorescent proteins during repetitive
switching. In the screening for improved RSFPs, all RSFP variants on the same agar plate
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were repetitively switched with the same switching scheme. In the evaluation, the ratio of
the on-state fluorescence signals in the first and in the last switching cycle was compared
for all variants. The residual fluorescence in the off-state of the last switching cycle was
additionally analyzed.
To compare the switching fatigue of the new developed RSFPs with the switching fatigue of
published RSFPs, the fluorescent proteins were switched on and off for 250-500 switching
cycles. The illumination duration were chosen on the basis that the RSFPs were switched on
to 90 % (negative-switching) or 95 % (positive-switching) of the maximal fluorescence
signal. The off-switching times were selected that each protein was switched off by 95 % of
its potential off-switching range (1-0.95*(1–relative fluorescence in the off-state)).
To compare the switching fatigue for different switching wavelengths, a fixed switching
scheme was applied for 100-250 switching cycles. All switching fatigue curves were
normalized to the second switching cycle to exclude incomplete switching and altered
bleaching behavior often found in the first switching cycle.
2.4.1.6 Equilibrium state and relaxation kinetics
The equilibrium state of the red RSFPs was determined by dividing the first fluorescence
signal without previous irradiation except for the autofocus by the fluorescence signal in the
on-state using the same 561 nm laser intensity. A break of 15 s was applied between the
autofocus and the measurements.
For the final switchable mRuby2 variants, the thermal relaxation from the on- and off-state
to the thermal equilibrium was investigated using the automated microscope. This was
realized by switching the proteins completely on (30 ms 561 nm, 14.5 kWcm-2) or off (12 ms
445 nm, 14.9 kWcm-2) followed by a break with varying length. Next, the switchable
mRuby2 variants were irradiated with light at 561 nm (14.5 kWcm-2) for 30 ms. The ratio
of the first fluorescent signal after the break to the on-state signal was plotted against the
duration of the break.
2.4.2 Confocal microscopy of fusion constructs
The confocal imaging of RSFP fusion constructs expressed in mammalian cells was
performed at the confocal laser scanning microscope Leica TCS SP8 (Leica Microsystems,
Wetzlar, Germany) using a 63x/1.4 NA oil objective (HC PL APO CS2; Leica Microsystems,
Wetzlar, Germany). The fluorescent proteins were excited at 561 nm. Sc10 and Sc21 were
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simultaneously irradiated at 458 nm for on-switching of the proteins. The pinhole was set
to 1 Airy unit and the fluorescence emission was detected from 570 nm to 630 nm.
2.4.3 Characterization of the new RSFPs for RESOLFT microscopy
The red RSFPs developed in this work were analyzed for their applicability in live-cell
RESOLFT nanoscopy. Two different RESOLFT microscopes were used for these
experiments depending on the switching mode of the respective RSFP (see below).
2.4.3.1 Characterization of switchable mRuby2 variants for RESOLFT microscopy
For the switching of Ru63, Ru85 and Ru87 fused to vimentin and for the establishment of
RESOLFT imaging, an RESOLFT quad scanning microscope (Abberior Instruments,
Göttingen, Germany) was adapted to the needs of the red positive-switching RSFPs by
Sebastian Schnorrenberg. The RESOLFT microscope, which is based on an Olympus IX83
inverted microscope stand, was extended by a 561 nm laser (Jive 500 mW; Cobalt, Solna,
Sweden) for on-switching and readout with a Gaussian profile. Furthermore, a laser diode
at 445 nm (MLD 80 mW, fiber pigtailed; Cobalt, Solna, Sweden) was added to the
microscope. The Easy3D Upgrade (spatial light modulator for 400-700 nm; Abberior
Instruments, Göttingen, Germany) enabled a doughnut-like shape for the 445 nm beam in
the focal plane, which was used for off-switching.
A 100x/1.4 NA oil objective (UPLSAPO; Olympus, Tokyo, Japan) was used for imaging and
the pinhole was set to 1 Airy unit for all measurements. The fluorescence signal was detected
above 568 nm using an avalanche photodiode (APD). The RESOLFT microscope was
controlled by the software Imspector (Imspector0.12.10680M; Abberior Instruments,
Göttingen, Germany). The alignment of the laser beams was controlled by the beam
reflection at 80 nm gold beads and its detection with a photomultiplier tube (Figure 2.4-1).
The point spread functions were additionally controlled using TetraSpeck Microspheres
(0.1 µm; Thermo Fisher Scientific, Waltham, MA, USA) and fluorescence detection by the
APD.
A pulse generator (9520 Series; Quantum Composers, Bozeman, MT, USA) was utilized for
the pixel-wise acquisition of switching curves. The vimentin fusion constructs were
irradiated with the 445 nm doughnut-shaped beam (0.48 kWcm-2) for 8 ms to switch the
RSFPs off. After a break of 2 ms, the positive-switching proteins were switched on with the
561 nm Gaussian-shaped beam (0.43 kWcm-2) for 20-25 ms. The switching curves of all
pixels of the chosen section were added up.
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Figure 2.4-1: Examples for beam reflections at gold beads.
Example for the alignment of the RESOLFT microscope used for the positive-switching mRuby2 variants.
A: Reflection of the 561 Gaussian-shaped beam B: Reflection of the 445 nm doughnut-shaped beam. Scale
bars: 0.2 µm. C: Overlay of the line profiles of the cross sections shown in A and B. The fluorescence was
normalized to the maximal signal. Black: 445 nm doughnut-shaped beam; red: 561 nm Gaussian-shaped
beam.
The RESOLFT imaging of the keratin18-Ru63 filaments was conducted pixel-by-pixel with
a dwell-time of 4.95 ms. The applied pulse scheme was 2 ms on-switching with the 561 nm
Gaussian-shaped beam (0.64 kWcm-2), followed by 2 ms off-switching with the 445 nm
doughnut-shaped beam (0.48 kW/cm-2) and subsequent readout for 944 µs by excitation at
561 nm (0.64 kWcm-2). The confocal image of the same image section was acquired by 2 ms
on-switching with the Gaussian 561 nm beam and subsequent readout for 944 µs by
excitation at 561 nm (0.43 kWcm-2). The images of the first 200 µs readout time was used
for comparison of the confocal and the RESOLFT image.
2.4.3.2 Characterization of switchable mScarlet variants for RESOLFT microscopy
A RESOLFT microscope built by Abberior Instruments (Göttingen, Germany) was used for
the switching of Sc10, Sc21, rsFusionRed2 and rsFusionRed3 fused to vimentin. The
microscope is equipped with a 405 nm and a 561 nm laser. The 561 nm beam is divided into
two beam paths. One of them can be modulated by a spatial light modulator to either a
Gaussian or a doughnut-shaped beam. The pinhole was set to 1 Airy unit and a 100x/1.4 NA
oil objective (UPLSAPO; Olympus, Tokyo, Japan) was used for all measurements. The
microscope was controlled by the software Imspector (Imspector16.1.7707; Aberrior
Instruments, Göttingen, Germany). The fluorescence emission was detected in the range of
580 to 630 nm. The alignment of the three beams was done as described in chapter 2.4.3.1.
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The switching curves of the vimentin fusion constructs were acquired pixel-by-pixel using
a pulse generator (9400 Series; Quantum Composers, Bozeman, MT, USA). The red
negative-switching RSFPs were switched on for 12 ms by irradiation with the Gaussian-
shaped 405 nm beam (0.35 or 1.65 kWcm-2). Subsequently, the proteins were switched off
using the modulatable 561 nm beam with a Gaussian profile (1.44 kWcm-2). The switching
curves of all pixels were added up.
2.4.4 Image analysis
The recorded confocal and RESOLFT images were imported in the image processing
package FIJI [171, 172] and the lookup tables “Red Hot” or “Green” were applied. For the
confocal images of the fusion constructs (chapter 3.2.4 and 3.3.5), the background was
subtracted (max. 2 counts) and the color table was adjusted to the maximal signal. All
images were exported as TIFF files. In the RESOLFT image, the line profiles (three pixel





This work aimed to develop novel reversibly switchable fluorescent proteins (RSFPs)
emitting in the red region of the visible spectrum. For this purpose, screening approaches
were established and tailored to the development of red-emitting RSFPs (chapter 3.1). By
applying these screening systems, novel positive-switching RSFPs were generated from the
template protein mRuby2 (chapter 3.2) and negative-switching RSFPs were developed from
the fluorescent protein mScarlet (chapter 3.3). The new RSFPs were characterized in detail
regarding their switching and spectral properties, their applicability as fusion tag and their
use in RESOLFT microscopy.
3.1 Development of screening assays to identify and
characterize new RSFPs
To date, the search for fluorescent proteins and RSFPs with improved properties has been
implemented mostly by the expression of mutant libraries in E. coli followed by the
screening of these libraries (chapter 1.4.1). Likewise, the development of novel RSFPs in this
work was mainly based on the microscopic screening of bacterial colonies expressing
fluorescent protein mutants (chapter 3.1.1). To complement this well-established and
beneficial screening approach, an alternative concept was established based on the screening
of mammalian cells expressing single fluorescent protein variants (chapter 3.1.2).
3.1.1 Microscopic screening of red RSFPs expressed in E. coli colonies
A custom built microscope (chapter 2.4.1) facilitates the comparison of fluorescent protein
variants expressed in bacterial colonies regarding their fluorescence and switching
characteristics. An automated microscope and the workflow of screening were well-
established in the research group and in the past, this screening technique was already
applied for the generation of other RSFPs like rsEGFP2 [96].
The workflow was adjusted to provide a suitable approach for the development of red RSFPs
(Figure 3.1-1). In each screening round, the mutagenesis strategy was chosen first. The
analysis of the structure and the sequence comparison to published fluorescent proteins and
RSFPs guided the selection of mutation sites for the (multiple) site-directed mutagenesis.
Alternatively, error-prone mutagenesis was applied. Consequently, a library of pBad
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plasmids containing mutated versions of the respective red fluorescent protein was
generated by one of the described protocols (chapter 2.1.10) and was used for the
transformation of E. coli cells (chapter 2.2.2). On the resulting agar plates, each colony
expressed only a single fluorescent protein variant.
Figure 3.1-1: Screening for improved RSFPs using the automated microscope.
An overview of the mutagenesis and screening workflow using the automated microscope is shown (starting
at the bottom). The chosen mutagenesis strategy is derived from the analysis of the coding sequence and the
structure of the template protein. Consequently, a library of mutated template genes is generated and used for
the transformation of E. coli. Each colony growing on the resulting agar plates expresses one variant. The
automated microscope identifies the expressing clones and illuminates the fluorescent proteins by alternating
irradiation with light of 445 nm and 561 nm. The resulting fluorescence is detected and the data is analyzed.
Colonies expressing an RSFP with improved characteristics are picked to inoculate an overnight culture,
respectively. The plasmid DNA is isolated and the obtained mutations are examined by sequencing. The
analysis of the mutation sites can guide the next mutagenesis strategy.
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The automated microscope was used to determine the switching characteristics of the red-
emitting mutants expressed in the bacterial colonies. The wavelengths 445 nm and 561 nm
were chosen as switching wavelengths due to the switching characteristics of other red
RSFPs like rsCherry and rsCherryRev [91]. In all screenings, a switching scheme of
alternating illumination at 445 nm and 561 nm was applied and the resulting fluorescence
was detected. If the template protein was switchable, the illumination times were adjusted
to switch the template protein completely on and off (chapter 2.4.1.1).
In the following data analysis step, the characteristics of the fluorescence development in
the different switching cycles was quantified. It was screened for RSFPs with a high
fluorescence in the on-state, a low residual fluorescence in the off-state, a high switching
speed and a low switching fatigue (chapters 2.4.1.3-2.4.1.5), since these characteristics
determine the applicability of RSFPs in RESOLFT microscopy (chapter 1.3.2). The colonies
expressing RSFP variants with at least one improved switching characteristic compared to
the template protein were selected if all other characteristics were not drastically impaired.
However, the introduction of switching to a fluorescent protein as well as the improvement
of the switching contrast or switching speed in a RSFP is commonly accompanied by a
reduction in the ensemble brightness, which was tolerated to some extent.
The chosen colonies were used to inoculate overnight cultures (chapter 2.2.1) and the
plasmid DNA was isolated (chapter 2.1.1). The mutations were analyzed by sequencing
(chapter 2.1.8) and as appropriate, the new fluorescent protein variants were used as
templates in the next mutagenesis and screening round.
The microscopic screening of RSFPs expressed in E. coli colonies comprises various
advantages like the detailed switching characterization for each variant and the rapid
process of this approach. Thus, this type of screening was mainly applied in this work for
the development of the new red RSFPs (chapter 3.2.1 and 3.3.1). However, the main
application field of RSFPs has been and will be the expression of fusion constructs in
mammalian cells. Hence, an additional screening system based on the expression in
mammalian cells was established (chapter 3.1.2).
3.1.2 Establishment of a mammalian landing pad cell line for screening
This work aimed to establish a new screening system to identify improved fluorescent
proteins based on the expression in mammalian cells. For the screening, it is necessary to
ensure that only a single fluorescent protein variant of a mutant library is expressed in each
mammalian cell. Since this is not feasible by simple transfection, a site-specific recombinase
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approach was chosen to achieve this. Similar to the approach of Duportet et al. [140]
(chapter 1.4.2), a suited Bxb1 landing pad cell line was generated. The concept of the Bxb1
landing pad cell line for screening is described in the following.
3.1.2.1 Conception of a Bxb1 landing pad cell line for screening
A Bxb1 landing pad cell was defined as a suitable option to enable single variant expression
in mammalian cells, which is required for the screening of fluorescent proteins. In this
approach, a landing pad is placed in the genome of a mammalian cell. The landing pad
selected in this work consists of the constitutive CAG promoter and a downstream Bxb1
attP site (see the middle of Figure 3.1-2). The landing pad is placed into the AAVS1 locus
(19q13.4 qtr), a well-characterized locus for the knock-in of gene cassettes and known to
facilitate long-term expression of transgenes [158, 173]. Important for the concept is, that
only a single landing pad is integrated into the genome.
Figure 3.1-2: Integration of an integration plasmid into the Bxb1 landing pad.
A schematic overview of the Bxb1 recombinase-mediated integration event. A Bxb1 expression plasmid and
an integration plasmid encoding a transgene next to the Bxb1 attB site, are used for cotransfection of the Bxb1
landing pad cell line. The landing pad is located in the AAVS1 locus and is composed of a CAG promoter and
the Bxb1 attP site. The Bxb1 recombinase is transiently expressed from the Bxb1 expression plasmid and
catalyzes the integration of the complete integration plasmid into the landing pad by recombination via the attB
and attP sites. Accordingly, the transgene is stably expressed by the CAG promoter of the landing pad.
Once a monoclonal cell line with a single landing pad is generated, cells of this Bxb1 landing
pad cell line can be used for the stable integration and expression of a single transgene (e.g.
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a fluorescent protein mutant) per cell (Figure 3.1-2). This is done by the cotransfection of
these cells with a Bxb1 recombinase expression plasmid and a promoter-less integration
plasmid containing the Bxb1 attB site and the transgene (downstream the attB site). In
successfully transfected cells, the Bxb1 recombinase is transiently expressed, which can then
mediate the integration of an integration plasmid into the genome via the attP site in the
landing pad and the attB site on the integration plasmid. By this recombination, the
complete plasmid is integrated into the genome. Since the recombination catalyzed by the
Bxb1 recombinase is unidirectional, only a single plasmid can be integrated per cell. The
transgene of the integrated plasmid is then stably expressed under the control of the CAG
promoter in the landing pad (shown below in Figure 3.1-2).
This concept is suitable for the screening of fluorescent proteins in mammalian cells. The
cells of the Bxb1 landing pad cell line can be cotransfected with the Bxb1 expression plasmid
and a mutant library of integration plasmids encoding the fluorescent protein variants. As
the integration plasmid does not contain a promoter for transient expression, only the
fluorescent protein variant integrated into the landing pad is expressed in the cell. The cells
with a positive recombination event can be used for screening and comparison of the
fluorescent protein variants (see chapter 3.1.2.5). Thus, various integration plasmids
(chapter 3.1.2.2) and a Bxb1 landing pad cell line (chapter 3.1.2.3) were generated in this
work.
3.1.2.2 Preparation of basic integration plasmids
Prior to the generation of the monoclonal Bxb1 landing pad cell line, a set of integration
plasmids (pInt) was prepared for different applications and flexible use of the cell line (Table
3; cloning: chapter 2.1.9.3). Each integration plasmid contains the Bxb1 attB site for the
recombination step and a multiple coning site (MCS) to add the coding sequence of a
fluorescent protein (a plasmid map of pInt-MCS-P2A-HygroR is shown in the Appendix
Figure 6.1-3).
The generated integration plasmids can be used to compare the expression, maturation and
fluorescence characteristics of fluorescent proteins in a Bxb1 landing pad cell line, for
instance by flow cytometry. An additional transgene can be stably expressed by using the
P2A self-cleaving linker [174] (see Table 3). The P2A sequence is inserted between two
transgenes and during translation a cleavage occurs within the P2A linker due to the skip of
a peptide bond within the proline-glycine-proline motif.
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Table 3: Prepared basic integration plasmids.
MCS: Multiple cloning site, HygroR: Hygromycin resistance gene, codEGFP: coding sequence of mEGFP with















While the integration plasmids containing the P2A-HygroR element allow for selection of
cells with positive integration by Hygromycin B treatment, the integration plasmids
containing the P2A-mEGFP or P2A-mCherry can be used for normalization to the
expression level in each cell, based on the fluorescence signal of mEGFP or mCherry. The
integration plasmids with keratin or vimentin fusion constructs can be applied to control
the tagging performance of the fluorescent proteins. Additional fusion constructs can be
cloned in the future.
3.1.2.3 CRISPR Cas9 knock-in of a Bxb1 landing pad into the AAVS1 locus
The method of CRISPR/Cas9 genome editing [143, 144] was chosen to integrate a Bxb1
landing pad into the AAVS1 locus of HeLa cells. The plasmid pTRE-TIGHT-EGFP [158]
served as backbone for the cloning of a suitable donor plasmid (chapter 2.1.9.2). The pTRE-
TIGHT-EGPF plasmid already contained homology arms for the knock-in into the
PPP1R12C intron 1 (AAVS1 locus). In this plasmid, an element composed of a splicing
acceptor site, a thosea asigna virus 2A self-cleaving peptide sequence (T2A) and a
Puromycin resistance gene is placed downstream of the left homology arm. This element
facilitates the expression of the Puromycin resistance gene by the endogenous PPP1R12C
promoter, if the knock-in was successful. The landing pad consisting of the CAG promoter
and the Bxb1 attP site was assembled into the donor plasmid with addition of a simian virus
40 (SV40) polyA sequence and a cHS4 insultor to shield the landing pad from endogenous
genes (plasmid map of the applied donor plasmid: Appendix Figure 6.1-2).
Accordingly, HeLa cells were cotransfected with the Bxb1 landing pad donor plasmid and
the plasmid px458-AAVS1 gRNA2 encoding the Cas9 protein and an appropriate gRNA
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sequence for the AAVS1 locus (chapter 2.2.4.1). The transfected cells with positive knock-
ins were selected by Puromycin treatment (chapter 2.2.5). The remaining cells were used to
generate monoclonal cell lines by single-cell sorting and the screening for a functional Bxb1
landing pad cell line was realized by an integration assay. In this assay, cells of each
monoclonal cell line were contransfected with the Bxb1 expression plasmid pCAG-NLS-
HA-Bxb1 [167] and the integration plasmid pInt-mEGFP-P2A-HygroR (chapter 2.2.7). As
a result, the clone K21 was identified as a functional Bxb1 landing pad cell line by the
positive expression of mEGFP. In the following, the cell line based on this clone will be
called K21.
In Figure 3.1-3 A, the expected genomic situation for a successful knock-in is presented.
Three genotyping PCR reactions were performed on the isolated genomic DNA of K21 cells
and non-edited HeLa cells (chapter 2.1.11). The first PCR amplifies the DNA strand from
the CAG promoter to the right homology arm (expected size: 1081 bp; PCR1 in Figure
3.1-3 A). As expected, the PCR only yielded a PCR product for the K21 cells containing the
Bxb1 landing pad (Figure 3.1-3 C). Sequencing of this PCR product confirmed the expected
sequences and an intact Bxb1 attP site. In the second genotyping PCR, a landing pad- and
a genome-specific primer were applied (PCR2 in Figure 3.1-3 A). Once more, only the PCR
with the genomic DNA of K21 cells resulted in a PCR product with the anticipated size
(1439 bp; Figure 3.1-3 D). Sequencing of this PCR product verified the knock-in into the
AAVS1 locus.
In the third PCR, a PCR product of 441 bp is amplified for the wild-type AAVS1 locus as
template (Figure 3.1-3 B). PCR products of this size were received from the genomic DNA
of HeLa and K21 cells (Figure 3.1-3 E). Consequently, the K21 cells contain at least one
wild-type and one edited AAVS1 locus. For the application of the K21 cells in a screening
approach, a single landing pad knock-in is necessary. However, the copy number of the
AAVS1 locus in HeLa cells is not entirely clear, since karyograms of HeLa cells showed
varying numbers of chromosome 19 from two to three with addition of marker
chromosomes [175, 176]. Thus a single or a double knock-in of the landing pad is possible.
Furthermore additional off-target knock-ins would be conceivable. Therefore, further




Figure 3.1-3: Verification of the Bxb1 landing pad knock-in for cell line K21.
A: Scheme for the successful knock-in of the Bxb1 landing pad into the PPP1R12C intron 1 (AAVS1 locus) of
HeLa cells using CRISPR/Cas9 genome editing. B: Representation of the wild-type locus; sequences of the
homology arms are indicated. A+B: Dark red: homology arm left (HAL)/right (HAR), dark green: splicing
acceptor site, light green: T2A, orange: Puromycin resistance gene, grey: SV40 polyA, light blue: CAG
promoter, pink: Bxb1 attP site, dark blue: cHS4 insulator. Expected DNA fragments of the genotyping PCRs
(PCR1-3) are highlighted. C-E: Genotyping PCRs on genomic DNA of HeLa and K21 cells analyzed in
analytical gel electrophoresis. C: PCR products of PCR1 in A, expected size: 1081 bp. D: Control of the knock-
in localization, PCR2 in A, expected size: 1439 bp. E: The PCR yields a product of 441 bp for wild-type
chromosomes (PCR3 in B).
3.1.2.4 Characterization of the generated Bxb1 landing pad cell line K21
Several specific integration plasmids were cloned (chapter 2.1.9.3, Table 1) to characterize
the generated Bxb1 landing pad cell line and the stable expression of fusion constructs in
these cells. In all experiments, the cells of the K21 cell line were cotransfected with 1 µg of
the Bxb1 expression plasmid (pCAG-NLS-HA-Bxb1) and 1 µg of each integration plasmid.
To determine the integration efficiency of this approach, the plasmid pInt-mEGFP-P2A-
HygroR was used. Five days after transfection, the analysis of 20,000 cells in flow cytometry
revealed that 1.15 % of the single cells displayed green fluorescence higher than the
autofluorescence of HeLa cells. The expression level varied considerably, as the fluorescence
signal ranged from approximately 10 to 2,500 a.u. (Figure 3.1-4 A).
Another batch of K21 cells was cotransfected with pCAG-NLS-HA-Bxb1, pInt-mEGFP-
P2A-HygroR and pInt-mRuby2-P2A-HygroR. In the analysis of 20,000 cells in flow
cytometry five days after transfection, 0.64 % of the cells exhibited detectable green
fluorescence and 0.44 % of the cells exhibited detectable red fluorescence (Figure 3.1-4 B).
No cells were detected which displayed both green and red fluorescence, neither in flow
cytometry analysis nor in fluorescence microscopy (data not shown). Thus, a double knock-
in of the Bxb1 landing pad is determined to be unlikely.
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After contransfection of K21 cells with pCAG-NLS-HA-Bxb1 and pInt-mRuby2-P2A-
mEGFP, the K21 cells with positive integration showed both, red (mRuby2) and green
(mEGFP) fluorescence (Figure 3.1-5 A). The fluorescence signals of mRuby2 and mEGFP
were correlated in flow cytometry (Figure 3.1-4 C). Hence, the expression of mEGFP from
integrated plasmids with P2A-mEGFP can serve as an internal reference for the expression
level in screening approaches.
Figure 3.1-4: Expression of fluorescent proteins in K21 cells analyzed in flow cytometry.
Flow cytometry analysis of K21 cells cotransfected with different integration plasmids and the Bxb1 expression
plasmid. The green fluorescence (Exc: 488 nm, Em: 495-525 nm) measured for single cells is plotted against
the red fluorescence (Exc: 561, Em: 570-640 nm). A: 20,000 cells cotransfected with pCAG-NLS-HA-Bxb1 and
pInt-mEGFP-P2A-HygroR were analyzed 5 days after transfection; 1.15 % of the cells were green fluorescent.
B: 20,000 cells cotransfected with pCAG-NLS-HA-Bxb1, pInt-mEGFP-P2A-HygroR and pInt-mRuby2-P2A-
HygroR were analyzed 5 days after transfection; 0.64 % green and 0.44 % red fluorescent cells. No two-colored
cells were detected. C: 50,000 cells cotransfected with pCAG-NLS-HA-Bxb1 and pInt-mRuby2-P2A-mEGFP
were analyzed 6 days after transfection. The green fluorescence is correlated to the red fluorescence for cells
with positive integration.
In the following, different integration plasmids with fusion constructs and selection
markers were analyzed. Therefore, K21 cells were cotransfected with the Bxb1 recombinase
expression plasmid and the respective integration plasmid. K21 cells with a successfully
integrated pInt-mEGFP-P2A-HygroR plasmid could be enriched by incubation in
Hygromycin-containing medium (400 µg/µl). After 4 days of selection, almost all cells
showed stable expression of mEGFP (Figure 3.1-5 C). The integration of the plasmids pInt-
Keratin-mEGFP-P2A-HygroR (Figure 3.1-5 B), pInt-Vimentin-mEGFP-P2A-HygroR
(Figure 3.1-5 D) and pInt-Ker-mRuby2-P2A-mEGFP (Figure 3.1-5 E) into the landing pad
of K21 cells resulted in the expression of the cytoskeleton fusion constructs with a
characteristic localization pattern. For the integration of pInt-Ker-mRuby2-P2A-mEGFP,
the mEGFP signal was detectable in the cytoplasm and in the nucleus (Figure 3.1-5 E right).
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Figure 3.1-5: Stable expression of fusion constructs in K21 cells.
Cells of the Bxb1 landing pad cell line K21 were cotransfected with the respective integration plasmid and the
Bxb1 expression plasmid (pCAG-NLS-HA-Bxb1). A: Integration of the plasmid pInt-mRuby2-P2A-mEGFP
yields the expression of mRuby2 and mEGFP resulting in both red (left) and green (right) fluorescent cells. B:
Expression of keratin18-mEGFP in a K21 cell after integration of the plasmid pInt-Keratin-mEGFP-P2A-HygoR
into the landing pad (confocal image). C: K21 cells were transfected with the plasmids pCAG-NLS-HA-Bxb1
and pInt-mEGFP-P2A-HygroR. 5 days after transfection, the cells were selected with Hygromycin B (400 µg/µl)
for 4 days (images acquired in the imaging plate reader, see chapter 2.2.5). The Hygromycin selection enriched
cells with successful plasmid integration. D: Expression of Vimentin-mEGFP after integration of the plasmid
pInt-Vimentin-mEGFP-P2A-HygroR (confocal image). E: Expression of keratin18-mRuby2 (left) and mEGFP
(right) after integration of the plasmid pInt-Keratin-mRuby2-P2A-mEGFP (confocal images). Scale bars: A, C:
50 µm; B, D, E: 10 µm.
This indicates that the integration of the plasmids into the Bxb1 landing pad of the K21 cells
occur as assumed and presented in chapter 3.1.2.1 (Figure 3.1-2). Additionally, the correct
and complete integration of an integration plasmid into the landing pad was verified. In
order to do this, a monoclonal cell line was generated by cotransfection of K21 cells with
the plasmids pCAG-NLS-HA-Bxb1 and pInt-Keratin-Ru63-P2A-mEGFP (Ru63: developed
Results
64
RSFP in this work) with following single-cell sorting of fluorescent cells. A monoclonal cell
line with an integrated pInt-Keratin-Ru63-P2A-mEGFP plasmid (Figure 3.1-6 A) was
identified by the expression of the keratin construct. The genomic DNA was isolated and
used for genotyping PCRs. The size of the PCR products was controlled in analytic gel
electrophoresis and met the expectations (Figure 3.1-6 B; PCR1: 2214 bp, PCR2: 2310 bp,
PCR3: 1374 bp, PCR 4: 1439 bp). The sequencing of the PCR products verified the accurate
integration of the plasmid pInt-Keratin-Ru63-P2A-mEGFP into the landing pad of the K21
cells.
Figure 3.1-6: Control of the integration of an integration plasmid into the landing pad.
A: Expected genomic arrangement after successful integration of the plasmid pInt-Keratin-Ru63-P2A-mEGFP
into the Bxb1 landing pad of K21 cells catalyzed by the Bxb1 recombinase. Light blue: CAG promoter, pink:
attL and attR resulting from recombination event, dark grey: keratin18, red: Ru63, orange: P2A, light green:
mEGFP, dark green: Kanamycin resistance gene (KanR), greenish-blue: ColE1 origin (ori), light grey: SV40
polyA, dark blue: insulator cHS4, dark red: homology arm right (HAR). Expected DNA fragments of the
genotyping PCRs are indicated (PCR1-4). B: PCR products of the genotyping PCRs on genomic DNA of the
monoclonal K21 cell line with the integrated plasmid pInt-Keratin-Ru63-P2A-mEGFP analyzed in analytical gel
electrophoresis. Expected PCR product size: PCR1: 2214 bp, PCR2: 2310 bp, PCR3: 1374 bp, PCR 4:
1439 bp.
3.1.2.5 Screening for improved fluorescent proteins using the K21 cell line
The generated Bxb1 landing pad cell line K21 was used to screen libraries of fluorescent
proteins for the effective brightness and expression performance in mammalian cells. At the
beginning of the screening workflow (Figure 3.1-7), a library of integration plasmids with
mutant fluorescent proteins was prepared using error-prone mutagenesis (chapter 2.1.10).
In the applied screenings, the integration plasmid pInt-MCS-P2A-codEGFP served as
backbone in order to take the expression level into account. The generated plasmid library
was then used for the cotransfection of K21 cells along with the Bxb1 expression plasmid.




Figure 3.1-7: Screening for fluorescent proteins with improved brightness in K21 cells.
A schematic overview of the screening for fluorescent proteins (FP) or RSFPs with enhanced brightness or
improved expression using the landing pad cell line K21 (starting at the bottom). One of the described
mutagenesis protocols is applied to generate a library of integration plasmids with mutant fluorescent proteins.
The integration plasmid library and the Bxb1 expression plasmid are used for cotransfection of K21 cells. In
each cell, only one of the transfected integration plasmids can be integrated into the landing pad by the
transiently expressed Bxb1 recombinase. The respective mutant is expressed after the recombination step.
Cells expressing different mutants can be compared in the fluorescence activated cell sorting (FACS), and the
cells with the highest fluorescence intensity are sorted into a well plate. The genomic DNA of the cells is isolated
and the coding sequences of the fluorescent protein variants are amplified by PCR. For the application of
directed evolution, further rounds of mutagenesis and screening can be applied. Alternatively, the coding
sequences of the mutants can be cloned into pBad plasmids and their characteristics can be analyzed using
the automated microscope.
After five to seven days, the fluorescence signals were analyzed by flow cytometry. The cells
with the highest fluorescence intensity or the cells with the highest red-to-green
fluorescence ratio were sorted for further cultivation. The genomic DNA of these cells was
isolated and the coding sequences of the selected protein variants were amplified by PCR.
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The PCR products were used for an additional round of mutagenesis and screening or
alternatively the coding sequences of the fluorescent protein variants were cloned into the
pBad vector for analysis of the mutants in E. coli.
In summary, a Bxb1 landing pad cell line was generated, which enables single variant
expression per cell. A screening system based on this cell line was established for the
development of novel fluorescent proteins. The protocols for the microscopic screening of
E. coli colonies and the protocols for the screening of K21 cells using flow cytometry were
specifically adapted for the development of red RSFPs. The development of novel red RSFPs
using these screening systems is described in the following.
3.2 Novel positive-switching red RSFPs based on mRuby2
This work aimed to develop novel red-emitting and reversibly switchable fluorescent
proteins with excellent characteristics. The non-switching fluorescent protein mRuby2 [57]
was considered to be an appropriate template to design new RSFPs. mRuby2 is a bright
fluorescent protein (ε: 113,000 M-1cm-1, QY: 0.38) emitting in the red region of the visible
spectrum with its maximum at 600 nm. Furthermore, mRuby2 was shown to be applicable
in a large number of fusion constructs. The chromophore of its precursor mRuby was found
to adopt a trans-conformation in crystal form 1 at pH 8.5 and a mixture of cis- and trans-
conformations in the crystal form 2 at pH 8.0 [177]. The development of novel red RSFPs
from this template protein is described in the following.
3.2.1 Development of novel RSFPs by screening of mutant mRuby2 libraries
3.2.1.1 An initial variant for the development of positive-switching RSFPs
The amino acids in the chromophore pocket were shown to have a great influence on the
switching ability of red fluorescent proteins (chapter 1.3.4). The mutagenesis of these amino
acids can introduce switching into non-switching proteins as a result of changing the
hydrogen bonding network or providing space for the cis-trans isomerization [82, 91].
Hence, the amino acids in the proximity of the chromophore of mRuby2 were mutated
using site-directed and multiple-site mutagenesis. The resulting mutant libraries were
expressed in bacterial colonies and screened by alternating irradiation with 445 nm and
561 nm using the automated microscope (chapter 2.4.1). A mutant with the mutation
M164T was found to be switchable in a positive-switching mode, since the light of 561 nm
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switched the protein slightly on, while illumination with light of 445 nm attenuated the
fluorescence.
So far, only the tetrameric asFP595 and the monomeric rsCherry were available red
fluorescent and positive-switching proteins [33, 91], but both were not applicable in live-
cell RESOLFT microscopy. Thus, it was aimed to develop positive-switching RSFPs with
improved characteristics derived from the mRuby2-M164T mutant, albeit the brightness of
this mutant was reduced compared to the template protein.
3.2.1.2 Switching and screening of positive-switching red RSFPs
The microscopic screening (chapter 2.4.1 and 3.1.1) was applied to identify superior red
RSFPs derived from the mRuby2-M164T mutant. Figure 3.2-1 shows exemplary switching
curves for a positive-switching red RSFP acquired with the automated microscope. Light of
561 nm, which efficiently excites the proteins, was used for on-switching, while light of
445 nm was applied to switch the RSFPs off. Accordingly, the screening was performed by
alternating irradiation at 561 and 445 nm (chapter 2.4.1.1).
Figure 3.2-1: Switching of a red-emitting and positive-switching fluorescent protein.
The graph shows an example for the switching of a positive-switching red RSFP expressed in E. coli using the
automated microscope (in particular: switching curves of Ru87 are shown, see chapter 3.2.1.3). As indicated,
the fluorescence signal resulting from the alternating irradiation with light of 561 nm and 445 nm is plotted
against the time. The red RSFPs show almost no red fluorescence after irradiation at 445 nm.
The analysis of the switching characteristics was primarily based on the on-switching
process. It was screened for positive-switching mRuby2 variants with the highest brightness
and contrast between the on and the off-state, meaning the highest maximal fluorescence
signal in the on-state and the lowest possible residual fluorescence in the off-state. The
residual fluorescence in the off-state was determined by the ratio of the first to the averaged
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last points of the on-switching curve. Furthermore, a low halftime for the on-switching
process as well as a low switching fatigue were preferred. The switching fatigue was
measured by the reduction of the on-state fluorescence signal per switching cycle upon
repetitive switching.
3.2.1.3 Evolution of positive-switching red RSFPs from mRuby2-M164T
Several consecutive rounds of mutagenesis and screening were performed for the
generation of new improved positive-switching red RSFPs from mRuby2-M164T (Ru27).
Both, random and site-directed mutagenesis were applied in this process with the addition
of one to three mutations in each round (Figure 3.2-2 A). Only crystal structures of the
progenitor mRuby were available (Figure 3.2-2 B). In the screening of randomly mutated
libraries, mainly variants with mutations in loops or outside the beta-barrel structure were
identified. The amino acids A63, T162 and M164 were mutated specifically due to their
close proximity to the chromophore (Figure 3.2-2 close-up). The mutagenesis of C176 was
conducted due to the structural based investigations of photobleaching by Duan et al. [99].
Ten generated mutants were compared using the same switching protocol in the automated
microscope (alternating: 12 ms 445 nm with 6.6 kWcm-2 and 24 ms 561 nm with
14.5 kWcm-2) (Figure 3.2-3). For each mRuby2 variant, the measurements were performed
at ten bacterial colonies grown at 37 °C for two days.
With each screening round, the residual fluorescence in the off-state relative to the
fluorescence in the on-state decreased (Figure 3.2-3 B). Using the given switching times and
light intensities, the residual fluorescence in the off-state was noticeable higher in the second
switching cycle for the variants from Ru27 to Ru63. After the off-switching, the fluorescence
of the initial variant Ru27 was reduced to 78 % of the maximal signal in the first switching
cycle. The three final variants Ru63, Ru85 and Ru87 showed a residual fluorescence in the
off-state of below 5 % in the first cycle and of below 7 % in the second cycle.
The addition of the mutations M67L (Ru34) and T162A (Ru37) strongly reduced the
ensemble brightness in bacterial colonies, measured by the maximal fluorescence signal in
the on-state (Figure 3.2-3 A). It should be noted that the M67L mutation directly modifies
the structure of the chromophore. This reduction of the ensemble brightness could be partly
recovered in the last mutagenesis and screening rounds (Ru63, Ru85, Ru87).
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Figure 3.2-2: Development of positive-switching red RSFPs on basis of mRuby2.
A. Evolution of the red-emitting and positive-switching mRuby2 variants. The mutations added at each step are
given below the arrows. B: Localization of the mutation sites (original amino acids) mapped in the structure of
mRuby [177] (PDB: 3U0N) visualized with PyMOL. The crystal structure of mRuby crystal form 2 at pH 8.0
revealed chromophores in both, the cis and the trans-conformation. Green: amino acids outside the beta-barrel,
cyan: amino acids inside the beta-barrel, dark red: chromophore. Left: Overview of the mutations in the overall
structure. Right: Close-up of the chromophore and mutation sites in the direct chromophore environment
(mutation site M67: part of the chromophore).
Using laser light of 561 nm with an intensity of 14.5 kWcm-2, an on-switching halftime of
3 ms was determined for the initial variant Ru27. The addition of the mutations M67L
(Ru34) and R159K (Ru39) increased the on-switching halftime by 48 and 34 %, though this
was reverted by the mutations T162A (Ru37) and A63S (Ru46) (Figure 3.2-3 C). The
switching scheme for the comparison of the variants was not adjusted to the respective
switching kinetics, which partially does not allow for the direct comparison of the switching
fatigue, since photobleaching of the on-state proteins appears at prolonged illumination.
However, the addition of the mutation C176A (Ru48) did not change the on-switching
kinetics (Figure 3.2-3 C), but reduced the switching fatigue, as the fluorescence in the on-
state of cycle 54 compared to the first cycle was 77 % instead of 60 % (Figure 3.2-3 D).
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Figure 3.2-3: Characteristics of positive-switching mRuby2 variants found in screenings.
The switching characterization of the positive-switching mRuby2 variants representing the individual rounds of
mutagenesis and screening (mutations added in each round: see Figure 3.2-2 A). The switching scheme for
all variants: alternating 12 ms 445 nm (6.6 kWcm-2) and 24 ms 561 nm (14.5 kWcm-2) illumination, 54 switching
cycles. 10 bacterial colonies grown at 37 °C for 2 days were selected for each measurement. A: Fluorescence
signal in the on-state (switching cycle 1). B: Residual fluorescence in the off-state for switching cycle 1 (grey)
and 2 (red) normalized to the on-state. Inset: close-up for Ru46-Ru87 with smaller scales for the y-axis. C: On-
switching halftimes (switching cycle 1). D: The ratio of the fluorescence signal in the on-state of cycle 54 relative
to cycle 1.
The three final variants Ru63, Ru85 and Ru87 were determined to be the most promising
new red RSFPs, since they showed the best switching characteristics like the lowest residual
fluorescence in the off-state. The switching characteristics did not vary considerably
between these variants, only the ensemble brightness measured in the E. coli colonies was
higher for Ru85 and even higher for Ru87. However, Ru63 contains less mutations,
especially outside the beta-barrel, and was therefore further characterized along with Ru85
and Ru87.
The new RSFP Ru63 differs from mRuby2 by ten mutations (A63S, M67L, R99S, R159K,
T162A, M164T, H173R, C176A, K192L, F225L). Ru85 was obtained from Ru63 by addition
of the two mutations M15T and V188D, while the addition of N37A and G157V to Ru85
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revealed Ru87 (sequence alignment with mRuby2: Appendix Figure 6.2-1). In the following,
Ru63, Ru85 and Ru87 were characterized in detail regarding their switching properties. In
addition, the new RSFPs were compared to the only available monomeric, red fluorescent
and positive-switching protein, rsCherry [91].
3.2.2 Switching characterization of Ru63, Ru85 and Ru87 expressed in
E. coli
The detailed switching characterization of Ru63, Ru85 and Ru87 and the comparison to
rsCherry was performed by the expression in E. coli colonies and the acquisition of
switching curves using the automated microscope at room temperature (chapter 2.4.1.2).
The thermal relaxation from the off- and on-state to the equilibrium was investigated in two
independent experiments (different transformations) with measurements at four colonies
for each data point. All other characterizations were done in three independent experiments
with measurements at four to ten colonies for each data point.
3.2.2.1 Ensemble brightness and off-state fluorescence of positive RSFPs
First, the ensemble brightness in E. coli colonies was compared for Ru63, Ru85, Ru87 and
rsCherry. Therefore, the bacterial colonies were grown at 30 °C or 37 °C for two days (Figure
3.2-4 A). The RSFPs were completely switched on with light of 561 nm (14.5 kWcm-2) and
the on-state fluorescence signal was measured. For the switchable mRuby2 variants, the
fluorescence in the on-state was higher for the colonies grown at 37 °C than for the colonies
grown at 30 °C (factor 1.5 to 1.8). The expression at 37 °C yielded a 1.3 times higher
fluorescence for Ru85 and a 1.8 times higher fluorescence for Ru87 in comparison to Ru63.
The RSFP rsCherry was barely expressed at 37 °C (reduced by the factor of 0.15 compared
to 30 °C) and exhibited a 1.9 to 4.5-fold lower fluorescence in the on-state than Ru63, Ru85
and Ru87 at 30 °C. However, spectral differences between the switchable mRuby2 variants
and rsCherry might slightly contribute to a lower fluorescence signal for rsCherry. For
further characterizations, rsCherry was expressed at 30 °C and the switchable mRuby2
variants at 37 °C.
The residual fluorescence in the off-state relative to the on-state fluorescence was as well
determined for the positive-switching RSFPs. The proteins were switched off with light of
445 nm (14.9 kWcm-2) and switched on with light of 561 nm (14.5 kWcm-2). Under this
condition, the determined residual fluorescence in the off-state ranged from 4.3-5.1 % for
the three switchable mRuby2 variants in both, the first and the second switching cycle
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(Figure 3.2-4 B). A residual fluorescence in the off-state of 16 % in the first cycle and of 25 %
in the second cycle was measured for rsCherry. A lower residual fluorescence in the off-state
of 10 % in the first and 16 % in the second switching cycle was measured for rsCherry, when
lower light intensities were used (445 nm: 2.5 kWcm-2, 561 nm: 3.2 kWcm-2; data not
shown). However, the switching contrast of each switchable mRuby2 variant was still
superior.
Figure 3.2-4: Ensemble brightness and off-state fluorescence of positive RSFPs.
Comparison of the novel positive-switching proteins Ru63, Ru85 and Ru87 with rsCherry. For all
measurements: 445nm: 14.9 kWcm-2, 561 nm: 14.5 kWcm-2. Switching schemes for Ru63, Ru85, Ru87: 12 ms
445 nm, 30 ms 561 nm; for rsCherry: 140 ms 445 nm, 400 ms 561 nm. A: The fluorescence in the on-state of
cycle 1 for the different RSFPs expressed at 30 °C (grey) or 37 °C (red) for two days. The mean values and
error bars of a single experiment with 10 colonies each are shown. Two repetitions of the experiment yielded
comparable ratios. B: The residual fluorescence in the off-state relative to the fluorescence in the on-state in
switching cycle 1 (grey) or 2 (red). rsCherry was expressed at 30 °C, Ru63, Ru85 and Ru87 were expressed
at 37 °C. The values measured at 10 colonies in each experiment were averaged. The mean values and error
bars of three independent experiments are shown.
3.2.2.2 On-switching kinetics of positive-switching proteins
For the measurements of on-switching curves, the positive-switching red RSFPs were
switched off by 445 nm laser illumination (14.9 kWcm-2) before the on-switching curves
were acquired using light of 561 nm (14.5 kWcm-2). The on-switching curves demonstrated
substantial faster on-switching kinetics for the switchable mRuby2 variants than for
rsCherry (Figure 3.2-5 A+B). At the applied 561 nm laser intensity, the determined on-
switching halftimes of Ru63, Ru85 and Ru87 were 19 times lower than the halftime of
rsCherry (Figure 3.2-5 C). In addition, the 561 nm light intensity for on-switching was
varied from 3.2 to 63.1 kWcm-2 for Ru63, Ru85 and Ru87. These laser intensities yielded on-
switching halftimes from 0.3 to 15.7 ms (Figure 3.2-5 D). The on-switching halftimes at
each laser intensity was comparable for the three variants. The on-switching halftimes and
the laser intensities were not linearly related in the examined intensity range.
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Figure 3.2-5: On-switching kinetics of positive-switching red RSFPs.
A+B: On-switching curves of Ru63 (dark red), Ru85 (medium red), Ru87 (light red) and rsCherry (black) for
two different x-axis scales. The curves are normalized to the on-state fluorescence. Switching scheme (445nm:
14.9 kWcm-2; 561 nm: 14.5 kWcm-2) for Ru63, Ru85, Ru87: 12 ms 445 nm, 30 ms 561 nm; for rsCherry: 140 ms
445 nm, 400 ms 561 nm. The averaged curves measured at 10 colonies are shown. Two additional experiments
with 10 colonies each showed comparable on-switching kinetics. C: On-switching halftimes determined for the
switching curves presented in A+B using a biexponential function. D: The on-switching halftimes in dependency
of the 561 nm laser intensity for Ru63, Ru85 and Ru87. The measurements of 4 colonies at each of three
experiments were averaged first and the mean values and error bars of the three independent experiments are
shown.
3.2.2.3 Off-switching kinetics of positive-switching proteins
Due to the insufficient fluorescence emission induced by the irradiation at 445 nm, the off-
switching curves for the positive-switching RSFPs were obtained by modulation of the
445 nm off-switching times (chapter 2.4.1.4). The first fluorescence signal after off-
switching received by excitation at 561 nm (14.5 kWcm-2) was normalized to the
fluorescence in the on-state and plotted against the off-switching time (Figure 3.2-6). The
off-switching times for the chosen 445 nm laser intensity (2.5 kWcm-2) were as well
considerably lower for the switchable mRuby2 variants than for rsCherry. The determined
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off-switching halftimes were 0.67 ms for Ru63, 0.48 ms for Ru87, 0.51 ms for Ru87 and
48 ms for rsCherry.
Figure 3.2-6: Off-switching kinetics of positive-switching red RSFPs.
A+B: Off-switching curves of Ru63 (dark red), Ru85 (medium red), Ru87 (light red) and rsCherry (black) for
two different x-axis scales. Switching scheme (445nm: 2.5 kWcm-2; 561 nm: 14.5 kWcm-2) for Ru63, Ru85,
Ru87: 25 ms 561 nm, 0-20 ms 445 nm, 25 ms 561 nm; for rsCherry: 400 ms 561 nm; 0-500 ms 445 nm; 400 ms
561 nm. The first fluorescence after off-switching divided by the on-state fluorescence signal was plotted
against the 445 nm switching time. The curves were fitted by a biexponential function. In a single experiment,
each data point was measured at 5 different colonies. The mean values and error bars of the three independent
experiments are shown.
3.2.2.4 Switching fatigue of positive-switching proteins
For the comparison of switching fatigue, the positive-switching RSFPs were repetitively
switched on and off to 95 % (chapter 2.4.1.5) using light of 561 nm (14.5 kWcm-2) and
445 nm (2.5 kWcm-2). The irradiation times for switching the proteins to 95 % (listed in
Figure 3.2-7 B) were determined on the basis of the on- and off-switching curves acquired
with the same laser intensities (Figure 3.2-5, Figure 3.2-6). In Figure 3.2-7 the minimal and
maximal signal of each on-switching curve was normalized to the maximal signal of the
second switching cycle. Using these light intensities, rsCherry showed extremely high
switching fatigue, resulting in a loss of switching after 40 cycles. In switching cycle 40, the
maximal fluorescence signal was reduced to 58 % for rCherry and only to 85-89 % for the
switchable mRuby2 variants (Figure 3.2-7 C). The switching fatigue curves revealed, that
Ru63, Ru85 and Ru87 could be switched more than 350 times before the maximal
fluorescence decreased to 50 %. The minimal fluorescence signal represents the fluorescence
in the off-state, which increased for all three switchable mRuby2 variants during repetitive
switching, but strongest for Ru63.
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Figure 3.2-7: Switching fatigue of positive-switching red RSFPs.
A: Repeated switching of Ru63 (dark red), Ru85 (medium red), Ru87 (light red) and rsCherry (black). The
proteins were switched off with 445 nm (2.5 kWcm-2) and on with 561 nm (14.5 kWcm-2) to 95 % on the basis
of the switching curves measured before (switching times: see B). Ru63, Ru85, Ru87: 500 switching cycles;
rsCherry: 40 switching cycles. The switching curves were normalized to the maximal fluorescence in cycle 2.
The minimal and maximal fluorescence signal of the on-switching curve are plotted against the switching cycle.
The mean values and error bars of one experiment with 10 colonies each are shown. Two repetitions of the
experiment yielded comparable results. B: Applied switching times for the switching fatigue measurements
C: The table lists the maximal signal in switching cycle 40 relative to cycle 2 and the number of cycles until
50 % of the maximal fluorescence of cycle 2 is reached. These values were determined using averaged curves
of three individual experiments.
3.2.2.5 Alternative off-switching wavelengths for Ru63, Ru85 and Ru87
The wavelengths 405 nm and 488 nm are typical switching wavelengths for green RSFPs. In
order to examine the potential for simultaneous switching in dual color RESOLFT, these
wavelengths were tested as alternative off-switching wavelengths for Ru63, Ru85 and Ru87.
The proteins were switched on with light of 561 nm (3.2 kWcm-2) and subsequently
switching curves were acquired by simultaneous laser irradiation at 561 nm (2.6 kWcm-2)
and 405 nm, 445 nm or 488 nm. Using light of 445 nm with an intensity of 2.5 kWcm-2, the
off-switching was dominant. Adjusting the laser intensities to 7.5 kWcm-2 for 405 nm and
to 10.4 kWcm-2 for 488 nm, off-switching curves with comparable switching kinetics were
observed (Figure 3.2-8 A, C, E). After 10 ms of simultaneous switching, the fluorescence
signal of each variant was decreased to a similar level for the three different wavelengths
(Ru63: 17.7-18.7 %, Ru85: 11.7-13.0 %, Ru87: 11.9-12.0 %).
Results
76
Figure 3.2-8: Alternative off-switching wavelengths for Ru63, Ru85 and Ru87.
405 nm: purple, 7.5 kWcm-2; 445 nm: blue, 2.5 kWcm-2; 488 nm: cyan, 10.4 kWcm-2. Averaged curves of three
individual experiments with 5 colonies each. A (Ru63), C (Ru85), E (Ru87): Off-switching curves resulting from
simultaneous laser irradiation at 561 nm (2.6 kWcm-2) and at 405, 445 or 488 nm after switching into the on-
state (80 ms 561 nm, 3.2 kWcm-2). The fluorescence was normalized to the on-state fluorescence. B (Ru63),
D (Ru85), F (Ru87): Switching fatigue curves for the different off-switching wavelengths, 250 switching cycles.
Switching scheme: Alternating 7 ms 405 nm, 445 nm or 488 nm and 20 ms 561 nm (14.5 kWcm-2).The minimal
and maximal fluorescence signal of the on-switching curves were normalized to the maximal signal in cycle 2
and plotted against the switching cycle.
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The laser intensities for 405 nm, 445 nm and 488 nm which were found to induce similar
switching kinetics were used for repetitive switching of Ru63, Ru85 and Ru87 (Figure 3.2-8
B, D, F). The same switching scheme was applied for all measurements and 250 switching
cycles were acquired. For each switchable mRuby2 variant, the switching fatigue curves for
the different off-switching wavelengths were comparable. Thus, 405 nm and 488 nm
represent potential alternatives to 445 nm for the off-switching of Ru63, Ru85 and Ru87,
however, higher light intensities are necessary to achieve the same effect.
3.2.2.6 Equilibrium state and thermal relaxation from the on- and off-state
Finally, the equilibrium state and the thermal relaxation from the on- and off-state to the
thermal equilibrium were investigated utilizing the automated microscope (chapter 2.4.1.6).
The measurements revealed 10 % of the on-state fluorescence signal at the equilibrium of
Ru63, 32 % at the equilibrium of Ru85 and 20 % at the equilibrium of Ru87 (Figure 3.2-9).
Interestingly, the equilibrium state differs for the three variants, although all other
characteristics analyzed so far showed a high similarity.
Figure 3.2-9: Thermal relaxation to the equilibrium state for Ru63, Ru85 and Ru87.
A+B: Dark red: Ru63, medium red: Ru85, light red: Ru87. A: The thermal relaxation from the on-state to the
equilibrium after 30 ms of on-switching at 561 nm (14.5 kWcm-2). The relaxation curves were fitted using a
biexponential function. B: The thermal relaxation from the off-state to the equilibrium state after 12 ms of off-
switching at 445 nm (14.9 kWcm-2). A+B: The proteins were switched on (A) or off (B) and the fluorescence
after varying breaks was measured by 561 nm excitation (14.5 kWcm-2). The first fluorescence signal after the
break was normalized to the on-state signal and plotted against the duration of the break. The mean values
and error bars of a single experiment with measurements at 4 colonies for each data point are presented. A
repetition of both experiments yielded comparable result.
The thermal relaxation from the on- (Figure 3.2-9 A) and off-state (Figure 3.2-9 B) was
tracked for Ru63, Ru85 and Ru87. All three proteins relaxed from the on- and off-state to
the equilibrium in less than 4 s. The determined halftimes for the relaxation from the on-
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state revealed that Ru63 (t1/2,on-relax = 216 ms) relaxed 2.1-2.2 times faster than Ru85
(t1/2,on-relax = 478 ms) and Ru87 (t1/2,on-relax = 470 ms). No halftimes were determined for the
relaxation from the off-state. However, Ru63 relaxed also faster from the off-state than Ru85
and Ru87.
To conclude on the performed switching characterizations, the switchable mRuby2 variants
Ru63, Ru85 and Ru87 outperformed the only available monomeric, positive-switching red
RSFP rsCherry in all analyzed switching characteristics. Most switching characteristics of
the three variants Ru63, Ru85 and Ru87 were comparable. The major differences were
found in the equilibrium state of the proteins and in the ensemble brightness measured in
E. coli.  The wavelengths 405 nm and 488 nm represent suitable alternatives for the off-
switching. All three variants were analyzed further in the following.
3.2.3 Characterization of isolated Ru63, Ru85 and Ru87 protein samples
For further characterizations, all three mRuby2 variants were expressed in E. coli and
isolated. The standard protein purification protocol had to be adjusted, because the isolated
Ru63, Ru85 and Ru87 proteins tended to precipitate (protocol: chapter 2.3.1.2). The
switchable mRuby2 variants could be purified in a sufficient quantity and purity (controlled
in SDS-PAGE, see Appendix Figure 6.3-1 A) when 1 mM EDTA and 1 mM DTT were added
to the buffers and sonication was used for lysis. The fluorescent proteins mRuby2, mCherry
and dTomato were purified using the same protocol for comparison.
3.2.3.1 Spectral characteristics of the switchable mRuby2 variants
The absorption spectra of the purified Ru63, Ru85 and Ru87 samples in comparison to the
absorption spectrum of mRuby2 revealed a distinct lower absorption of the deprotonated
chromophore in the range of 500 to 600 nm (Figure 3.2-10 A). In this range, the Ru63
absorption spectrum displayed a main and a minor maximum, while Ru85 and Ru87
showed a broad absorption peak in this region (Figure 3.2-10 B). The main maximum is
shifted from 560 nm for the template protein mRuby2 to 570 nm for Ru63, 565 nm for Ru85
and 562 nm for Ru87. For the three switchable variants, an absorption maximum in the
region of 390 to 400 nm was detected, which might be the absorption of an incomplete
matured chromophore (chapter 1.2.2). For Ru85 and Ru87 a smaller maximum at about
450 nm was visible, which might be the absorption band of the protonated chromophore.
No changes in the absorption spectra were detectable when the protein solutions of Ru63,
Ru85 and Ru87 were illuminated with blue or yellow-green light for switching
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(chapter 2.3.5; data not shown). This might be due to the rapid relaxation of these RSFPs
from the on- and off-state to the equilibrium (see chapter 3.2.2.6).
Figure 3.2-10: Spectra of mRuby2 and the generated switchable variants.
A-C: black: mRuby2, dark red: Ru63, medium red: Ru85, light red: Ru87. Averaged spectra of three
independent protein samples. A+B: Absorption spectra normalized to the maximum absorbance at 280 nm. B:
Detailed section of the absorption spectra from 350-650 nm for Ru63, R85 and Ru87. C: Excitation (dashed
lines, Em: 600 nm) and emission spectra (solid lines, Exc: 540 nm) normalized to the maximal fluorescence.
D: Wavelengths at maximal absorption or fluorescence.
The shape of the excitation spectrum was similar for mRuby2 and the switchable variants,
but the maxima were shifted by 5 nm to the blue region of the spectrum for Ru63, Ru85 and
Ru87 (Figure 3.2-10 C). The emission spectra of mRuby2 and the switchable variants were
comparable as well, with shifts of 1-2 nm (Figure 3.2-10 D).
3.2.3.2 Fluorescence and extinction characteristics of Ru63, Ru85 and Ru87
The quantum yield (QY) of Ru63, Ru85 and Ru87 was measured by two different methods
(chapter 2.3.7). In the first method based on the emission spectra, the quantum yield was
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determined relative to the published quantum yield of mRuby2 (QY: 0.38 [57]). As the
switchable mRuby2 variants are not stable in the on-state (chapter 3.2.2.6), the quantum
yield could only be determined for the RSFPs in the equilibrium state in this method.
Applying the relative method, low quantum yields of 3.8-7.7 % were measured (Table 4). In
the second method, the quantum yield was determined using the nanocavity-based method
[169]. This method is independent from the state of the RSFPs, since the method is based
on the measurement of fluorescence lifetimes and detects only fluorescent molecules. The
nanocavity-based method yielded substantial higher quantum yields of 18-20 % for the
switchable mRuby2 variants (conducted by Alexey I. Chizhik, Third Institute of Physics,
Georg August University, Göttingen). Despite the different values determined in the two
methods, the highest quantum yield was determined for Ru87 in both methods. The QY
published for rsCherry is only about 2 % [178].
Table 4: Fluorescence and extinction characteristics of Ru63, Ru85 and Ru87.
QY (absolute method): Single measurement, fluorescence lifetime: Two independent protein samples








Ru63 3.8 ± 0.1 18 24,021 ± 3513 1.13
Ru85 7.4 ± 0.3 17 14,098 ± 2280 1.20
Ru87 7.7  ± 0.4 20 20,464 ± 3603 1.25
mRuby2 38* 113,000* 2.5*
* Data taken from [57]
For Ru63, Ru85 and Ru87, the extinction coefficient (ε) of the deprotonated chromophore
was determined in the equilibrium state and relative to the published value of mRuby2
(113,000 M-1cm-1). The extinction coefficients of Ru63, Ru85 and Ru87 were distinctly lower
than the extinction coefficient of mRuby2 (Table 4) and also lower than the one of rsCherry
(80,000 M-1cm-1 [178]). The fluorescence lifetimes decreased by the factor of 2.0-2.2 for all
three variants in comparison to their template protein mRuby2.
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3.2.3.3 The pH stability of Ru63, Ru85 and Ru87
Figure 3.2-11: Effect of the pH on absorption and fluorescence of Ru63, Ru85 and Ru87.
A-C: Absorption spectra of the novel positive-switching RSFPs at different pH values (pH 5.0 to 10.5 in red
shades from dark to light) normalized to the absorption at 280 nm. A: Ru63, B: Ru85, C: Ru87. Averaged
spectra of three replicates are plotted. An independent repetition yielded comparable results. D: Fluorescence
signals (Exc: 560 nm, Em: 595 nm) of protein samples diluted in different pH buffers normalized to the
fluorescence at pH 9.5. Dark red: Ru63, medium red: Ru85, light red: Ru87. Averaged values of two
independent experiments with three replicates each and fit functions of the data (see chapter 2.3.8) from pH 4
to 9.5 are shown. E: pKa values determined from data in D.
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The influence of the pH on the absorption spectra and on the fluorescence was examined
by dilution of the purified Ru63, Ru85 and Ru87 samples in buffers with different pH values
(chapter 2.3.8). For all of the three proteins, the absorption between 520 and 600 nm
increased with rising pH values, which was assigned to be the absorption of the
deprotonated chromophore (Figure 3.2-11 A-C). In this range, the absorption of Ru63
reached its maximum at pH 8.0, while the absorption of Ru85 and Ru87 increased until the
highest tested pH value of 10.5. The absorption band between 430 and 470 nm emerged
with decreasing pH values and was assigned to be the absorption of the chromophore with
a protonated hydroxyphenyl ring. At particularly high pH values (9-10.5) an additional
sharp absorption maximum at about 500 nm became apparent.
For the analysis of the pH stability, the fluorescence of the isolated proteins samples in the
different pH buffers were measured by exciting the proteins at 560 nm and detecting the
emission at 595 nm (Figure 3.2-11 D). The fluorescence of Ru63, Ru85 and Ru87 increased
with higher pH values due to the deprotonation of the chromophores. However, the
fluorescence slightly decreases above pH 9-9.5 and this is especially visible for Ru87. This
effect might occur by unfolding of the proteins at high pH values. Fitting of the data from
pH 4 to 9.5 (function: see chapter 2.3.8) determined the pKa values of the switchable
mRuby2 variants to 6.1-6.5 (Figure 3.2-11 E).
3.2.3.4 The oligomeric state of the switchable mRuby2 variants
The oligomeric state of the novel red RSFPs was determined by analytical size-exclusion
chromatography (chapter 2.3.4). The purified protein samples of dTomato, mCherry,
mRuby2 and the switchable mRuby2 variants were diluted to 10 µM and were applied
independently to the size-exclusion column at 6 °C. The elution of the proteins was detected
by absorption measurements at 280 nm (Figure 3.2-12). The dimeric protein dTomato [58]
eluted with a retention volume of 14.75 ml. The proteins mCherry and mRuby2 are both
monomers [57, 58], however, the retention volumes of these two proteins were slightly
different with 16.04 ml for mCherry and 16.55 ml for mRuby2. Ru63 eluted at 16.24 ml,




Figure 3.2-12 Size-exclusion chromatography of Ru63, Ru85 and Ru87.
Analytical size-exclusion chromatography of mRuby2, mCherry, dTomato and the generated mRuby2 variants.
All proteins were isolated from bacteria with the same purification protocol (see chapter 2.3.1.2). 10 µM protein
samples were applied to a Superdex 200 Increase 10/300 L column with a flow rate of 0.75 ml/min at 6 °C. The
chromatography profiles at 280 nm are shown. Dark grey: dTomato (dimer); light grey: mCherry (monomer);
blue: mRuby2 (monomer); dark red: Ru63; medium red: Ru85; light red: Ru87.
In summary, the characterization of the isolated protein samples revealed some differences
for Ru63, Ru85 and Ru87. For instance, the absorption spectra differed for the three variants
(Figure 3.2-10). The determined pKa value for Ru85 (6.5) was slightly higher compared to
the pKa values of Ru63 (6.1) and Ru87 (6.2). All three variants were determined to be
monomeric. The variant Ru87 was characterized by the highest quantum yield. In total,
Ru87 showed small advantages in some characteristics (e.g. ensemble brightness in E. coli,
quantum yield). Hence, the investigation of the performance as fusion tags was partly
focused on Ru87, but also the characterization of Ru63 and Ru85 was further pursued.
3.2.4 The positive RSFPs used as fusion tags in fluorescence microscopy
An important application of RSFPs is the use as fusion tags in mammalian cells and the
imaging of these fusion constructs using conventional or super-resolution microscopy.
Hence, the performance of the switchable mRuby2 variants as fusion tag was controlled
with a focus on Ru87. The transient expression in various constructs (chapter 3.2.4.1) as
well as the stable expression in keratin and vimentin constructs (chapter 3.2.4.2) were
analyzed.
3.2.4.1 Transient expression of Ru63, Ru85 and Ru87 in fusion constructs
To control the performance of Ru87 in fusions, eight different fusion constructs were
generated (chapter 2.1.9.4), which target different cellular compartments. The prepared
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plasmids were used for the transfection of HeLa cells. The day after transfection, the
transiently expressed fusion constructs were imaged using confocal microscopy (chapter
2.4.2). The expected localizations were observed for all eight constructs (Figure 3.2-13).
Figure 3.2-13: Fusion constructs of the switchable Ru87 expressed in HeLa cells.
Confocal images of Ru87 fusion constructs transiently expressed in HeLa cells and excited at 561 nm. A (from
left to right): Vimentin-Ru87, Ru87-ER (ER signal), Ru87-PTS (peroxisomal targeting signal), Ru87-Histone1
(H2BN). B (from left to right): Lifeact-Ru87, Mito-Ru87 (mito targeting signal), Keratin-Ru87 (keratin18),
Caveolin1-Ru87. Scale bars: 10 µm.
Cytoskeleton components were visualized by the expression of Lifeact, vimentin and keratin
constructs. In addition, Ru87 was targeted to the cell organelles mitochondria, endoplasmic
reticulum (ER) and peroxisomes by fusion to the respective targeting signal peptides. The
localization to the nucleus and caveolae were achieved by Histone1 H2BN and Caveolin1
fusions. While Ru87 was applied as an N-terminal tag for the ER signal, the peroxisomal
targeting signal and for Histone1, it served as a C-terminal tag in all other fusions.
Consequently, Ru87 was applicable for targeting different cell compartments as N- or C-
terminal tag in HeLa cells and will be probably suitable as a tag in other applications as well.
Since Ru87 performed well in the tested fusion constructs and contained all mutations of
Ru63 and Ru85, the two variants Ru63 and Ru85 were assumed to be applicable in the same
fusion constructs. Nevertheless, the fusion constructs of vimentin, the ER signal, the
peroxisomal targeting signal and Histone1 were also generated and tested for these two
RSFPs. Confocal imaging of HeLa cells transfected with the Ru63 and Ru85 constructs
revealed the same expected localizations (Figure 3.2-14).
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Figure 3.2-14: Fusion constructs of Ru63 and Ru85 expressed in HeLa cells.
Confocal images of Ru63 (A) and Ru85 (B) fusion constructs transiently expressed in HeLa cells and excited
at 561 nm. A (from left to right): Vimentin-Ru63, Ru63-ER (ER signal), Ru63-PTS (peroxisomal targeting
signal), Ru63-Histone1. B (from left to right): Vimentin-Ru85, Ru85-ER (ER signal), Ru85-PTS (peroxisomal
targeting signal), Ru85-Histone1. Scale bars: 10 µm.
3.2.4.2 Stable expression of Ru63, Ru85 and Ru87 constructs
The stable expression of fusion constructs gains more and more importance in cell biology.
To test the applicability of Ru63, Ru85 and Ru87 in long-term expressions, monoclonal cell
lines stably expressing keratin fusions were generated using the K21 cell line developed in
this work (chapter 3.1.2). For this, K21 cells were cotransfected with the plasmids pCAG-
NLS-HA-Bxb1 and pInt-Keratin-Ru63, pInt-Keratin-Ru85 or pInt-Keratin-Ru87. Single
fluorescent cells were sorted into 96 well plates. For each approach, a stably expressing
monoclonal cell line was selected and imaged in confocal microscopy (Figure 3.2-15 A-C).
The expression of the keratin fusion constructs was detected in all three cell lines with
normal morphology of the cells. A genotyping PCR was conducted on the isolated genomic
DNA of these cell lines using a landing pad specific (binding at the end of the CAG
promoter) and an mRuby2 specific primer (expected size: 2144 bp). The PCR products were
analyzed in gel electrophoresis (Figure 3.2-15 D) and by sequencing. The integration of the
plasmids into the Bxb1 landing pad of the K21 cells was thereby verified.
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Figure 3.2-15: Stable expression of keratin tagged with Ru63, Ru85 or Ru87.
Monoclonal cell lines were generated by cotransfection of K21 cells with pCAG-NLS-HA-Bxb1 and pInt-Keratin-
Ru63/Ru85/Ru87 and single-cell sorting using flow cytometry. A-C: Confocal images of the monoclonal cell
lines stably expressing the keratin fusion constructs (Exc: 561 nm). Scale bars: 10 µm. A: Keratin18-Ru63, B:
Keratin18-Ru85, C: Keratin18-Ru87. D: PCR products of the genotyping PCRs on genomic DNA of K21 cells
(CTR) and of the monoclonal cell lines in A-C analyzed in gel electrophoresis. Expected PCR product size:
2144 bp.
Furthermore, endogenous tagging of the vimentin gene with the Ru87 coding sequence was
tested using a comparable CRISPR/Cas9 approach as described in Ratz et al., 2015 [97].
Therefore, U2OS cells were cotransfected with the Vimentin-Ru87 donor plasmid and the
plasmid encoding the gRNA and Cas9 (chapter 2.1.9.4, chapter 2.2.4). The knock-in of the
Ru87 coding sequence was targeted to the C-terminal end of the endogenous vimentin gene.
Monoclonal cell lines were generated as described (chapter 2.2.7) and a cell line with
positive knock-in was identified in confocal microscopy (Figure 3.2-16 A).
Figure 3.2-16: Tagging of endogenous vimentin with Ru87.
CRISPR/Cas9 genome editing was used to tag endogenous vimentin with Ru87 in U2OS cells. A monoclonal
cell lines was generated. A: Confocal images of the monoclonal cell line stably expressing the vimentin-Ru87
fusions (Exc: 561 nm). Scale bars: 20 µm. B: The PCR product of the genotyping PCR on genomic DNA of the
monoclonal cell line in A analyzed in analytical gel electrophoresis. Expected PCR product size: 1722 bp.
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The knock-in was controlled by a genotyping PCR using a genome-specific and a Ru87
specific primer (expected product: 1722 bp). Analysis of the PCR product by gel
electrophoresis (Figure 3.2-16 B) and sequencing verified the knock-in into the vimentin
locus. If the cell line is homozygous or heterozygous tagged was not determined.
Cytotoxicity tests were not performed in this work, however, the four generated cell lines
were viable, proliferated and stably expressed the fusion constructs for the time of
cultivation (weeks to months). The experiments revealed the utility of the switchable
mRuby2 variants for the stable expression in mammalian cells. In the next step, the novel
positive-switching RSFPs were characterized for their application in live-cell RESOLFT
microscopy.
3.2.5 Characterization of Ru63, Ru85 and Ru87 for RESOLFT microscopy
To examine, which of the three novel RSFPs is most suitable for the application in live-cell
RESOLFT microscopy, switching curves of Ru63, Ru85 and Ru87 expressed in mammalian
cells were acquired. For this purpose, vimentin fusion constructs of the red RSFPs were
transiently expressed in HeLa cells. For the switching at each pixel, the pulse generator in
the RESOLFT microscope for positive-switching red RSFPs was utilized (chapter 2.4.3.1).
Figure 3.2-17: Switching of Ru63, Ru85 and Ru87 in mammalian cells.
A: Vimentin fusion constructs with Ru63 (dark red), Ru85 (medium red) or Ru87 (light red) were transiently
expressed in HeLa cells. The proteins were switched off for 8 ms with the doughnut-shaped 445 nm beam
(0.48 kWcm-2) and switched on for 20 ms (Ru63, Ru85) or 25 ms (Ru87) at 561 nm (0.43 kWcm-2). The on-
switching curves were normalized to the on-state and the averaged curves of one experiment with 5 different
cells are shown. B: Residual fluorescence in the off-state relative to the on-state and on-switching halftimes
determined for three independent experiments (5 cells each).
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In the added switching curves of each pixel, the highest residual fluorescence in the off-state
was found for Ru87 (22.3 %), whereas the lowest off-state signal of 10 % was measured for
Ru63 (Figure 3.2-17). In contrast to the on-switching kinetics measured in E. coli (Figure
3.2-5), the on-switching halftimes for Ru63, Ru85 and Ru87 expressed in the vimentin
constructs differed (Figure 3.2-17 B). Although the on-switching halftime of Ru85 was 29 %
lower than the on-switching halftime of Ru63, Ru63 was chosen for the establishment of
RESOLFT imaging due to the lower residual fluorescence in the off-state (10 % instead of
14 %).
The generated K21 cell line stably expressing keratin-Ru63 (chapter 3.2.4.2) was selected for
the first establishment of RESOLFT imaging. For this purpose, the proteins were first
switched on with light of 561 nm (2 ms, Gaussian beam, 0.64 kWcm-2), then the Ru63
proteins in the periphery were switched off with the doughnut-shaped 445 nm beam (2 ms,
0.48 kW/cm-2), and finally the fluorescence signal was readout with light of 561 nm (944 µs,
Gaussian beam, 0.64 kWcm-2). Afterwards the corresponding confocal image was acquired
by on-switching (2 ms) and subsequent readout with light of 561 nm (944 µs, 0.43 kWcm-2).
Both, the confocal and RESOLFT images were acquired pixel-by-pixel.
Figure 3.2-18: Point-scanning RESOLFT microscopy using the positive-switching Ru63.
Confocal (A) and RESOLFT (B) microscopy of K21 cells stably expressing keratin-Ru63. Both images display
raw data with a pixel size of 35 nm. The color table is given below the respective image. The pinhole was set
to 1 Airy unit. Scale bars: 1 µm. Imaging schemes: A: 2 ms on-switching with the Gaussian 561 nm beam,
944 µs readout with the Gaussian 561 nm beam (both 0.43 kWcm-2). B: 2 ms on-switching with the Gaussian
561 nm beam (0.64 kWcm-2), 2 ms off-switching with the doughnut-shaped 445 nm beam (0.48 kW/cm-2),
944 µs readout with the Gaussian 561 nm beam (0.64 kWcm-2). A+B: Only the images of the first 200 µs of the
readout are shown. B: The line profiles 1 and 2 were measured at the indicated positions with a three pixels
width. C: The lines profiles 1 (above) and 2 (below), as indicated in B, were normalized to the maximal
fluorescence and fitted with a Lorentz function (red line). The FWHM was determined using the fit function.
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The highest resolution improvement was measured in the RESOLFT image displaying only
the fluorescence signals of the first 200 µs of the readout (Figure 3.2-18 A+B). The
resolution was analyzed by drawing perpendicular line profiles across the keratin filaments.
FWHM of 106 nm and 125 nm were determined (Figure 3.2-18 C), thus a resolution lower
than the diffraction-limit was achieved. A slight shift in the field of view was observed from
the RESOLFT to the confocal image due to cellular movements or mechanical drift
(compare line profiles confocal and RESOLFT image: Appendix Figure 6.3-2). This
RESOLFT image represents the first attempts to establish RESOLFT microscopy with the
new positive-switchable mRuby2 proteins. To my knowledge, this is the first live-cell
RESOLFT image applying a red RSFP with positive-switching mode.
3.3 Novel negative-switching red RSFPs based on mScarlet
In 2017, Bindels et al. introduced a new red fluorescent protein named mScarlet [85]. To
date, mScarlet is the brightest monomeric fluorescent protein (ε: 100,000 M-1cm-1, QY: 0.70)
which emits in the red spectral region (maximum: 594 nm). Due to this advantage, mScarlet
was selected as template protein for the development of new negative-switching red RSFPs.
[85]. The evolution and the characterization of switchable mScarlet proteins is described in
this chapter.
3.3.1 Development of novel RSFPs by screening of mutant mScarlet libraries
3.3.1.1 Initial mutagenesis and screening for switchable mScarlet variants
For the development of switchable mScarlet proteins, a mutant mScarlet library was
prepared, expressed in bacterial colonies and screened by alternating irradiation at 445 nm
and 561 nm using the automated microscope as described before (chapter 3.1.1).
Comparable to the development of switchable mRuby2 variants (chapter 3.2.1), the amino
acids in the proximity of the chromophore were mutated first in mScarlet. The mutagenesis
of the amino acids S147, I162 and M164 yielded various negative-switching variants. All
switching variants showed lower cellular brightness than mScarlet. In this initial
mutagenesis and screening round, the highest negative-switching capability was measured
for the variant mScarlet-I162Q, M164G (Sc1).
At the beginning of this project, the application of red negative-switching RSFPs in live-cell
RESOLFT microscopy had only been demonstrated for rsCherryRev1.4, which exhibits
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dimerization tendency [98]. Hence, it was aimed to generate monomeric and superior
RSFPs with a negative-switching mode from the variant mScarlet-I162Q, M164G. During
the process of the development, new negative-switching red RSFPs were introduced by
Pennacchietti et al. in 2018, which were obtained by mutagenesis of FusionRed. The two
RSFPs rsFusionRed2 and rsFusionRed3 were shown to be applicable in live-cell RESOLFT
microscopy [118].
3.3.1.2 Switching and screening of negative-switching red RSFPs
The screening for negative-switching mScarlet variants with improved characteristics was
performed by alternative on- and off-switching in the automated microscope. Exemplary
switching curves for a negative-switching red RSFP are presented in Figure 3.3-1. Laser
irradiation at 445 nm was used for on-switching of the RSFPs, while light of 561 nm was
used for off-switching.
Figure 3.3-1 Switching of a red fluorescent and negative-switching protein.
The graph shows an example for the switching curves of a negative-switching red RSFP expressed in E. coli
colonies which were acquired in the automated microscope (in particular: switching curves of Sc21 are shown,
see chapter 3.3.1.3). As indicated above the graph, the fluorescence signal resulting from alternating irradiation
at 445 nm and 561 nm is plotted against the time. The red RSFPs show no red fluorescence after excitation at
445 nm.
In the screenings, the switching was performed repetitively (chapter 2.4.1.1). The analysis
of the switching characteristics was based primarily on the off-switching process. As already
described for the screening of mRuby2 variants, switchable mScarlet variants with low
residual fluorescence in the off-state, high fluorescence in the on-state, low switching
halftimes and low switching fatigue were preferred. The residual fluorescence in the off-




3.3.1.3 Evolution of negative-switching RSFPs from mScarlet-I162Q, M164G
Mainly site-directed mutagenesis was performed to generate novel negative-switching
RSFPs with favorable characteristics in a few mutagenesis and screening rounds. Figure
3.3-2  gives an overview of the mutations added in each round (A) and displays the positions
of the mutation sites in the beta-barrel structure of mScarlet (B). To compare the generated
variants (Figure 3.3-2 C-F), the same switching scheme was applied for all variants
expressed in E. coli colonies using the automated microscope (30 ms 445 nm with 2.5
kWcm-2, 170 ms 561 nm with 14.5 kWcm-2).
Using the given switching scheme and light intensities, the initial variant mScarlet-I162Q,
M164T (Sc1) featured an off-switching halftime of 8.9 ms (Figure 3.3-2 F) and 17.2 %
residual fluorescence in the off-state (Figure 3.3-2 D). A saturated mutagenesis was
performed at position 164 for Sc1 and revealed that an alanine at position 164 (Sc8) reduced
the residual fluorescence in the off-state to 13.2 %. However, the addition of this mutation
also reduced the fluorescence in the on-state by 25 % (Figure 3.3-2 C).
The site-specific mutation S147G (Sc10) was chosen due to its proximity to the
chromophore and strongly reduced the fluorescence in the off-state to 3.2 %. It increased
the fluorescence in the on-state by 45 %. In addition, the switching fatigue was strongly
reduced, which was observed by a higher on-state fluorescence in cycle 54 relative to cycle 1
(63 % instead of 27 %; Figure 3.3-2 E).
The screening of an error-prone Sc10 library revealed that position R217 can affect the
switching characteristics of the switchable mScarlet proteins. The saturated site-directed
mutagenesis of this position determined R217Q (Sc19) as most beneficial. In addition, the
mutation D161K (Sc21) was introduced based on the findings of Shaner et al., who showed
that this mutation improved the folding efficiency of mOrange2 (there: E160K) [77]. The
D161K mutation improved the ensemble brightness in the on-state, which was reduced by
the addition of the mutation R217Q. Both mutation sites were positioned outside the beta-
barrel structure (Figure 3.3-2 B close-up). In comparison to Sc10, the addition of R217Q
and D161K in Sc21 slightly reduced the residual fluorescence in the off-state (2.2 %) and
slightly increased the fluorescence in the on-state. Using the given light intensities, the
determined off-switching halftimes differed for the two RSFPs and were 8.9 ms for Sc10 and
5.6 ms for Sc21 (Figure 3.3-2 F).
The negative-switching RSFPs Sc10 and Sc21 were both chosen for further
characterizations. Sc10 differs from mScarlet by only three mutations and exhibited already
preferable characteristics. Sc21 contains five mutations and was additionally selected due to
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the slight improvements in switching (sequence alignment: Appendix Figure 6.2-2). Both
variants were characterized in detail regarding their switching characteristics and were
compared to the recently published rsFusionRed2 and rsFusionRed3, which were suggested
to be the fastest switching red RSFPs so far and to feature a lower residual fluorescence in
the off-state than rsCherryRev1.4 [118].
Figure 3.3-2: Development and characterization of negative-switching mScarlet variants.
A. Evolution of the red-emitting and negative-switching mScarlet variants. The mutations added at each step
are given below the arrows. B: Localization of the mutation sites (original amino acids) mapped in the structure
of mScarlet [85] (PDB: 5LK4) using PyMOL. Green: amino acids outside the beta-barrel, cyan: amino acids
inside the beta-barrel, dark red: chromophore. Top: Overview of all mutations in the protein structure of
mScarlet. Bottom: Close-up of the chromophore environment. C-F: The switching characterization of the
negative-switching mScarlet variants representing the individual rounds of mutagenesis and screening. The
switching scheme for all variants: Alternating 30 ms 445 nm (2.5 kWcm-2) and 170 ms 561 nm (14.5 kWcm-2).
5 bacterial colonies grown at 37 °C for 2 days were selected. C, D and F: Values for switching cycle 1. C:
Fluorescence signal in the on-state. D: Residual fluorescence in the off-state. E: The ratio of the fluorescence
signal in the on-state of cycle 54 relative to cycle 1. F: Off-switching halftimes.
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3.3.2 Detailed switching characterization of Sc10 and Sc21
For the detailed switching characterization of Sc10 and Sc21 and the comparison to
rsFusionRed2 and rsFusionRed3, the negative-switching red RSFPs were expressed in
bacterial colonies (two days at 37 °C) and switched on and off using the automated
microscope (chapter 2.4.1.2). All experiments were performed in two to three independent
experiments with measurements at five to ten colonies for each data point.
3.3.2.1 Ensemble brightness, off-state fluorescence and equilibrium state of
negative RSFPs
The cellular brightness in E. coli was measured by the fluorescence signal in the on-state and
was compared for the negative-switching RSFPs. Both, Sc10 and Sc21 exhibited
6.8-8.0 times higher fluorescence in the on-state than rsFusionRed2 and rsFusionRed3
(Figure 3.3-3 A). Furthermore, the residual fluorescence in the off-state was determined and
no significant increase was observed from the first to the second switching cycle (Figure
3.3-3 B). The determined residual fluorescence in the off-state ranged from 1.8 to 3.4 % for
the different RSFPs with the lowest value measured for Sc21 and the highest for
rsFusionRed3.
Figure 3.3-3: Ensemble brightness and off-state fluorescence for the negative RSFPs.
Comparison of the novel negative-switching proteins Sc10 and Sc21 with rsFusionRed2 (rsFR2) and
rsFusionRed3 (rsFR3) expressed in E. coli. The proteins were switched on with light of 445 nm (1.2 kWcm-2)
for 10 ms (Sc10, Sc21) or 100 ms (rsFusionRed2, rsFusionRed3) and subsequently switched off with light of
561 nm (14.5 kWcm-2) for 250 ms (Sc10, Sc21) or 500 ms (rsFusionRed2, rsFusionRed3). In switching cycle 2,
the 445 nm switching was extended to 400 ms for rsFusionRed2 and rsFusionRed3 for sufficient on-switching.
A: The fluorescence in the on-state in cycle 1. B: Residual fluorescence in the off-state relative to the
fluorescence in the on-state in switching cycle 1 (grey) or 2 (red). A+B: The values were measured at 5 colonies
each and averaged. The mean values and error bars of three independent experiments are shown.
For Sc10 and Sc21, the equilibrium state was additionally determined (chapter 2.4.1.6).
Measurements without previous illumination (except for the autofocus) yielded
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92.4 ± 2.9 % fluorescence signal in the equilibrium state relative to the on-state fluorescence
for Sc10 and 90.1 ± 1.2 % for Sc21. Hence, the major fraction of the proteins is in the on-
state at the thermal equilibrium.
3.3.2.2 Off-switching kinetics of negative-switching RSFPs
To measure the off-switching curves of Sc10, Sc21, rsFusionRed2 and rsFusionRed3, the
negative-switching proteins were first switched to the on-state using light of 445 nm
(14.9 kWcm-2). Subsequently the off-switching curves were acquired by irradiation at
561 nm (14.5 kWcm-2). The off-switching curves revealed the fastest off-switching kinetic
for Sc21 (Figure 3.3-4 A). At the given 561 nm laser intensity, an off-switching halftime of
6.0 ms was determined for Sc21 and an off-switching halftime of 10.5 ms was determined
for Sc10. The off-switching halftime of Sc21 was 2.5 and 3.7 times lower than the halftimes
of rsFusionRed2 (15.0 ms) and rsFusionRed3 (22.0 ms).
Likewise, the off-switching halftimes for Sc21 at further 561 nm laser intensities (tested
range: 6.3 to 63.1 kWcm-2) were lower than those of the other examined negative-switching
RSFPs (Figure 3.3-4 B). Sc10 exhibited as well lower switching halftimes than rsFusionRed2
and rsFusionRed3 at all examined laser intensities. For all four proteins, the off-switching
halftimes and the laser intensities were not linearly related in the examined intensity range.
Figure 3.3-4: Off-switching kinetics of negative-switching red RSFPs.
A+B: Dark red: Sc10, light red: Sc21, black: rsFusionRed2, grey: rsFusionRed3. A: Off-switching curves
normalized to the on-state. All proteins were first switched on with light of 445 nm (14.9 kWcm-2) for 10 ms.
The off-switching curves were then acquired by irradiation at 561 nm (14.5 kWcm-2) for 250 ms (Sc10, Sc21)
or 500 ms (rsFusionRed2, rsFusionRed3). The averaged curves measured at 5 colonies are shown. Two
additional experiments yielded comparable off-switching kinetics. B: Off-switching halftimes in dependency of
the 561 nm laser intensity. The x-axis starts at 5 kWcm-2. The normalized off-switching curves measured at 5
colonies in each experiment were averaged and then the off-switching halftimes were determined. The mean
values and error bars of three independent experiments are shown.
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3.3.2.3 On-switching kinetics of negative-switching RSFPs
The on-switching of negative-switching red RSFPs cannot be directly detected due to the
insufficient fluorescence emission induced by the excitation at 445 nm. Thus, the on-
switching curves were obtained by modulation of the 445 nm on-switching times (chapter
2.4.1.4). The fluorescence after on-switching (1.2 kWcm-2) was readout using light of
561 nm (14.5 kWcm-2). The fluorescence signals were normalized to the fluorescence in the
on-state and plotted against the 445 nm switching time (Figure 3.3-5 A+B).
While Sc10 and Sc21 were completely switched on within the irradiation time of 25 ms
(t1/2,on = 1.6-1.7 ms), rsFusionRed2 and rsFusionRed3 did not even reach the on-state
fluorescence after 400 ms of irradiation. Moreover, the shape of the on-switching curve
differed between the switchable FusionRed proteins and the switchable mScarlet proteins.
Due to this discrepancy, the on-switching was additionally investigated by simultaneous
irradiation at 561 nm (2.6 kWcm-2) and 445 nm (1.2 kWcm-2) after full off-switching with
light of 561 nm (14.5 kWcm-2). For all four negative-switching RSFPs, the on-switching was
dominant at the simultaneous irradiation (Figure 3.3-5 C+D). Sc10 and Sc21 were again
switched on within 25 ms with slightly reduced on-switching halftimes (Figure 3.3-5 E).
In this approach, the on-switching curves of rsFusionRed2 and rsFusionRed3 reached a
plateau within 400 ms of simultaneous irradiation. The on-switching halftimes determined
in the simultaneous approach were 19.6 ms for rsFusionRed2 and 20.4 for rsFusionRed3,
thus 2.6 and 2.9 times lower compared to the approach with the modulated 445 nm
switching times. With both approaches, the on-switching curves demonstrated substantial
faster on-switching kinetics for Sc10 and Sc21 than for rsFusionRed2 and rsFusionRed3 at
the applied 445 nm light intensities.
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Figure 3.3-5: On-switching kinetics of negative-switching red RSFPs.
A-D: Dark red: Sc10, light red: Sc21, black: rsFusionRed2, grey: rsFusionRed3. A+B: On-switching curves after
switching into the off-state for two different x-axis scales, measured by the modulation of the 445 nm irradiation
times. 445 nm: 1.2 kWcm-2; 561 nm: 14.5 kWcm-2. Switching schemes for Sc10 and Sc21: 250 ms 561 nm,
0-25 ms 445 nm; switching scheme for rsFusionRed2 and rsFusionRed3: 500 ms 561 nm, 0-400 ms 445 nm.
The first fluorescence signal after on-switching divided by the on-state fluorescence was plotted against the
445 nm switching time along with the bioexponential fit. In a single experiment, each data point was measured
at 5 different colonies. The mean values and error bars of three independent experiments are shown. C+D:
On-switching curves acquired by simultaneous irradiation at 445 nm (1.2 kWcm-2) and 561 nm (2.6 kWcm-2)
(Sc10, Sc21: 25 ms; rsFusionRed2, rsFusionRed3: 400 ms) after switching into the off-state with 561 nm
(14.5 kWcm-2) (Sc10, Sc21: 200 ms; rsFusionRed, rsFusionRed3: 500 ms). Averaged on-switching curves
measured at 5 colonies normalized to the on-state. A repetition of the experiment yielded comparable switching




3.3.2.4 Switching fatigue of negative-switching RSFPs
Next, the negative-switching RSFPs Sc10, Sc21, rsFusionRed2 and rsFusionRed3 were
compared regarding their switching fatigue. Therefore the RSFPs were switched on to 90 %
using light of 445 nm (1.2 kWcm-2) and switched off to 95 % using light of 561 nm
(14.5 kWcm-2) (chapter 2.4.1.5). The switching times (listed in Figure 3.3-6 B) were chosen
on the basis of the measured off-switching curves (Figure 3.3-4 A) and on the basis of the
on-switching curves acquired by simultaneous irradiation at 561 and 445 nm (Figure 3.3-5
C+D). 250 switching cycles were acquired.
Figure 3.3-6: Switching fatigue of negative-switching red RSFPs.
A: 250 switching cycles of Sc10 (dark red), Sc21 (light red), rsFusionRed2 (black) and rsFusionRed3 (grey).
The proteins were switched off to 95 % with light of 445 nm (1.2 kWcm-2) and switched on to 90 % with light of
561 nm (14.5 kWcm-2). Switching times: listed in B. The switching curves were normalized to the maximal
fluorescence in cycle 2. The minimal and maximal fluorescence signal of the off-switching curves are plotted
against the switching cycles. The mean values and error bars of one experiment with measurements at
10 colonies each are shown. Two repetitions of the experiment yielded comparable results. B: Applied
switching times for the respective proteins. C: The maximal signal in switching cycle 100 relative to cycle 2,
and the number of cycles until 50 % of the maximal fluorescence of cycle 2 is reached. These values were
determined using averaged curves of three individual experiments.
The minimal and the maximal signal of the off-switching curves were normalized to the
maximal signal in the second switching cycle (Figure 3.3-6 A). Using the stated switching
schemes, a smaller fraction of the switchable mScarlet variants (~9 %) and a larger fraction
of rsFusionRed2 and rsFusionRed3 (~30 %) could not be switched after the first switching
cycle.
The RSFPs Sc10 and Sc21 showed higher switching fatigue than rsFusionRed2 and
rsFusionRed3. After 100 switching cycles, the maximal fluorescence signal was reduced to
54-56 % for the switchable mScarlet variants and to 75-77 % for the switchable FusionRed
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proteins (Figure 3.3-6 C).  While Sc10 and Sc21 could be switched 111 and 118 times before
the maximal signal was bleached to 50 %, rsFusionRed3 could be switched 237 times. The
maximal signal of rsFusionRed2 was not reduced to 50 % after 250 switching cycles. In the
first 70 switching cycles, Sc10 and Sc21 showed a slight increase in the minimal signal, which
represents the residual fluorescence in the off-state.
3.3.2.5 Alternative on-switching wavelength for Sc10 and Sc21
The common wavelengths 405 nm and 488 nm were tested as alternatives for the switching
of Sc10 and Sc21, like it was already conducted for the positive-switching mRuby2 variants
(chapter 3.2.2.5). For this purpose, Sc10 and Sc21 were switched into the off-state with light
of 561 nm (3.2 kWcm-2) and subsequently on-switching curves were acquired by
simultaneous irradiation at 561 nm (2.6 kWcm-2) and 405 nm, 445 nm or 488 nm. Applying
the light intensities of 4.3 kWcm-2 for 405 nm, 1.2 kWcm-2 for 445 nm and 5.6 kWcm-2 for
488 nm yielded on-switching curves with comparable switching kinetics for both Sc10
(t1/2,on=1.1-1.3 ms) and Sc21 (t1/2,on=1.0-1.1 ms) (Figure 3.3-7 A+C). In these on-switching
curves, a similar fluorescence in the off-state was determined for the different switching
wavelengths (Sc10: 4.0-4.2 %, Sc21: 3.1-3.2 %).
The laser intensities for 405 nm, 445 nm and 488 nm which induced similar on-switching
kinetics were also applied in switching fatigue experiments (Figure 3.3-7 B+D). The off-
switching was performed with light of 561 nm (14.5 kWcm-2) and the same switching
scheme was applied for all measurements. In the acquired 100 switching cycles, the
normalized maximal and minimal signals did not show major differences for the different
on-switching wavelengths. Thus, 405 nm and 488 nm represent alternative switching
wavelengths, but only if the light intensities are adjusted to higher levels.
To summarize the switching characterization of negative-switching red RSFPs, the
advantages of Sc10 and Sc21 over rsFusionRed2 and rsFusionRed3 are the considerable
higher ensemble brightness in E. coli colonies and the faster on- and off-switching kinetics.
The advantage of rsFusionRed2 and rsFusionRed3 is the higher stability in repetitive
switching. The determination of the equilibrium state revealed that the major fraction of
Sc10 and Sc21 proteins are in the on-state. Furthermore, the wavelengths 405 nm and
488 nm represent suitable alternatives for the on-switching of Sc10 and Sc21. In the
following, both switchable mScarlet variants were characterized further.
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Figure 3.3-7: Switching of Sc10 and Sc21 with alternative on-switching wavelengths.
A-D: 405 nm: purple, 4.3 kWcm-2; 445 nm: blue, 1.2 kWcm-2; 488 nm: cyan, 5.6 kWcm-2. The averaged curves
of three individual experiments with measurements at 5 colonies each are plotted. A (Sc10), C (Sc21): On-
switching curves resulting from simultaneous irradiation at 561 nm (2.6 kWcm-2) and at 405 nm, 445 nm or
488 nm after switching into the off-state (700 ms 561 nm, 3.2 kWcm-2). The curves were normalized to the on-
state fluorescence. B (Sc10), D (Sc21): Switching fatigue curves with different on-switching wavelengths for
100 switching cycles. Switching scheme: alternating 10 ms 405, 445 or 488 nm and 100 ms 561 nm
(14.5 kWcm-2). The minimal and maximal fluorescence signals of each off-switching curve were normalized to
the maximal signal in cycle 2.
3.3.3 Characterization of isolated Sc10 and Sc21 protein samples
To further characterize the switchable mScarlet variants, Sc10 and Sc21 were expressed in
E. coli colonies and isolated (protocol: chapter 2.3.1.1). Additionally, mScarlet, mCherry,
dTomato, DsRed, FusionRed, rsFusionRed2 and rsFusionRed3 were purified as reference
or for comparison using the same protocol. All proteins were isolated in a sufficient quantity
and purity, which was controlled by SDS-PAGE (Appendix Figure 6.3-1 B+C).
Results
100
3.3.3.1 Spectral characteristics of switchable mScarlet variants
The absorption spectra of isolated Sc10, Sc21 and mScarlet samples were recorded and
revealed distinct lower absorbance of the deprotonated chromophore at 500 to 600 nm for
the switchable variants (Figure 3.3-8 A). The absorption of Sc10 was slightly higher in this
range than the absorption of Sc21. All three absorption spectra featured a main absorption
maximum at 570 nm and a minor maximum at about 535 nm. The absorption spectra of
Sc10 and Sc21 showed an additional absorption band at 400 nm, while the spectrum of
mScarlet was characterized by an additional band at 340 nm.
The emission spectra of Sc10 and Sc21 were slightly red-shifted by about 7 nm compared to
the emission spectrum of mScarlet (Figure 3.3-8 B). Furthermore, the excitation spectra of
mScarlet, Sc10 and Sc21 share a main excitation maximum at 570 nm.
Figure 3.3-8: Spectra of mScarlet and generated switchable variants.
A+B: black: mScarlet, dark red: Sc10, light red: Sc21. Averaged spectra of three independent protein samples.
A: Absorption spectra normalized to the absorption at 280 nm. B: Excitation (dashed lines, Em: 620 nm) and
emission spectra (solid lines, Exc: 545 nm) normalized to the maximal fluorescence. D: Wavelengths of the
maximum absorption or fluorescence.
The Sc10 and Sc21 protein solutions were switched in a quartz cuvette (chapter 2.3.5) to
measure the absorption spectra of the on- and off-state. Both absorption spectra changed
when the protein solutions were illuminated with blue or yellow-green light. The on-
switching by illumination with light of 450/40 nm slightly increased the absorption at
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570 nm by the factor of 1.1 for Sc10 and of 1.2 for Sc21 (Figure 3.3-9 A+B). Proceeding from
the on-switched protein solutions, the illumination with light of 550/40 nm reduced the
absorption at 570 nm by the factor of 8.6 for Sc10 and 12.2 for Sc21. In addition, an
absorption maximum at 450 nm appeared by the off-switching with light of 550/40 nm. The
relaxation from the off-state was monitored by repetitive measurements of the absorption
spectra without further illumination. Using the course of the absorption at 570 nm (Figure
3.3-9 C), the determined halftimes for the relaxation from the off-state were 2.0 min for
Sc10 and 1.9 min for Sc21.
Figure 3.3-9 The absorption changes of switched Sc10 and Sc21 protein solutions.
A+B: Absorption spectra of purified protein samples in the equilibrium state (eq, dark red), after on-switching
with light of 450/50 nm for 1 min (on, light red) and after off-switching with light of 550/40 nm for 1 min (off,
black). The absorption spectra were normalized to the absorption at 280 nm. A: Sc10, B: Sc21. C: Thermal
relaxation from the off-state to the equilibrium state for isolated Sc10 (dark red) or Sc21 (light red) samples
after off-switching with yellow-green light for 1 min. The relaxation is visualized by the absorption at 570 nm
normalized to the absorption at the equilibrium. The relaxation curves were fitted using a monoexponential
function. A-C: A repetition of the experiments yielded comparable results.
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3.3.3.2 Fluorescence and extinction characteristics of the negative RSFPs
Two different methods were applied to determine the quantum yields of Sc10 and Sc21
(chapter 2.3.7). In the first method (relative method) based on the emission spectra, the
quantum yields of Sc10 and Sc21 was determined relative to the reference mScarlet (QY:
0.70 [85]). The on-switching of the two RSFPs before the measurements did not yield
significantly different values and are thus not presented. The quantum yields were
additionally determined using the QY spectrometer. Both methods revealed comparable
values of 23.6 % and 23.7 % for Sc10 and 24.1 % and 24.7 % for Sc21 (Table 5). These
quantum yields of Sc10 and Sc21 exceed all quantum yields which were measured for red-
emitting RSFPs so far.
The extinction coefficient ε of the deprotonated chromophore was determined for Sc10 and
Sc21 as well relative to the published value of mScarlet (100,000 M-1cm-1). Both, the
extinction coefficients of the RSFPs in the equilibrium and in the on-state were measured.
Slightly higher extinction coefficients were obtained for the on-switched proteins compared
to the proteins in the equilibrium (Table 5). The fluorescence lifetimes were reduced from
3.9 ns for mScarlet to 1.8 ns (Sc10) and 1.6 ns (Sc21).
Table 5: Fluorescence and extinction characteristics of switchable mScarlet variants.
QY (relative method) and extinction coefficient: three independent protein samples. QY (QY spectrometer) and
fluorescence lifetime: two independent protein samples.
FP
QY (%) ε (M-1cm-1) Lifetime
(ns)relative method(spectra) QY spectrometer equilibrium on-state
Sc10 23.7 ± 0.3 23.6 20,448 ± 923 22,460 ± 302 1.8
Sc21 24.7 ± 1.3 24.1 16,267 ± 788 20,678 ± 699 1.6
mScarlet 70* 100,000* 3.9*
* Data taken from [85]
The quantum yields and the extinction coefficients were also measured for rsFusionRed2
and rsFusionRed3 using the same protocols. Their template protein FusionRed served as
reference protein. Four independent protein samples were isolated for each protein and the
determined extinction coefficients varied strongly for the different rsFusionRed2 and
rsFusionRed3 samples (Appendix Table 16). In Table 6, only the highest determined
extinction coefficient is listed for each protein. Both, the quantum yields and the extinction
coefficients determined in this work were lower than the published values (shown in Table
6) [118].
The molecular brightness was calculated by multiplying the quantum yield with the
extinction coefficient. For rsFusionRed2 and rsFusionRed3, this calculation resulted in a
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2.4-2.5-fold lower molecular brightness determined in this work than in the work of
Pennacchietti et al. [118]. Consequently, the advantage of the molecular brightness of Sc10
and Sc21 is more apparent when compared to the values measured in this work.
Table 6: Comparison of QY and ε for the negative-switching red RSFPs.
QY: Determined by the relative method (spectra) for three to four independent protein samples.
RSFP
QY (%) ε (M-1cm-1) Brightness (QY * ε * 10-3)
this work published this work published this work published
Sc10 23.7 ± 0.3 / 22,460 ±  302 / 5.3 /
Sc21 24.7 ± 1.3 / 20,678 ± 699 / 5.1 /
rsFusionRed2 7.2 ± 0.7 12* 25.101** 35500* 1.8 4.3
rsFusionRed3 5.4 ± 0.6 8* 22,678** 38000* 1.2 3.0
* Data taken from [118]
** Highest ε determined in four independent measurements, see Appendix Table 16
3.3.3.3 The pH stability of Sc10 and Sc21
The isolated protein samples of Sc10 and Sc21 were diluted in buffers with different pH
values to examine the influence of the pH on the absorption spectra and on the fluorescence
(chapter 2.3.8). With increasing pH values, the absorption in the range of 500-600 nm
increased, which represents the deprotonated chromophore (Figure 3.3-10 A+B). The
reduction of the pH decreased the absorption in this range and at the same time gave rise to
an absorptions maximum at about 445 nm, which was assigned to be the absorption of the
chromophore with a protonated hydroxyphenyl ring. The pH-dependent changes were
comparable for Sc10 and Sc21.
The pH stability of Sc10 and Sc21 was measured by their fluorescence in different pH buffers
at 570 nm excitation and 600 nm detection. The fluorescence of Sc10 and Sc21 increased
with rising pH values (Figure 3.3-10 C) and revealed high pKa values of 7.7 for Sc10 and
7.8 for Sc21 (fit fuction: see chapter 2.3.8).
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Figure 3.3-10: pH-dependent absorption spectra and pH stability of Sc10 and Sc21.
A+B: Absorption spectra of Sc10 (A) and Sc21 (B) at different pH values: pH 5.0-10.0 in red shades from dark
to light red. The spectra are normalized to the absorption at 280 nm. The averaged spectra of three replicates
are plotted. Two independent repetitions yielded comparable results. C: Fluorescence (Exc: 570 nm, Em:
600 nm) of protein samples diluted in different pH buffers normalized to the fluorescence at pH 10.5. Dark red:
Sc10, light red: Sc21. Averaged values and error bars of three independent experiments with three replicates
each. Fits (see chapter 2.3.8) of the data from pH 4.0 to 10.5 are shown.
3.3.3.4 The oligomeric state of the switchable mScarlet variants
Analytical size-exclusion chromatography was applied to determine the oligomeric state of
Sc10 and Sc21. The fluorescent proteins DsRed, dTomato, mCherry and mScarlet were
additionally analyzed for comparison. All protein samples were diluted to 10 µM and were
applied separately to the size-exclusion column. The chromatography profiles which were
detected by the absorption at 280 nm are plotted in Figure 3.3-11. The tetrameric
DsRed [34] eluted with a retention volume of 13.75 ml, the dimeric dTomato with a
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retention volume of 14.71 ml and the monomeric mCherry with a retention volume of
16.01 ml [58]. The monomeric mScarlet eluted with a slightly higher retention volume of
16.16 ml. The RSFPs Sc10 and Sc21 were determined monomeric due to their retention
volumes of 16.21 ml and 16.23 ml.
Figure 3.3-11: Size-exclusion chromatography of Sc10 and Sc21.
Analytical size-exclusion chromatography of Sc10, Sc21 and fluorescent proteins for comparison. All proteins
were isolated from bacteria with the same purification protocol (see chapter 2.3.1.1). 10 µM protein samples
were applied to the Superdex 200 Increase 10/300 L column with a flow rate of 0.75 ml/min at 6 °C. The
chromatography profiles at 280 nm are shown. Black: DsRed (tetramer), dark grey: dTomato (dimer), light grey:
mCherry (monomer), blue: mScarlet (monomer), medium red: Sc10, light red: Sc21.
To conclude this chapter, the performed characterizations of isolated protein samples
showed a high similarity between the two mScarlet variants Sc10 and Sc21. The recorded
absorption, excitation and emission spectra of both proteins were comparable. Only the
absorption quantity in the range of 500 to 600 nm slightly differed and as a consequence,
the determined extinction coefficients were slightly different. Sc10 and Sc21 were both
determined monomeric, showed a similar molecular brightness and a comparable response
to the change of the surrounding pH. In the following, the expression of the negative-
switching RSFPs in mammalian cells was investigated.
3.3.4 Ensemble brightness of the negative-switching RSFPs in HeLa cells
As shown above, the fluorescence in the on-state of Sc10 and Sc21 in E. coli colonies was 6.8
to 8.0 times higher than those of rsFusionRed2 and rsFusionRed3 (chapter 3.3.2.1). Since
the expression and maturation can differ in bacterial and mammalian cells, the effective
cellular brightness in HeLa cells was compared as well. The plasmids Sc10-P2A-mEGFP,
Sc21-P2A-mEGFP, rsFusionRed2-P2A-mEGFP and rsFusionRed3-P2A-mEGFP (chapter
2.1.9.4) enable the transient expression of the red RSFPs together with mEGFP in the same
Results
106
ratio and were used for the transfection of HeLa cells. The day after transfection, the HeLa
cells were analyzed in flow cytometry regarding their green and red fluorescence. The
ensemble brightness in the equilibrium state was measured, since the RSFPs were not
switched on prior to the analysis.
The fluorescence of the individual transfected cells varied considerably (Figure 3.3-12 A).
On average, higher red fluorescence signals were measured for the cells expressing Sc10 or
Sc21 than for the cells expressing rsFusionRed2 or rsFusionRed3. The red fluorescence
signal was normalized to the green fluorescence signal of mEGFP in order to take the
introduced plasmid DNA into account. The averaged and normalized red-to-green
fluorescence ratio of all fluorescent cells revealed the highest ensemble brightness for Sc10
(set to 1; Figure 3.3-12 B), with a value 1.35-fold higher than for Sc21, 1.66-fold higher than
for rsFusioRed2, and 2.60-fold higher than for rsFusionRed3.
Figure 3.3-12: Expression of the negative-switching red RSFPs in HeLa cells.
A: HeLa cells transfected with Sc10-P2A-mEGFP (medium red), Sc21-P2A-mEGFP (light red), rsFusionRed2-
P2A-mEGFP (black) or rsFusionRed3-P2A-mEGFP (grey) were analyzed in flow cytometry the day after
transfection. The fluorescence signal occurring from the excitation at 488 nm (detection: 494-525 nm) is plotted
against the fluorescence signal resulting from the excitation at 561 nm (detection: sum of fluorescence at 570-
640 nm and above 645 nm). 10,000 cells were analyzed, only single cells are displayed. B: The averaged red-
to-green ratio of the cells shown in A normalized to the averaged ratio of Sc10-P2A-mEGFP.
3.3.5 The RSFPs Sc10 and Sc21 as fusion tag in fluorescence microscopy
The application of the switchable mScarlet variants as fusion tags was tested by the
expression of Sc10 and Sc21 fusion constructs in mammalian cells and their imaging in
confocal microscopy (chapter 2.4.2). Since the negative-switching RSFPs are switched off
by the excitation light of 561 nm, the imaging of the fusion constructs was performed by
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additional and simultaneous irradiation at 458 nm for on-switching. Sc10 and Sc21 were
tested in transient expressions (chapter 3.3.5.1) as well as in stable expressions
(chapter 3.3.5.2).
3.3.5.1 Transient expression of Sc10 and Sc21 in fusion constructs
The tagging performance of Sc21, the switchable mScarlet variant with most mutations, was
controlled in eight different fusion constructs. As already shown for Ru87 (chapter 3.2.4.1),
the plasmids encoding the fusion constructs were prepared and used for transfection of
HeLa cells. Sc21 was targeted to cytoskeletal structures by fusion to Lifeact, vimentin and
keratin, and to different organelles by fusions to the respective targeting signal peptides (ER,
mitochondria and peroxisomes). The detection of the Sc21 fluorescence in confocal
microscopy revealed the expected localizations (Figure 3.3-13). In addition, the expression
of Sc21 fused to Histone1 and Caveolin1 targeted Sc21 to the nucleus and to the caveolae.
The successful expression of Sc21 as C- and N-terminal tag and its correct cellular targeting
to different cell compartments promotes its applicability in transient expressions.
Figure 3.3-13: Fusion constructs of Sc21 expressed in HeLa cells.
Confocal images of Sc21 fusion constructs transiently expressed in HeLa cells. Sc21 was switched on with
458 nm and excited at 561 nm. A (from left to right): Vimentin-Sc21, Sc21-ER (ER signal), Sc21-PTS
(peroxisomal targeting signal), Sc21-Histone1 (H2BN). B (from left to right): Lifeact-Sc21, Mito-Sc21 (mito
targeting signal), Keratin-Sc21 (keratin18), Caveolin1-Sc21. Scale bars: 10 µm.
The four fusion constructs of vimentin, ER signal, peroxisomal targeting signal and
Histone1 were as well generated for Sc10. The transient expression of these constructs in
HeLa cells resulted in the expected localizations and revealed their natural occurring pattern
(Figure 3.3-14) which suggests also the applicability of Sc10 as fusion tag in microscopy.
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Figure 3.3-14: Fusion constructs of Sc10 expressed in HeLa cells.
Confocal images of Sc10 fusion constructs transiently expressed in HeLa cells, switched on with 458 nm and
excited at 561 nm. From left to right: Vimentin-Sc10, Sc10-ER (ER signal), Sc10-PTS (peroxisomal targeting
signal), Sc10-Histone1 (H2BN). Scale bars: 10 µm.
3.3.5.2 Stable expression of Sc10 and Sc21 fusion constructs
The application of Sc10 and Sc21 in long-term expression was controlled by the generation
of monoclonal cell lines stably expressing keratin fusion constructs. For this purpose, cells
of the K21 cell line generated in this work (chapter 3.1.2) were cotransfected with the
plasmids pCAG-NLS-HA-Bxb1 and pInt-Keratin-Sc10 or pInt-Keratin-Sc21. Monoclonal
cell lines were generated by single-cell sorting of the transfected cells. For both approaches,
a monoclonal cell line stably expressing the keratin fusion constructs was identified and
imaged in confocal microcopy (Figure 3.3-15 A+B). The expected cytoskeletal structures
were observed in the cells.
Figure 3.3-15: Stable expression of keratin constructs with Sc10 and Sc21 as fusion tag.
Monoclonal cell lines were generated by cotransfection of K21 cells with pCAG-NLS-HA-Bxb1 and pInt-Ker-
Sc10/Sc21 and single-cell sorting in flow cytometry. A+B: Confocal images of the monoclonal cell lines stably
expressing the keratin fusion constructs (on-switching: 458 nm, Exc: 561 nm). A: Keratin18-Sc10, B: Keratin18-
Sc21. Scale bars: 10 µm. C: PCR products of the genotyping PCRs on genomic DNA of K21 cells (CTR) and
of the monoclonal cell lines in A+B analyzed in gel electrophoresis. Expected PCR product size: 2129 bp.
A genotyping PCR was performed on the isolated genomic DNA using a landing pad-
specific (binding at the end of the CAG promoter) and a Sc10/Sc21 specific primer
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(expected size: 2129 bp). The analysis of the PCR product in gel electrophoresis (Figure
3.3-15 C) and sequencing verified the integration into the Bxb1 landing pad of the K21 cells.
The tagging of the endogenous vimentin gene with the coding sequence of Sc10 was tested
using CRISPR/Cas9 genomic editing. For this, U2OS cells were cotransfected with the
Vimentin-Sc10 donor plasmid and the plasmid encoding the Cas9 and a suitable gRNA
(chapters 2.1.9.4 and 2.2.4). The knock-in of the Sc10 coding sequence was targeted to the
C-terminal end of the endogenous vimentin gene. By single-cell sorting of the transfected
cells, monoclonal cell lines were generated and a cell line with positive knock-in was
identified in confocal microscopy (Figure 3.3-16 A+B). The stable expression of vimentin-
Sc10 was detectable in all cells. The genomic DNA of these knock-in cells was isolated and
applied in genotyping PCRs with a genome-specific and a Sc10 specific primer. The analysis
of the PCR products by gel electrophoresis and sequencing verified the knock-in into the
vimentin locus. It was not determined whether the cell line is homozygous or heterozygous
tagged.
Figure 3.3-16: Tagging of endogenous vimentin with Sc10.
CRISPR/Cas9 genome editing was used to label the endogenous vimentin with Sc10 in U2OS cells. A
monoclonal cell line was generated. A: Confocal images of the monoclonal cell line stably expressing the
vimentin-Sc10 (on-switching: 458 nm, Exc: 561 nm). Scale bars: 20 µm. B: A genotyping PCR was conducted
using the genomic DNA of the monoclonal cell line in A as template. The PCR product was analyzed in gel
electrophoresis. Expected PCR product size: 1707 bp.
In all three generated cell lines, the expression of the fusion constructs was stable for the
time of cultivation (weeks to months). The cells were viable and proliferated. The examined
transient and stable expressions emphasized the applicability of the switchable mScarlet
variants as fusion tags in fluorescence microscopy. Finally, Sc10 and Sc21 were
characterized for their application in live-cell RESOLFT microscopy.
Results
110
3.3.6 Characterization of Sc10 and Sc21 for RESOLFT microscopy
To compare the switching of Sc10, Sc21, rsFusionRed2 and rsFusionRed3 under live-cell
RESOLFT conditions, the negative-switching RSFPs were transiently expressed in vimentin
fusions in HeLa cells. Off-switching curves were acquired utilizing the pulse generator of
the RESOLFT microscope for negative-switching red RSFPs (chapter 2.4.3.2). The proteins
were switched on for 12 ms with a Gaussian 405 nm beam and the off-switching curves were
detected for 80 ms using a Gaussian 561 nm beam (1.44 kWcm-2). To achieve similar values
for the residual fluorescence in the off-state, rsFusionRed2 and rsFusionRed3 had to be
switched with higher 405 nm laser intensities (1.65 kWcm-2) compared to Sc10 and Sc21
(0.35 kWcm-2). The off-switching curves were acquired in three individual experiments with
measurements in five cells per protein.
Figure 3.3-17: Switching of negative-switching red RSFPs expressed in HeLa cells.
A+B: Vimentin fusion constructs with Sc10 (dark red), Sc21 (light red), rsFusionRed2 (black) or rsFusionRed3
(grey) were transiently expressed in HeLa cells. The proteins were switched on for 12 ms using light of 445 nm
(Sc10, Sc21: 0.35 kWcm-2; rsFusionRed2, rsFusionRed3: 1.65 kWcm-2). The off-switchting curves were
acquired by irradiation at 561 nm (1.44 kWcm-2) for 80 ms. The off-switching curves were normalized to the
fluorescence in the on-state. Curves of one experiment with 5 different cells were averaged and plotted with
different scales in A and B. C: The off-switching halftimes determined in three independent experiments (5 cells
each) showing large variations.
The residual fluorescence in the off-state and the off-switching halftimes fluctuated in the
different experiments (halftimes: see Figure 3.3-17 C). The off-switching curves of Sc10 and
Sc21 showed two distinctly different kinetics (Figure 3.3-17 A+B). In the first 2 ms of the
off-switching, the fluorescence was reduced faster for Sc10 and Sc21, while the fluorescence
of rsFusionRed2 and rsFusionRed3 was reduced stronger in the following milliseconds. The
resulting overall off-switching halftimes were lower for Sc10 and Sc21 than for
rsFusionRed2 and rsFusionRed3 (Figure 3.3-17 C). After 80 ms of off-switching, the
residual fluorescence relative to the fluorescence in the on-state was comparable for the four
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negative-switching RSFPs. Although the measured values fluctuated in the different
experiments, the determined residual fluorescence in the off-state were below 8 % in all
experiments (4.0-7.7 %).
The switching characteristics in mammalian cells and the performance as fusion tags for
transient and stable expression (chapter 3.3.5) indicate that Sc10 and Sc21 might be suitable
for live-cell RESOLFT imaging. This needs to be tested in the future. The advantage of
rsFusionRed2 and rsFusionRed3 for RESOLFT microscopy might be their lower switching
fatigues, which were only analyzed in this work for the RSFPs expressed in E. coli
(chapter 3.3.2.4). Compared to rsFusionRed2 and rsFusionRed3, the higher molecular and
cellular brightness of Sc10 and Sc21 (chapter 3.3.3.2 and 3.3.4), the faster off-switching in
the first milliseconds (Figure 3.3-17) and the lower light doses needed for on-switching
(chapter 3.3.5) can be advantageous for live-cell RESOLFT microscopy. In comparison to
rsCherryRev1.4, Sc10 and Sc21 might be preferential due to their monomeric state




The demand for reversibly switchable red fluorescent proteins with suitable characteristics
for the super-resolution method RESOLFT is still high, since the number of available red
RSFPs is still low and most red RSFPs have disadvantages. Thus, this work aimed to develop
novel red-emitting RSFPs which are applicable in RESOLFT microscopy. To achieve this, a
microscopic screening of mutant libraries expressed in E. coli colonies was adapted for the
development of red RSFPs (chapter 3.1.1). Furthermore, a screening strategy based on the
expression in mammalian cells was established (chapter 3.1.2). Based on their high
brightness, the two red fluorescent proteins mRuby2 and mScarlet were chosen as templates
to develop novel RSFPs (chapter 3.2 and 3.3). Screening of mutant libraries with the
established and adapted screening strategies yielded novel positive- and negative-switching
red RSFPs with exceptional features.
4.1 Screening for novel RSFPs
4.1.1 The automated microscope for screening and characterization of
RSFPs
The search for fluorescent proteins with the ability of being switchable and the search for
RSFPs with improved switching characteristics was realized by microscopic screening of
E. coli colonies each expressing one mutant. Comparable screenings have already been
applied for the generation of other RSFPs [92, 96, 98]. In this work, the wavelengths 445 nm
and 561 nm were chosen as switching wavelengths (chapter 3.1.1). During the screening,
the illumination with those wavelengths was performed alternating and not simultaneously
(chapter 3.2.1.2 and 3.3.1.2), since the simultaneous illumination might already cause
repetitive switching of single proteins and might not allow for complete on- and off-
switching of the protein ensemble.
The microscopic screening enabled a detailed characterization of each expressed variant.
The throughput of this screening method is restricted by the number of E. coli colonies on
the agar plates and by the time needed for the identification of fluorescent colonies, the
autofocussing and the illumination protocol. However, the overall process is rapid, since
one mutagenesis and screening round, including the isolation of the respective plasmid
DNA and sequencing, (Figure 3.1-1) can be accomplished within five days.
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The automated microscope was also used for the characterization of the final switchable
variants expressed in E. coli colonies due to the opportunity to flexibly modulate the
switching protocols (chapter 3.2.2 and 3.3.2). The light intensities in this approach exceeded
the light intensities which were used in the RESOLFT microscopes for switching of the
RSFPs expressed in mammalian cells. Nevertheless, in the case of Ru63, Ru85 and Ru87, the
times needed for on-switching were comparable for the switching in E. coli colonies with a
light intensity of 14.5 kWcm-2 (chapter 3.2.2.2) and for the switching in HeLa cells with a
light intensity of 0.43  kWcm-2 (chapter 3.2.5). An explanation to this intensity discrepancy
might be the size of the detection volume due to the non-confocal setup of the automated
microscope as well as the scattering and absorption of the light in the first layers of the
bacterial colonies. However, the switching data can be used to compare different RSFPs,
because this effect is comparable in each colony.
4.1.2 Screening for improved fluorescent proteins in mammalian cells
So far, most approaches of engineering fluorescent proteins were based on the expression
of mutants in E. coli (e.g.: [54, 58, 85, 118]). The screening of mutant libraries expressed in
E. coli colonies or in single E. coli cells allows for multiparametric analysis and has been
capable to produce numerous fluorescent proteins with certain requested properties
(chapter 1.2.3). Likewise, the screening of mutant libraries expressed in bacteria yielded new
RSFPs in this work (chapter 3.2.1 and 3.3.1). However, the expression in E. coli does not
present an accurate prediction regarding the characteristics of the fluorescent proteins in
mammalian cells. This was also shown in this work, since the ensemble brightness and the
switching properties of different RSFP variants differed between the E. coli colonies and the
HeLa cells (e.g. chapter 3.2.2 and 3.2.5).
The screening of fluorescent proteins in mammalian cells allows for the characterization in
a cellular context equal or comparable to the prospective expression host. Furthermore, the
screening in mammalian cells will prefer fluorescent proteins with low cytotoxicity. Since
the realization of screenings based on the expression in mammalian cells is complicated,
only a few applications have been shown [84, 139, 179, 180] (see chapter 1.4.1). However
these have certain disadvantages, for instance, the introduction of mutant libraries into
mammalian cells using viruses [139] bear the risk of introducing the coding sequences of
more than one variant per cell.
In this work, an approach was established which enables single variant expression per
mammalian cell, a requirement for the screening of fluorescent proteins. This was achieved
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by generating and employing a Bxb1 landing pad cell line (chapter 3.1.2). During the
processing of this work, a similar approach was introduced by Matreyek et al. [181]. They
integrated a landing pad into the AAVS1 locus of HEK cells and used this cell line along
with high throughput sequencing to investigate the effect of different N-terminal codons on
the expression of EGFP [181].
4.1.2.1 Generation of a Bxb1 landing pad cell line for screening
The Bxb1 landing pad cell line K21 was generated by knock-in of the designed landing pad
into the genome of HeLa cells using CRISPR/Cas9 genome engineering (chapter 3.1.2.3).
The knock-in of the landing pad was targeted to the AAVS1 locus, and the positive and
accurate knock-in was verified by genotyping PCRs and sequencing of the PCR products.
A double knock-in of the Bxb1 landing pad is determined to be unlikely (chapter 3.1.2.4),
however, it could not be entirely ruled out. As the single knock-in is essential for the
specificity of the screening approach, the verification of the single knock-in should be
addressed in the future.
The integrated landing pad was composed of a CAG promoter and the Bxb1 attP site.
Similar to the approach of Duportet et al. [140], a constitutive promoter was selected for the
landing pad in this work, whereas Matreyek et al. chose a Tet-inducible promoter [181]. A
landing pad with an inducible promoter offers the option to not permanently expose the
cells to the transgene expression. However, for the screening it is advantageous to have a
constitutive promoter, since fluorescent proteins with a low cytotoxicity in permanent
expressions will be enriched [84]. In addition, the need for induction prolongs the time
between transfection and possible fluorescence analysis. While Matreyek et al. controlled
the transgene expression 7-11 days after transfection [181], the fluorescence in transfected
K21 cells was analyzed 5-6 days after transfection (chapter 3.1.2.4). Moreover, the induction
could add a variability to the expression of the fluorescent proteins in each cell.
Different to the generated HeLa K21 cell line in this work, the Bxb1 landing pad cell lines of
Duportet et al. and Matreyek et al. stably express a fluorescent protein (EYFP or mTagBPF2)
[140, 181]. After integration of a plasmid into these landing pads, the expression of the
respective fluorescent protein is interrupted. Thereby it can be monitored, if an integration
event occurred. However, this can be disadvantageous for the screening of fluorescent
proteins with emission at similar spectral ranges. Since no fluorescent protein gene is
encoded in the landing pad of the K21 cells, the cell line generated in this work can be used
for the screening of all types of fluorescent proteins, independent from their spectral
characteristics. Furthermore, the monitoring of the integration event is not needed, because
Discussion
115
the integration can be detected by the fluorescence of the integrated and expressed
fluorescent protein.
4.1.2.2 The efficiency of plasmid integration into the Bxb1 landing pad
To determine the integration efficiency, K21 cells were cotransfected with the Bxb1
expression plasmid and the integration plasmid pInt-mEGFP-P2A-HygroR.  1.15 % of the
cells were green fluorescent, but the integration efficiency is presumably higher, since the
transfection efficiency was not determined and therefore non-transfected cells could not be
excluded. However, this percentage of fluorescent cells was lower than expected from the
literature [140, 181]. The highest integration efficiency so far (10 %) was measured for a
landing pad cell line generated from HEK cells (non-transfected cells were excluded in the
analysis) [140]. The low integration efficiency for the K21 cells increases the amount of cells
which have to be analyzed to compare the same quantity of fluorescent protein variants.
Several strategies could improve the integration efficiency. In the applied Bxb1 expression
plasmid (pCAG-NLS-HA-Bxb1 [167]), a nuclear localization signal (NLS) was fused to the
N-terminus of the Bxb1 recombinase. Since it was shown, that an NLS sequence does not
improve the integration efficiency and a fusion to the N-terminus of the Bxb1 recombinase
can even reduce the integration efficiency [140], a new expression plasmid for the Bxb1
recombinase without NLS sequence should be generated. Furthermore, it was shown that
the transfection of the Bxb1 expression plasmid one day before the transfection of the
integration plasmids can improve the integration efficiency [181]. These strategies should
be tested to improve the integration efficiency and thereby increase the throughput in the
screening of mutant libraries.
4.1.2.3 Screening for brighter fluorescent proteins expressed in K21 cells
Using the generated Bxb1 landing pad cell line K21, a screening for fluorescent proteins
with improved brightness was established (chapter 3.1.2.5). This was implemented by in
vitro mutagenesis, transfection of the mutant library along with the Bxb1 expression
plasmid, and fluorescence analysis of the transfected cells in flow cytometry. The variants
with the highest red fluorescence signal or the best red-to-green fluorescence ratio were
selected by fluorescence-activated cell sorting. The cells were cultivated for a few days to
increase the cell number for the subsequent isolation of genomic DNA. The coding
sequences of the selected variants were amplified by PCR and cloned into a suitable vector.
One mutagenesis and screening round took about three weeks.
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In contrast to viral approaches [140], all fluorescent protein variants are expressed from the
same genomic locus. For this reason, the fluorescence signals were expected to be more
comparable. Surprisingly, the fluorescence signals of the K21 cells with the same integrated
plasmid (pInt-mEGFP-P2A-HygroR) varied strongly (Figure 3.1-4 A). This variation might
arise from varying expression levels depending on the cell cycle phase or random
transcription bursts [182, 183]. Thus, the utilization of the integration plasmids with the
element P2A-mCherry or P2A-mEGFP is useful in terms of assigning the quantity of
expressed proteins. The correlation of the mRuby2 and mEGFP signals in the K21 cells with
integrated pInt-mRuby2-P2A-mEGFP plasmid proved this concept to be suitable (Figure
3.1-4 C).
In the plasmid pInt-MCS-P2A-codEGFP (chapter 3.1.2.2), the codon usage at the N- and
C-terminus of the mEGFP gene was modified (codons of the first and last 7-8 amino acids).
This plasmid can be used as backbone, if the red template protein applied in the mutagenesis
and screening contains EGFP-ends. This minimizes the amount of primers that bind to the
mEGFP gene instead of the red fluorescent protein gene when the coding sequences of the
selected red variants are extracted from the genomic DNA by PCR.
The screening was applied to identify RSFPs with higher brightness. Mutations which
stabilize the chromophore and thereby improve the brightness could at the same time
prevent or impair the switching process. For this reason, a higher fluorescence signal of a
RSFP mutant measured in flow cytometry can be accompanied by a reduction or loss of
switching. Furthermore, the RSFPs were not switched on prior to the flow cytometry
analysis, thus a higher detected fluorescence signal might also be a consequence of an altered
equilibrium state. Consequently, a combinatory screening was conducted by cloning the
coding sequences of the selected mutants into the pBad vector and then controlling the
switching abilities of the RSFP variants in the automated microscope. However, it would be
preferable to reduce the number of experimental steps by characterizing the switching
characteristics of the bright RSFPs directly in the K21 cells (see chapter 4.1.2.4).
The screening for brighter fluorescent proteins based on the K21 cell line might be more
suited for non-switching proteins. Related to the development of novel RSFPs, the described
protocol could be applied at the beginning to identify brighter template proteins. This is in




4.1.2.4 The potential of the Bxb1 landing pad cell line
Various screening approaches for the evolution of fluorescent proteins are conceivable on
the basis of the generated Bxb1 landing pad cell line K21. In this work, the screening of
mutant libraries expressed in K21 cells was restricted to the fluorescence analysis in flow
cytometry. This type of screening can be used to identify brighter fluorescent protein
mutants.
The development of fluorescent proteins with improved tagging performance could be
implemented by transfection of the K21 cells with a mutant fusion construct library and an
imaging-based screening. The prepared integration plasmids for keratin and vimentin
constructs (chapter 3.1.2.2) could be utilized as vector backbone for this. In addition, a
screening which identifies RSFPs with improved switching characteristics in mammalian
cells is desirable. For this purpose, a suitable setup for repetitive switching and subsequent
sorting of single K21 cells is required. A microfluidic cell sorter [139, 184] with several
consecutive laser beams for switching and readout could be a solution to this [185].
Moreover, the Bxb1 landing pad cells can be used for the generation of monoclonal cell lines
stably expressing a fusion construct. This can be applied to investigate the applicability of
new fluorescent proteins in stable expressions (chapter 3.2.4.2 and 3.3.5.2). In addition, it
was shown that K21 cells stably expressing keratin fusion constructs can serve as samples
for the establishment of RESOLFT imaging due to the higher reproducibility from day to
day compared to transient overexpressions (chapter 3.2.5).
To conclude, the advantage of a Bxb1 landing pad cell line for screening is the option for
single variant expression per mammalian cell, which is not necessarily given in other
approaches like viral transfections. This enables the characterization and comparison of
different fluorescent protein variants. In contrast to other published Bxb1 landing pad cell
lines, the K21 cell line can be used for screening of all types of fluorescent proteins. In
addition, the permanent expression of the single mutant variants should facilitate the
selection of fluorescent proteins with low cytotoxicity. In combination with the
establishment of further screening techniques, the Bxb1 landing pad cell line K21 offers a
great potential for the development of new fluorescent proteins.
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4.2 Novel reversibly switchable red fluorescent proteins
The number of applicable red-emitting RSFPs for RESOLFT microscopy is limited, since
most of the available red RSFPs exhibit drawbacks like a low switching contrast or a
dimerization tendency [91, 98]. Numerous green RSFPs with favorable characteristics exist
[93], however using red RSFPs with longer excitation and switching wavelengths leads to
reduced phototoxicity, autofluorescence and light-scattering during imaging of living cells
[84]. Furthermore, red RSFPs with excellent characteristics can be used along with available
green RSFPs in dual color RESOLFT microscopy [98]. In this work, a series of novel RSFPs
emitting in the red region of the spectrum were developed. Both, positive- and negative-
switching RSFPs with a high switching contrast were generated from non-switching
template proteins. The new red RSFPs are potential probes for live-cell RESOLFT
microscopy.
4.2.1 Positive-switching RSFPs derived from mRuby2
The red fluorescent protein mRuby2 [57] was chosen as template for the development of
novel RSFPs due to its high molecular brightness and its monomeric state. Additionally, no
attempts of developing an RSFP on the basis of this protein were reported so far.
Mutagenesis of the chromophore-surrounding amino acids followed by screening yielded
the slightly switchable Ru27 variant (M164T) (chapter 3.2.1.1). This mutant switched in a
positive-switching mode, which was particularly favored, since no positive-switching red
RSFPs with characteristics suitable for live-cell RESOLFT microscopy were available.
A high number of mutagenesis and screening rounds were conducted to obtain switchable
mRuby2 variants with low residual fluorescence in the off-state (chapter 3.2.1.3). Only the
crystal structure of the mRuby2-precursor mRuby was available for the choice and analysis
of mutation sites (Figure 3.2-2 B). Among others, the positions T162 and M164 were
mutated, which are typical mutation sites for the introduction or improvement of switching
as both are located close to the chromophore (chapter 1.3.4). For instance, at least one of
these two positions were as well mutated in the development of the red RSFPs rsTagRFP
[82], rsCherry and rsCherryRev [91].
The mutation C176A was introduced due to the findings of Duan et al. who showed that
sulfoxidation of the cysteine at position 171 in IrisFP might be involved in the switching
fatigue mechanism of this protein [99]. The addition of the C176A mutation indeed
improved the switching fatigue in the switchable mRuby2 variants by about 28 % (Ru48;
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chapter 3.2.1.3). Altogether, 10-14 mutations were added in total to generate the final
variants Ru63, Ru85 and Ru87, eight of these are located in loops or outside the beta barrel
structure.
After the start of this work, the conventional fluorescent protein mRuby3 was reported
which is a variant of mRuby2 with 21 mutations. This proteins exhibits a higher molecular
brightness and an improved photostability compared to its progenitor [70]. However, one
of the key amino acids which improved the characteristics (M164I), is one of the mutation
sites in the switchable mRuby2 variants. Furthermore, the addition of the Ru48 mutations
to mRuby3 yielded switchable variants, but with worse switching characteristics compared
to Ru48 (data not shown, mutations and characteristics of Ru48: see chapter 3.2.1.3). Thus,
this template was not further pursued.
4.2.1.1 Comparison of available positive-switching red RSFPs
The switching behavior of Ru63, Ru85 and Ru87 was compared to the only other available
monomeric and positive-switching red RSFP, rsCherry [91]. The characterization of these
positive-switching RSFPs expressed in E. coli colonies revealed that all three switchable
mRuby2 variants outperform rsCherry (chapter 3.2.2). Ru63, Ru85 and Ru87 exhibited
lower residual fluorescence in the off-state (about 4.5 %) and substantial higher on- and off-
switching kinetics. All three could be switched in more than 350 switching cycles until the
maximal fluorescence was bleached to 50 %, while rsCherry lost its switching ability within
40 switching cycles. Some negative-switching RSFPs (green and red) were shown to be
switchable several hundreds or even thousands times before the on-state signal was reduced
to half [96, 98, 118]. However, these results are strongly dependent on the experimental
conditions like light intensities, completeness of switching per cycle and the cellular
conditions which varied in each measurement.
The only other reported positive-switching red RSFPs are asFP595 and its mutants, which
are not applicable in live-cell microscopy due to their obligate tetramerization [33, 74, 116].
By contrast, Ru63, Ru85 and Ru87 were shown to be monomeric in size-exclusion
chromatography (chapter 3.2.3.4). Hence, Ru63, Ru85 and Ru87 were identified as the
positive-switching RSFPs with the highest potential for the application in live-cell RESOLFT
microscopy to date.
4.2.1.2 Further characterization of the RSFPs Ru63, Ru85 and Ru87
A detailed switching characterization and a characterization of the purified protein samples
was performed for the final variants Ru63, Ru85 and Ru87 (chapter 3.2.2 and 3.2.3).
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Expressed in E. coli colonies, the three variants exhibited comparable switching
characteristics. However, the determined off-switching halftimes of Ru85 and Ru87 were
slightly lower for the applied light intensity (chapter 3.2.2.3) and the residual fluorescence
in the off-state increased less in the switching fatigue curves of these two RSFPs (chapter
3.2.2.4). The additional advantage of Ru87 is the highest ensemble brightness measured in
E. coli (chapter 3.2.2.1). All three switchable mRuby2 variants relaxed from the on- and off-
state within 4 s (chapter 3.2.2.6), while most other RSFPs exhibit thermal relaxation times
from minutes to hours (e.g. rsTagRFP, Padron, rsEGFP) [82, 88, 90, 118].
A greater difference was found in the equilibrium state (chapter 3.2.2.6) and in the shape of
the absorption spectra (chapter 3.2.3.1). The addition of the mutations M15T and V188D
increased the equilibrium state from 10 % of the on-state signal (Ru63) to 32 % (Ru85),
while further addition of the mutations N37A and G157V, both located in loops, reduced
the equilibrium state again to 20 % (Ru87). In the absorption spectra, the change from a
main and a minor maximum to a single broad maximum in the range of 500 to 600 nm was
introduced by either the M15T or the V188D mutation. The M15T mutation is located
inside the barrel and is closer to the chromophore than V188D. However, the explanation
for the changes in the spectra and in the equilibrium state remain unclear.
In addition, a small absorption maximum was detected at about 450 nm for Ru85 and Ru87
(Figure 3.2-10 B). As both RSFPs showed a higher fluorescence in the equilibrium state
compared to Ru63, this absorption band might represent a fraction of RSFPs in the on-state
which can be switched to the off-state by absorption of light at 445 nm. Furthermore, this
absorption band might rise from protonated chromophores, since the absorption at this
wavelength also increased when the proteins were diluted in buffers with low pH values
(Figure 3.2-11). An additional absorption maximum occurred at 500 nm when the Ru63,
Ru85 and Ru87 protein samples were diluted in buffers with pH values higher than 9.0. This
absorption band cannot be assigned, but due to the high pH values it should arise from the
deprotonation of a residue exhibiting a high pKa value.
No changes in the absorption spectra were measured after illumination of the Ru63, Ru85
and Ru87 protein samples with blue or yellow-green light (chapter 3.2.3.1). However, this
might be due to the rapid thermal relaxation and the time needed to start the absorption
measurements. Thus, the determination of the quantum yields and extinction coefficients
based on the absorption and emission spectra could only be performed for the proteins in
the equilibrium state (chapter 3.2.3.2). By contrast, the quantum yield determination based
on the nanocavity-based method [169] is independent from the state of the protein. This
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might explain the higher quantum yields measured in this method. The quantum yields of
Ru63, Ru85 and Ru87 determined in the nanocavity-based method (QYs = 17-20 %) are
comparably high for red RSFPs (comparison to other red RSFPs: see chapter 4.2.3).
Although it was not measurable, the absorption spectra might change upon switching, like
it was shown for Sc10, Sc21 (Figure 3.3-9), rsTagRFP [82] and most green RSFPs [88, 90,
96]. Hence, the extinction coefficients measured for the equilibrium state might not equal
the extinction coefficients of the on-state.
All three switchable mRuby2 variants showed high performance as fusion tags in the
transient and stable expressions in mammalian cells (chapter 3.2.4). Ru87 was even shown
to be applicable in endogenous tagging of vimentin (chapter 3.2.4.2). These experiments in
combination with the characterization of the switching in E. coli colonies suggest an
applicability of all three variants in live-cell RESOLFT microscopy, with Ru87 having small
benefits. However, when expressed in vimentin constructs in HeLa cells, the switching
curves of Ru63, Ru85 and Ru87 revealed differences to the once measured in E. coli
concerning the on-switching kinetics and the residual fluorescence in the off-state (Figure
3.2-17). This data suggests the highest applicability of Ru63 for live-cell RESOLFT imaging
because it exhibited the lowest fluorescence in the off-state (10 % of the on-state signal). For
this reason, Ru63 was chosen for the establishment of live-cell RESOLFT imaging with
positive-switching red RSFPs. In the future, the switching characteristics of Ru63, Ru85 and
Ru87 should be additionally tested and compared using further fusion construct in order to
examine the effect of the localization within the cell and the fusion construct on the
switching characteristics. Just recently, it was shown, that the packing can have an influence
on the switching mechanism in RSFPs [186] and the binding to another protein can alter
switching characteristics [187].
4.2.1.3 Live-cell RESOLFT image utilizing a positive-switching red RSFP
Before the start of this work, live-cell RESOLFT microscopy with red RSFPs had only been
implemented with negative-switching proteins [98, 118]. However, only two instead of
three laser beams are needed in RESOLFT microscopy with positive-switching RSFPs [100]:
A doughnut-shaped beam for off-switching and a Gaussian beam for on-switching and
fluorescence readout. The new RSFP Ru63 was selected for the establishment of live-cell
RESOLFT imaging with a positive-switching red RSFP. Indeed, a resolution improvement
was achieved using a point-scanning approach with a dwell time of about 5 ms per pixel
(Figure 3.2-18, protocol: 2.4.3.1). FWHM of 106 and 125 nm were determined in line
profiles across the keratin filaments. For comparison, a confocal image was acquired of the
Discussion
122
same field of view by 2 ms on-switching and subsequent fluorescence readout. It should be
mentioned that this confocal image might exhibit a higher resolution than expected, since
the RSFPs, especially the ones in the periphery, might be incompletely switched to the on-
state. Thus, the resolution improvement in the RESOLFT image might be less obvious
(Appendix Figure 6.3-2). The switching characteristics (chapter 3.2.2 and 3.2.5Figure
3.2-17) and the performance as fusion tag (chapter 3.2.4) suggest that Ru63 is a promising
candidate for live-cell RESOLFT microscopy. An adjustment of the RESOLFT imaging
scheme could further improve the obtained resolution in the future.
4.2.2 Negative-switching RSFPs derived from mScarlet
Due to its high molecular brightness, the recently introduced and non-switching red
fluorescent protein mScarlet [85] was additionally selected as template protein. In contrast
to the evolution of Ru63, Ru85 and Ru87, only a few mutagenesis and screening rounds
were needed to obtain red RSFPs with low residual fluorescence in the off-state
(chapter 3.3.1). In the semi-rational design, mainly saturated site-directed mutagenesis was
performed. Similar to the generation of switchable mRuby2 mutants, the mutagenesis of the
amino acids at positions 162 and 164 in mScarlet yielded switchable proteins, but this time
with a negative-switching mode. In addition, the position S147 was mutated, which was
previously shown to be a typical mutation site for the introduction or improvement of
switching [82, 91, 118], resulting in the final variant Sc10 (chapter 3.3.1.3). The other final
variant Sc21 contains two additional mutations located outside the beta barrel (R217Q,
D161K) which mainly improved the off-switching halftime. Also in the development of
switchable mRuby2 variants (chapter 3.2.1.3) and other red RSFPs [82, 91, 98], mutation
sites in loops or outside the beta-barrel structures were introduced, but these differ for the
individual RSFPs. Those mutations might influence the folding of the GFP-like proteins and
the exact position of the beta-strands.
4.2.2.1 Comparison of negative-switching RSFPs
During the processing of this work, new negative-switching RSFPs were reported, which
were obtained by mutagenesis of FusionRed [118]. Since rsFusionRed2 and rsFusionRed3
were successfully employed in live-cell RESOLFT microscopy and exceeded rsTagRFP and
rsCherryRev1.4 concerning off-switching halftimes [118], these two RSFPs were chosen for
the comparison to Sc10 and Sc21.
Both, rsFusionRed2 and rsFusionRed3 showed essentially lower ensemble brightness in
E. coli colonies compared to the negative-switching RSFPs generated in this work (factor of
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6.8-8.0; chapter 3.3.2.1). A lower cellular brightness was as well measured in HeLa cells
(chapter 3.3.4). However, the determined molecular brightness of Sc10 and Sc21 was only
slightly higher than the published values of rsFusionRed2 and rsFusionRed3 (factor 1.2-1.8;
chapter 3.3.3.2). Thus, the quantum yield, the extinction coefficient and the resulting
molecular brightness were also determined for rsFusionRed2 and rsFusionRed3 using the
protocols of this work. As a result, the molecular brightness of rsFusionRed2 and
rsFusionRed3 was 2.8 to 4.4-fold lower compared to the values of Sc10 and Sc21. It should
be noted, that the maturation varied strongly for rsFusionRed2 and rsFusionRed3 which
affected the extinction coefficient determination (Appendix Table 16). However, the
published values could not be reached in four experiments and the variation of the
measured extinction coefficients indicate problems in the maturation of these proteins.
Expressed in E. coli colonies, Sc21 exhibited the lowest fluorescence in the off-state
(chapter 3.3.2.1) and the lowest switching halftimes of the four examined negative RSFPs
(chapter 3.3.2.2 and 3.3.2.3). In the on-switching using light of 445 nm, the switching speeds
of Sc10 and Sc21 clearly exceeded the switching speeds of rsFusionRed2 and rsFusionRed3
(Figure 3.3-5). The high sensitivity of Sc10 and Sc21 to light of 445 nm was also visible in
the switching of RSFPs in HeLa cells, since 4.7-fold higher light intensity were applied for
the on-switching of rsFusionRed2 and rsFusionRed3 to obtain comparable switching
contrasts (chapter 3.3.6). Lower 445 nm light intensities or shorter on-switching times
reduce the doses of blue light needed in RESOLFT imaging, thus a lower phototoxicity is
expected for the application of Sc10 and Sc21 compared to the application of rsFusionRed2
and rsFuionRed3.
The off-switching curves acquired for Sc10 and Sc21 expressed in HeLa cells revealed
substantial higher off-switching kinetics in the first two milliseconds followed by a
fluorescence decrease with a slow kinetic (Figure 3.3-17). The impact of this effect on the
application of Sc10 and Sc21 in RESOLFT microscopy has to be addressed in the future.
The only advantage of rsFusionRed2 and rsFusionRed3 was found in the switching fatigue
experiments (chapter 3.3.2.4). Using the chosen switching scheme, rsFusionRed2 and
rsFusionRed3 could be switched 2.0-2.5 times more often until the maximal signal was
reduced by half. However, Sc10 and Sc21 were also switched more than 100 times before
the signal was reduced to 50 %. In addition, a fluorescence decrease of 30 % was observed
from the first to the second switching cycle for rsFusionRed2 and rsFusionRed3 and only
by 9 % for Sc10 and Sc21, which was not taken into account for the evaluation of the
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switching fatigue. The high loss of the on-state fluorescence is a severe disadvantage for the
application of rsFusionRed2 and rsFusionRed3.
4.2.2.2 Further characterization of the RSFPs Sc10 and Sc21
Most examined characteristics of Sc10 and Sc21 were comparable. Both RSFPs are
monomeric in size-exclusion chromatography (chapter 3.3.3.4) and both exhibited
comparable quantum yields (24-25 %; chapter 3.3.3.2). In difference to the switchable
mRuby2 variants, the absorption spectra of the isolated Sc10 and Sc21 protein samples
changed upon illumination with blue and yellow-green light (Figure 3.3-9). The off-
switching with yellow-green light gave rise to an absorption maximum at about 450 nm,
representing the absorption band which can be addressed by blue light for on-switching.
The pKa value was comparably high for Sc10 and Sc21 (7.7 and 7.8; chapter 3.3.3.3).
However, a cis-trans or trans-cis isomerization at reduced pH values was proven for some
proteins like mRuby and Gamillus [126, 177], thus a pH-dependent change of the
equilibrium state is conceivable for Sc10 and Sc21. This could be analyzed in the future by
examination of the switching ability and the equilibrium state of Sc10 and Sc21 samples
diluted in buffers with lower pH values.
The investigation of the absorption change at 570 nm revealed a halftime of about 2 min for
the thermal relaxation from the off-state for Sc10 and Sc21 (chapter 3.3.3.1), considerably
higher than the relaxation halftimes of Ru63, Ru85 and Ru87 (relaxation halftimes from the
on-state: 216-478 ms). Comparable to the switchable mRuby2 variants, the utility of Sc10
and Sc21 as fusion tags in transient and stable expressions in mammalian cells was shown
and Sc21 was even applicable in the endogenous tagging of vimentin (chapter 3.3.5). The
result of all characterizations is that both, Sc10 and Sc21, are potential candidates for live-
cell RESOLFT microscopy, which still needs to be proven in the future. Only the higher
switching fatigue shown for Sc10 and Sc21 might limit their use in this method.
4.2.3 Available red-emitting RSFPs
By now, more negative-switching than positive-switching RSFPs are available which emit
in the green and red region of the spectrum. In addition, most applications of RESOLFT
microscopy utilized negative-switching RSFPs [86]. Also in this work, the generation of
positive-switching red RSFPs with favorable characteristics required more effort than the
generation of negative-switching red RSFPs (chapter 3.2.1.3 and 3.3.1.3). However, this
might also be due to the chosen template proteins.
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The novel mRuby2 variants represent the only potential positive-switching and red
fluorescent candidates for live-cell RESOLFT microscopy and Ru63 has been shown to be
applicable in this super-resolution method (chapter 3.2.5). The poor switching
characteristics of rsCherry (chapter 3.2.2) [91] and the tetrameric state of asFP595 [33]
restrict their applicability as fusion tags in live-cell RESOLFT microscopy.
In addition to the novel negative-switching mScarlet variants, a few other negative-
switching and red-emitting RSFP exist (Table 7). The RSFP rsFusionRed1 was not
considered due to its low switching contrast (residual fluorescence in the off-state: 34 %)
[118]. From the negative-switching RSFPs, only rsFusionRed2, rsFusionRed3 and
rsCherryRev1.4 were applied in live-cell RESOLFT microscopy despite the dimerization
tendency of the latter [98, 118]. The switching characteristics of various RSFPs from the
literature are difficult to compare because of the different expression and switching
conditions applied. However, using the same protocol, Pennacchietti et al. presented that
rsFusionRed2 and rsFusionRed3 exhibited the fastest off-switching kinetics of the negative-
switching RSFPs available at that time [118]. In this work, the off-switching kinetics of the
novel RSFPs Sc10 and Sc21 even exceeded the ones of rsFusionRed2 and rsFusionRed3
(chapter 3.3.2.2).
Table 7: Characteristics of available red RSFPs.
Switching mode, absorption, excitation and emission maximum, extinction coefficient, quantum yield, molecular




















571 555 592 24,000 0.18 4.32 6.1 monomer
this
workRu85 565 555 593 14,100 0.17 2.40 6.5 monomer
Ru87 564 555 593 20,500 0.20 4.10 6.2 monomer
rsCherry 571 n.d. 610 80,000a 0.02a 1.6 6.0a monomer [91]




570 570 600 22,500 0.24 5.4 7.7 monomer this
workSc21 570 570 600 20,500 0.25 5.1 7.7 monomer
rsFusionRed2 564 580 607 35,500 0.12 4.3 4.7 monomer [118]
rsFusionRed3 565 580 607 38,000 0.08 3.0 4.7 monomer [118]
rsCherryRev 572 n.d. 608 84,000a 0.005a 0.4 5.5a monomer [91]
rsCherryRev1.4 572 n.d. 609 n.d. n.d. n.d. 5.5 dimerizationtendency [98]
rsTagRFP 567 567 585 36,800 0.11 4.0 6.6 monomer [82]
a: determined in Subach et al., 2009 [178]
All reported red RSFPs suffer from a low molecular brightness (Table 7). The five generated
red RSFPs in this work rank among the red RSFPs with the highest molecular brightness.
The quantum yield and the molecular brightness determined for Sc10 and Sc21 are the
highest values measured for red RSFPs by now. Nevertheless, a strong reduction in the
molecular brightness was as well observed for the novel red RSFPs compared to their
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template proteins (mRuby2: 43 [57], mScarlet: 70 [85]). Presumably, the introduction of
switching allows a higher probability for non-radiative processes [121]. However, it should
be noted that the molecular brightness of most available green RSFPs exceed the molecular
brightness of the red RSFPs (e.g.: rsEGFP2: 18.3 [96]).
The maturation process of red fluorescent chromophores is more complex than the
maturation of green fluorescent chromophores and involves the formation of a blue
fluorescent intermediate state, and in some cases even a break in the protein backbone [2,
46, 49, 188]. A fraction of incompletely matured chromophores might be visible in the
absorption spectrum of red fluorescent protein samples at lower wavelengths. Interestingly,
the absorption spectra of most red RSFPs (Ru63, Ru85, Ru87 (chapter 3.2.3.1), Sc10, Sc21
(chapter 3.3.3.1), rsCherry, rsCherryRev [91], rsCherryRev1.4 [98], rsFusionRed2,
rsFusionRed3 [118]) feature a distinct absorption maximum at about 390 to 420 nm and
partially a slightly increased absorption in the range of 320-380 nm. While the absorption
spectra of their progenitor (mRuby2, mScarlet, mCherry, FusionRed) showed only a
(slightly) increased absorption at 320-380 nm, but no distinct absorption maximum at
400 nm (chapter 3.2.3.1, chapter 3.3.3.1, [91] and [76]).
The 400 nm absorption maximum of the red RSFPs fits to the excitation maximum of the
blue fluorescent mTagBFP and mCherry-Blue, which was generated from the red
fluorescent TagRFP and mCherry by mutagenesis [61]. Among others, the positions 148
and 165 were mutated in these proteins, which are also typical mutations sites to generate
RSFPs (positions 143 and 162 in mScarlet and mRuby2). Furthermore, the mutation M65L
was introduced to obtain these blue fluorescent variants, which was also added in the
switchable mRuby2 variants (here: M67L). It was suggested that the blue fluorescent
proteins were obtained by preventing the last maturation steps from the blue intermediate
to the red fluorescent proteins [49, 61]. Thus, the distinct absorption maximum might result
from a higher fraction of blue fluorescent intermediates. However, this cannot explain the
differences between the red RSFPs and their template proteins (not detected for rsTagRFP,
rsFusionRed1). Hence, the introduction of switching by mutagenesis of the chromophore-
surrounding amino acids might affect the blue intermediate in an additional way.
4.2.4 Switching mechanisms in red RSFPs
Several studies investigated the underlying mechanism of switching in different RSFPs (e.g.
[40, 99, 116, 117, 120]). Even today the exact mechanism stays unclear and might differ for
the individual RSFPs. In all positive- and negative-switching RSFPs examined by now, cis-
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trans isomerization is a key event in switching. A change in the planarity and flexibility as
well as protonation and deprotonation of the chromophore are discussed to contribute to
the different fluorescence abilities of the cis- and trans-forms [125].
The chromophore of the non-switching mRuby protein adopted a trans-conformation in
crystal structures at pH 8.5 [177], while the chromophore of mScarlet adopted a cis-
conformation at pH 7.8 [85]. This raises the question, which conformations the
chromophores of the novel RSFPs adopt in the on- and off-states. Structural investigations
could reveal insights to this in the future. By now, almost all examined crystal structures of
on-switched RSFPs showed a chromophore in the cis-conformation [125]. For instance, the
on-state chromophore of rsTagRFP was found in the cis-form [117], although its non-
switching progenitor TagRFP exhibits a trans-chromophore [49]. In contrast, just recently
it was shown that the chromophore of the acid-tolerant RSFP rsGamillus-S adopts a trans-
form in the on-state and a cis-form in the off-state [126].
For all switchable mRuby2 and mScarlet proteins, the dilution in buffers with lower pH
values gave rise to an absorption maximum at about 450 nm, which was assigned to be the
chromophore protonated at the hydroxyphenyl ring (chapter 3.2.3.3 and 3.3.3.3). A
comparable absorption maximum was visible in the absorption spectra of the off-switched
Sc10 and Sc21 protein solutions (chapter 3.3.3.1). Furthermore, 445 nm represents a
wavelength for efficient switching of Ru63, Ru85, Ru87, Sc10 and Sc21 (chapter 3.2.2.5 and
3.3.2.5). Thus, it is reasonable that protonation and deprotonation is involved in the
switching mechanism, like it was already shown for other RSFPs [116, 117, 189].
The introduction of switching in mScarlet and mRuby2 was achieved by mutating M164 to
smaller amino acids (threonine, glycine, alanine, Figure 3.2-2, Figure 3.3-2). In addition, the
amino acid at position 157 was exchanged from a polar to a non-polar amino acid in
mScarlet (serine to glycine), while the amino acid at position 162 was mutated from a non-
polar to a polar amino acid (isoleucine to glutamine). By contrast, in mRuby2 the amino
acid at position 162 was exchanged from a polar to a non-polar amino acid (threonine to
alanine). The mentioned mutation sites are located in close proximity to the chromophore.
Hence, these mutations might enable switching in the generated RSFPs by offering more
space for cis-trans isomerization and by changing the hydrogen bonding network, like it
was shown for other RSFPs [125]. However, these speculations and the contribution of the




4.2.5 Alternative wavelengths for switching
The wavelength of 405 nm, 445 nm and 488 nm were compared for the off-switching of
Ru85, Ru85 and Ru87 and for the on-switching of Sc10 and Sc21 (chapter 3.2.2.5
and 3.3.2.5). The adjustment of the light intensities enabled switching with all three
wavelengths in a comparable manner. The lowest light intensities were needed for the
switching with light of 445 nm and therefore this wavelength is preferred. However, the
switching with 405 nm and 488 nm could enable simultaneous on- (Sc10, Sc21) or off-
switching (Ru63, Ru85, Ru87) of the red RSFPs along with green RSFPs in dual color
RESOLFT microscopy [98]. In addition, a higher switching wavelength is desirable to
reduce phototoxicity in living cells while imaging [118], but probably the switching times
need to be prolonged or the switching intensities needed to be increased, if light of 488 nm
instead of 445 nm is used for switching.
The application of different wavelengths for on-switching was also investigated for
rsFusionRed2 and rsFusionRed3 by Pennacchietti et al. [118]. There, the switching
wavelengths 405 nm, 488 nm and 510 nm were compared. They observed a lower switching
fatigue when applying light of 510 nm for on-switching. This is in contrast to the findings
of this work, which did not find significant variations for the switching with 405 nm, 445 nm
and 488 nm. The differences of both studies might result from the fact, that
Pennacchietti et al. did not adjust the light intensities to obtain comparable switching
kinetics [118] for the different switching wavelengths as it was done in this work.
4.2.6 Future perspective of the novel red RSFPs
Five novel monomeric and red-emitting RSFPs with high switching contrast were
developed and characterized in this work. Further mutagenesis and screening could be
applied to identify even further improved red RSFPs in the future, for example switchable
mScarlet variants with higher photostability. The application of the screening based on the
expression in K21 cells might further improve the molecular brightness and the expression
in mammalian cells. X-ray crystallography of on- and off-switched crystals [40] or time-
resolved serial femtosecond crystallography [190] could give insights into the switching
mechanism of the novel RSFPs, which could also guide the rational choice of further
mutation sites to improve these proteins.
The characteristics of the RSFPs generated in this work suggest an applicability in live-cell
RESOLFT microscopy. However, only for Ru63 a RESOLFT image with a resolution lower
than the diffraction limit has already been acquired. In the future, RESOLFT microscopy
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with Sc10 and Sc21 might be established and a detailed search for suitable switching
schemes could improve the resolution for RESOLFT microscopy utilizing Ru63.
Furthermore, different fusion constructs and different switching wavelengths like 405 nm,
488 nm and 590-595 nm could be tested [98, 118]. A parallelized RESOLFT strategy or smart
scanning could shorten the imaging times or reduce photobleaching during imaging [118,
129, 130].
This work focused on the application of red RSFPs in RESOLFT microscopy. However, the
application in other super-resolution methods like photochromic stochastic optical
fluctuation imaging (pcSOFI) [191] or protected STED [94] could be evaluated for the novel
red RSFPs in future experiments. In addition, the RSFPs might be tested for optoacoustic
imaging [192] and the observed photochromic behavior of Sc10 and Sc21 could allow the
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Table 8: Primers for cloning of fluorescent protein genes into pBad/His B.
























































Figure 6.1-1: Bxb1 landing pad donor plasmid with Bxb1 recombinase.
Only the restriction sites used for cloning are shown.
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Figure 6.1-2: Bxb1 landing pad donor plasmid 2 used in this work.
Only the restriction sites used for cloning are shown.


























Figure 6.1-3: Basic integration plasmid pInt-MCS-P2A-HygroR.
Only restrictions sites in the MCS and restrictions sites used for cloning are shown.
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Table 9: Primers for cloning of the Bxb1 landing pad donor plasmid.














Table 10: Primers for cloning of integration plasmids.














Table 11: Generated integration plasmids with lab ID.
MCS: see Figure 6.1-3.
















Table 12: Primers for cloning of specific integration plasmids.
Amplicon Primer sequence (5' to 3') Lab ID
mEGFP, mCherry CGTTCTAGAGCCGCCACCATGGTGAGCAAGGGCGAGGA 7596
mEGFP, mCherry GCTGGATCCCTTGTACAGCTCGTCCATGCCG 7597
mRuby2, Ru63 CGTTCTAGAGCCGCCACCATGGTGTCTAAGGGCGAAGAG 7598
mRuby2 GCTGGATCCCTTGTACAGCTCGTCCATCCCA 7599
mRuby2, Ru63 TCGAAGCTTAGGCATGGTGTCTAAGGGCGAAGA 7602
mEGFP TCGAAGCTTAGGCATGGTGAGCAAGGGCGAGGA 7761
mEGFP AACGAATTCCTTGTACAGCTCGTCCATGCCG 8185
mRuby2, Ru63 AACGAATTCCTTGTACAGCTCGTCCATCCCA 8186
Table 13: Primers used for cloning of mammalian expression plasmids.



































Figure 6.1-4: Plasmid map of Caveolin1-mEGFP-N.
Caveolin1: 597-1130; mEGFP: 1161-1880
Figure 6.1-5: Plasmid map of pcDNA3.1_Lifeact-EGFP.
Lifeact: 924-974; EGFP: 996-1709.
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Table 14: Primers used for mutagenesis of mRuby2 and mScarlet variants.
[Phos] indicates 5’ phosphorylation of the respective primer.








































Table 15: Primers used in genotyping PCRs for generated monoclonal cell lines.
Monoclonal cell













































6.2 Sequence alignments of the novel RSFPs with their template
proteins
Figure 6.2-1: Sequence alignment of mRuby2 and final positive-switchable variants.
Amino acid sequences of mRuby2, Ru63, Ru85 and Ru87. Mutations are highlighted in yellow.
Figure 6.2-2: Sequence alignment of mScarlet and final negative-switchable variants.
Amino acid sequences of mScarlet, Sc10 and Sc21. Mutations are highlighted in yellow.
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6.3 Isolation and characterization of fluorescent proteins
Figure 6.3-1: SDS-PAGE of purified fluorescent protein solutions.
The purity of the isolated fluorescent protein samples was controlled in SDS-PAGE. 2 µg protein was added to
each lane. Marker: PageRuler Prestained Ladder. A: Isolated switchable mRuby2 variants and proteins for
comparison. B: Isolated switchable mScarlet variants and proteins for comparison. C: Isolated FusionRed,
rsFusionRed2 and rsFusionRed3 samples.
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Figure 6.3-2: Comparison of line profiles in the RESOLFT and confocal image using Ru63.
Line profiles at the same positions in the confocal and RESOLFT image of keratin-Ru63 in Figure 3.2-18. The
data was fitted using a Lorentz function. Red:  RESOLFT, black: confocal image. A: Line profile 1, B: Line
profile 2 in Figure 3.2-18. Due to shifts in the field of view, the position of the maximal fluorescence is shifted
from the RESOLFT to the confocal image.
Table 16: Determination of ε and QY for rsFusionRed2 and rsFusionRed3.
Protein Purification ε [M-1cm-1] QY [%] Brightness
rsFR2
1 10381 7.7 0.80
2 7853 7.8 0.61
3 18413 6.6 1.22
4 25101 6.6 1.66
Average 15437 7.2 1.07
STDEV 7860 0.7 0.46
rsFR3
1 11020 5.8 0.64
2 9631 5.8 0.56
3 17660 5.2 0.92
4 22678 4.6 1.04
Average 15247 5.4 0.79
STDEV 6068 0.6 0.23
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Abbreviations
AAVS1  adeno-associated virus integration site 1
Abs   absorption
APS   ammonium persulfate
a.u.   arbitrary unit
bp   base pair
BSA   bovine serum albumin
CMV cytomegalovirus
codEGFP  mEGFP with altered codon usage at the N- and C-terminus
CRISPR  clustered regularly interspaced short palindromic repeats
DMEM  Dulbecco’s modified Eagle’s medium
DNA    deoxyribonucleic acid
dNTP   deoxyribonucleotide triphosphate
ε   extinction coefficient
E. coli    Escherichia coli
EDTA   ethylenediaminetetraacetic acid
Em   emission
ep   error-prone
eq.   equilibrium
ER   endoplasmic reticulum
Exc   excitation
FACS   fluorescence activated cell sorting
FBS   fetal bovine serum
FP   fluorescent protein
FRET   fluorescence resonance energy transfer
FWHM  full width at half maximum
GFP    green fluorescent protein
gRNA    guide ribonucleic acid
HAL/HAR  homology arm left/right
HygroR  Hygromycin resistance
KanR   Kanamycin resistance
LB   lysogeny broth
MCS   multiple cloning site
MINFLUX  nanoscopy with minimal photon fluxes
162
NA    numerical aperture
P2A   porcine teschovirus-1 2A self-cleaving peptide
PAGE    polyacrylamide gel electrophoresis
PALM   photoactivatable localization microcopy
PBS    phosphate-buffered saline
PCR   polymerase chain reaction
PSF   point spread function
PuroR   Puromycin resistance
QY   quantum yield
RESOLFT  reversible saturable optical fluorescence transitions
RSFP    reversibly switchable fluorescent protein
SDS    sodium dodecyl sulfate
SIM   structured illumination microscopy
STED    stimulated emission depletion
SV40   simian virus 40
T2A  thosea asigna virus 2A self-cleaving peptide
TEMED   tetramethylethylenediamine
Tris    tris(hydroxymethyl)aminomethane
wt   wild-type
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